ziprasidone has been researched along with thiazoles in 912 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 26 (2.85) | 18.2507 |
| 2000's | 503 (55.15) | 29.6817 |
| 2010's | 353 (38.71) | 24.3611 |
| 2020's | 30 (3.29) | 2.80 |
| Authors | Studies |
|---|---|
| Cole, RO; Fouda, HG; Janiszewski, JS | 1 |
| Guanowsky, V; Howard, HR; Lebel, LA; Lowe, JA; McLean, S; Schmidt, AW; Schulz, DW; Seeger, TF; Seymour, PA; Zorn, SH | 1 |
| Bench, CJ; Cuddigan, M; Dolan, RJ; Frackowiak, RS; Grasby, PM; Gunn, K; Lammertsma, AA; Osman, S; Turton, DJ; Warrington, SJ | 1 |
| Skarsfeldt, T | 1 |
| Bench, CJ; Brooks, DJ; Frackowiak, RS; Gunn, K; Hume, SP; Lammertsma, AA; Osman, S | 1 |
| Lahti, AC; Tamminga, CA | 1 |
| Alpert, NM; Babich, JW; Bonab, AA; Elmaleh, DR; Fischman, AJ; Rauch, SL; Rubin, RH; Shoup, TM; Williams, SA | 1 |
| Bench, CJ; Boyce, M; Brannick, LY; Dolan, RJ; Frackowiak, RS; Grasby, PM; Gunn, KP; Lammertsma, AA; Warrington, SJ | 1 |
| Anderson, W; Howard, H; Kamel, A; Prakash, C | 1 |
| Fouda, H; Hoffmaster, K; Janiszewski, J; Schneider, P; Swyden, M; Wells, D | 1 |
| Gummerus, J; Kamel, A; Prakash, C; Wilner, K | 1 |
| Cui, D; Kamel, A; Prakash, C | 1 |
| Davidson, M; Levy, A; Weizer, M | 1 |
| Goff, DC; Herz, L; Kletti, N; Ko, GN; Lapierre, K; Law, CG; Posever, T; Simmons, J; Wilner, KD | 1 |
| de Boer, P; de Vries, JB; Kruse, CG; Long, SK; Westerink, BH | 1 |
| Buffenstein, A; Feighner, J; Ferguson, J; Harrigan, EP; Jaffe, W; Keck, P; Morrissey, MR | 1 |
| Blake, JF; Chrunyk, B; Duffy, EM; Kim, Y; Massefski, W; Oksanen, DA | 1 |
| Kane, JM | 3 |
| Daniel, DG; Harrigan, EP; Lakshminarayanan, M; Potkin, SG; Reeves, KR; Zimbroff, DL | 1 |
| Blakely, RD; Jansen, K; Richelson, E; Tatsumi, M | 1 |
| Allison, DB; Cappelleri, JC; Chandler, LP; Cheskin, LJ; Fontaine, KR; Heo, M; Mentore, JL; Weiden, PJ | 1 |
| Braselton, JP; Reynolds, LS; Rollema, H; Sprouse, JS; Zorn, SH | 1 |
| Allison, DB; Cappelleri, JC; Chandler, LP; Heo, M; Infante, MC; Mentore, JL; Weiden, PJ | 1 |
| Bayle, FJ; Ghaoui, S; Olie, JP | 1 |
| Awad, AG; Voruganti, LN | 1 |
| Chappell, PB; Dittman, VM; Goetz, CG; Kurlan, R; Law, G; Sallee, FR; Scahill, L; Singer, H | 1 |
| Keck, PE; McElroy, SL; Strakowski, SM | 1 |
| Tandon, R | 1 |
| Apseloff, G; Gerber, N; Hansen, RA; Johnson, AC; Miceli, JJ; Wilner, KD | 1 |
| Baris, B; Colburn, WA; Hansen, RA; Smolarek, TA; Tensfeldt, TG; Turncliff, RZ; Wilner, KD | 1 |
| Anderson, KE; Anziano, RJ; Bauer, LA; Carithens, RL; Everson, G; Johnson, A; Lasseter, KC; Smolarek, TA; Turncliff, RZ; Wilner, KD | 1 |
| Anziano, RJ; Aweeka, F; Horton, M; Jayesekara, D; Lambrecht, L; Sherwood, J; Smolarek, TA; Swan, S; Turncliff, RZ; Wilner, KD | 1 |
| Cui, D; Kamel, A; Miceli, JJ; Prakash, C; Tweedie, D; Whalen, RD | 1 |
| Anziano, RJ; Apseloff, G; Demattos, SB; Gerber, N; Wilner, KD | 1 |
| Anziano, RJ; Harness, J; Holt, PR; Muirhead, GJ; Oliver, S | 1 |
| Folger, CJ; Geoffroy, P; Hansen, RA; Wilner, KD | 1 |
| Anziano, RJ; Apseloff, G; Gerber, N; Mullet, D; Pelletier, SM; Tensfeldt, TG; Wilner, KD | 1 |
| Anziano, RJ; Hansen, RA; Laurent, A; Miceli, JJ; Robarge, L | 1 |
| Laurent, A; Miceli, JJ; Morse, T; Robarge, L; Smith, M | 1 |
| Barnes, M; Burton, S; Harrison, K; Heslop, K | 1 |
| Bagnall, A; Kleijnen, J; Leitner, ML; Lewis, RA | 1 |
| Möller, HJ | 1 |
| McAskill, R; Taylor, DM | 1 |
| Lu, Y; Rollema, H; Schmidt, AW; Sprouse, JS; Zorn, SH | 1 |
| Bagnall, A; Leitner, ML; Lewis, RA | 1 |
| Copeland, LF; Daniel, DG | 1 |
| Kapur, S; Remington, G | 1 |
| Harrigan, EP; Keck, PE; Reeves, KR | 1 |
| Hilger, E; Kasper, S | 1 |
| Brook, S; Gunn, KP; Lucey, JV | 1 |
| Harrigan, EP; Lesem, MD; Reeves, KR; Swift, RH; Zajecka, JM | 1 |
| Cañas, F | 1 |
| Casey, DE; Zorn, SH | 1 |
| Dekeyne, A; Gobert, A; Millan, MJ; Rivet, JM | 1 |
| Daniel, DG; Harrigan, EP; Potkin, SG; Reeves, KR; Swift, RH | 1 |
| Carnahan, RM; Lund, BC; Perry, PJ | 1 |
| Fayek, M; Kingsbury, SJ; Simpson, GM; Trufasiu, D; Zada, J | 1 |
| Silva, RR | 1 |
| Hirsch, M | 1 |
| Howard, HR; Lebel, LA; Schmidt, AW; Zorn, SH | 1 |
| Arnold, LM; Keck, PE; McElroy, SL | 1 |
| Sussman, N | 1 |
| Millan, MJ; Newman-Tancredi, A; Touzard, M; Verrièle, L | 1 |
| Weizman, A; Weizman, R | 1 |
| Green, B | 1 |
| Goodnick, PJ | 1 |
| Gutierrez, MA; Lee, V; Stimmel, GL | 1 |
| Dai, J; Fowler, WL; Ichikawa, J; Meltzer, HY; O'Laughlin, IA | 1 |
| McIntyre, RS | 1 |
| Anziano, RJ; Fricke, JR; Johnson, AC; Miceli, JJ; Titus, CK; Wilner, KD | 1 |
| Davis, R; Risch, SC | 1 |
| Nomikos, GG; Rodriguez, DE; Shirazi-Southall, S | 1 |
| Albert, MJ; Baldessarini, RJ; Centorrino, F; Kelleher, JP | 1 |
| Caley, CF; Cooper, CK | 1 |
| Gunasekara, NS; Keating, GM; Spencer, CM | 2 |
| Crismon, L; Dorson, PG; Patel, NC; Sierk, P | 1 |
| House, M | 1 |
| Taylor, DM | 1 |
| Bäuml, J; Hirsch, SR; Kissling, W; O'Connor, R; Power, A | 1 |
| Cussac, D; Duqueyroix, D; Millan, MJ; Newman-Tancredi, A | 1 |
| Boeker, T | 1 |
| McNeely, MJ; Yang, SH | 1 |
| Ghaemi, SN; Rosenquist, KJ; Walker, SS | 1 |
| Kem, DL; McDougle, CJ; Posey, DJ | 1 |
| Mack, JE; Reeves, RR | 1 |
| Arato, M; Meltzer, HY; O'Connor, R | 1 |
| Jessen, LM | 1 |
| Alamy, SS; Jarskog, LF; Lieberman, JA; Sheitman, BB; Spivak, B | 1 |
| Bellnier, TJ | 1 |
| Hussar, DA | 1 |
| Chowdhury, WA; Firoz, AH; Mamun, AA; Rahman, AH | 1 |
| Kelly, DL; Love, RC | 1 |
| Chacko, RC; Mistry, SG; Murty, RG | 1 |
| Jordan, MP | 1 |
| Daniel, DG | 2 |
| Escalona, PR; Lu, BY; Lundgren, R; Roberts, BB | 1 |
| Danileviciūte, V | 1 |
| Cohen, S; Fitzgerald, B; Khan, A; Khan, S; Okos, A | 1 |
| Kimble, R; Reeves, RR | 1 |
| Kalkman, HO; Loetscher, E | 1 |
| Kaye, NS | 2 |
| Biswas, AK; Mayes, KL; Morris-Kukoski, CL; Zabrocki, LA | 2 |
| Baldassano, CF; Ballas, C; Datto, SM; Kim, D; Littman, L; O'Reardon, J; Rynn, MA | 1 |
| Ichikawa, J; Li, Z; Meltzer, HY | 1 |
| Giller, E; Ice, K; Keck, PE; Potkin, S; Versiani, M; West, SA | 1 |
| Bryant, SM; Costerisan, DD; Cumpston, KL; Magdziarz, DD; Zilberstein, J | 1 |
| Abdul-Monim, Z; Neill, JC; Reynolds, GP | 1 |
| Taylor, D | 1 |
| Leander, JD; Wolff, MC | 1 |
| Nolan, BP; Schulte, JJ | 1 |
| O'Sullivan, RL; Potkin, SG; Simpson, GM; Weiden, PJ | 1 |
| Bailey, RK | 1 |
| Freeman, MP; Gelenberg, AJ; Gnanadesikan, M | 1 |
| Woods, SW | 1 |
| Beedham, C; Miceli, JJ; Obach, RS | 1 |
| Teich, J | 1 |
| Jensen, PN; Stenstrøm, AD | 1 |
| Gilbert, DL; Miceli, JJ; Robarge, L; Sallee, FR; Vinks, AA; Wilner, K | 1 |
| Alessi, NE | 1 |
| Hauser, A; Larson, MF | 1 |
| Ramos, AE; Sanberg, PR; Shytle, RD; Silver, AA | 1 |
| Hedges, D; Jeppson, K; Whitehead, P | 1 |
| Lieberman, JA; Stroup, TS | 1 |
| Harvey, PD; Romano, S; Siu, CO | 1 |
| Daniel, DG; Romano, SJ; Simpson, G; Weiden, PJ | 1 |
| Sathpathy, S; Winsberg, B | 1 |
| Kropp, S; Schomerus, G; Ziegenbein, M | 1 |
| Cates, ME | 1 |
| Maharaj, K; Privitera, MR | 1 |
| Cooper, TB; Correll, CU; Fein, M; Suckow, RF | 1 |
| Tamminga, CA | 1 |
| Binder, EB; Holsboer, F; Keck, ME; Müller, MB; Sonntag, A | 1 |
| Shayegan, DK; Stahl, SM | 2 |
| Brook, S | 1 |
| Schooler, NR | 1 |
| Harvey, PD | 1 |
| Cohen, SA; Fitzgerald, BJ; Khan, A; Khan, SR | 1 |
| Brieger, P | 1 |
| Connemann, BJ; Schönfeldt-Lecuona, C | 1 |
| Bonelli, RM; Kapfhammer, HP; Mayr, BM; Niederwieser, G; Reisecker, F | 1 |
| Mandrioli, R; Pucci, V; Raggi, MA; Sabbioni, C | 1 |
| Buckley, PF; Glazer, W; Sebastian, CS | 1 |
| Berardi, D; De Ronchi, D; Lorenzi, C; Serretti, A | 1 |
| Coffey, B | 1 |
| Bantick, RA; de Vries, MH; Grasby, PM; Hirani, E; Hume, SP; Rabiner, EA | 1 |
| Correll, CU; Kane, JM; Leucht, S | 1 |
| Alpert, JE; Fava, M; Murakami, JL; Nierenberg, AA; Papakostas, GI; Petersen, TJ; Rosenbaum, JF | 1 |
| Levy, WO; Nunez, CY | 1 |
| Bitter, I | 1 |
| Cremonese, E; Garrido, R | 1 |
| Harvey, PD; Loebel, A; Meltzer, H; Potkin, SG; Romano, SJ; Simpson, GM; Siu, C | 1 |
| Gray, NS | 1 |
| Lublin, HK | 1 |
| Daniel, DG; Harrigan, EP; Swift, RH; Zimbroff, DL | 1 |
| Aboul-Enein, HY; El-Houssini, OM; El-Sherif, ZA; El-Zeany, B; Rashed, MS | 1 |
| Findling, RL; McNamara, NK | 1 |
| Loebel, A; Romano, S; Siu, C | 1 |
| Jaffe, R; Leavitt, R; Wind, T | 1 |
| Buchanan, RW; Buckley, PF; Chiles, JA; Conley, RR; Crismon, ML; Ereshefsky, L; Essock, SM; Finnerty, M; Hall, CS; Marder, SR; McEvoy, JP; Miller, A; Miller, DD; Rush, AJ; Saeed, SA; Schooler, NR; Shon, SP; Stroup, S; Tarin-Godoy, B | 1 |
| Kapur, S; Mamo, D; Mann, S; Papatheodorou, G; Remington, G; Shammi, CM; Therrien, F | 1 |
| Gaszner, G; Kosza, P | 1 |
| Martel, ML | 1 |
| McDougle, CJ; Meighen, KG; Shelton, HM | 1 |
| Assion, HJ; Schwenkreis, P | 1 |
| Dressing, H; Mase, E; Zink, M | 2 |
| Barnett, MS | 2 |
| Møller, P | 1 |
| Ewing, JD; Rund, DA; Votolato, NA | 1 |
| Davids, E; Gastpar, M; Hartwig, U | 1 |
| Ravasia, S; Swensen, E | 1 |
| Ross, DE | 2 |
| Barbee, JG; Conrad, EJ; Jamhour, NJ | 1 |
| Arnold, G; Meisel, A; Winter, C; Zschenderlein, R | 1 |
| Lujan, E; Young, CC | 1 |
| Aakhus, E | 1 |
| Hasan, RA; Leibold, J; Patel, V | 1 |
| Andersen, MP; Hogg, S; Pouzet, B | 1 |
| Dew, RE; Hughes, D | 1 |
| Alvarez, E; Barrachina, J; Oller, S; Pascual, JC; Pérez, V; Soler, J | 1 |
| Anghelescu, I; Wolf, J | 1 |
| Curtis, LH; Dans, PE; Hutchison, S; Krishnan, RR; Masselink, LE; Schulman, KA; Wright, A; Østbye, T | 1 |
| Andrade, C | 1 |
| Glick, ID; Romano, SJ; Simpson, GM; Siu, CO; Weiden, PJ | 1 |
| Cancro, R; Chuang, L; Jacobson, J; Lusskin, SI | 1 |
| Bryois, Ch; Sahli, Ch | 1 |
| Citrome, L; Volavka, J | 1 |
| Finkel, S | 1 |
| Katz, IR | 1 |
| Levy, WO; Nunez, C; Robichaux-Keene, NR | 1 |
| Jones, DN; Kirk, SL; Neill, JC; Reynolds, GP | 1 |
| Minov, C | 1 |
| Finzel, M; Fric, M; Laux, G | 1 |
| Baldessarini, RJ; Berry, JM; Centorrino, F; Fogarty, KV; Kidwell, JE; MacLean, E; Salvatore, P | 1 |
| Byerly, M; Carmody, T; Holland, R; Li, B; Miller, DR; Montgomery, JH; Varghese, F | 1 |
| Bobes, J; Cañas, F; Mackell, J; Rejas, J | 1 |
| Blair, J; Martin, A; Scahill, L; State, M | 1 |
| Aguilar, Y; Alvarez, E; Carrió, I; Catafau, AM; Corripio, I; Mena, E; Perez, V; Puigdemont, D | 1 |
| Addington, DE; Benattia, I; Dineen, M; Pantelis, C; Romano, SJ | 1 |
| Ananth, J; Burgoyne, KS; Niz, D; Smith, M | 1 |
| Ehret, J; Hazaray, E; McDougle, CJ; Petti, TA; Posey, DJ | 1 |
| Benattia, I; Brook, S; Romano, SJ; Siu, CO; Walden, J | 1 |
| Durkin, JP | 1 |
| Staller, JA | 1 |
| Sánchez-Barranco, P | 1 |
| Bares, M; Kopecek, M; Mohr, P | 1 |
| Blair, J; Leckman, JF; Martin, A; Scahill, L | 1 |
| Brown, RR; Estoup, MW | 1 |
| Khan, A; Preskorn, S; Ramadan, M | 1 |
| Johnson, CE; Mason, MN; Piasecki, M | 1 |
| Crane, DL | 1 |
| Bowie, CR; Harvey, PD | 1 |
| Härtter, S; Hiemke, C; Sachse, J | 1 |
| Allison, DB; Casey, DE; Cope, MB; Fernández, JR; Geary, N; Nagy, TR | 1 |
| Vieta, E | 1 |
| Korchounov, A; Oechsner, M | 1 |
| Dubois, D | 1 |
| Kamel, A; Miao, Z; Prakash, C | 1 |
| Frecska, E; Gaszner, G; Keresztes, M | 1 |
| Baldassano, C; Ballas, C; Ballas, P; O'Reardon, J; Yang, C | 1 |
| Cleveland, NJ; Dewitt, CD; Heard, K | 1 |
| Cosi, C; Newman-Tancredi, A; Rollet, K; Tesori, V; Waget, A | 1 |
| Fell, MJ; Gibson, R; Marshall, KM; McDermott, E; Neill, JC; Sisodia, G | 1 |
| Miceli, JJ; Swan, SK; Tensfeldt, TG; Wilner, KD | 1 |
| Kuehn, BM | 2 |
| Goikolea, JM; Vieta, E | 1 |
| Benabarre, A; Bernardo, M; Prieto, T | 1 |
| Bartholomä, A; Gregor, A; Hein, J; Heinz, A; Juckel, G | 1 |
| Baker, TM; Matza, LS; Revicki, DA | 1 |
| Cole, SA; Jyringi, D; Sablosky, M; Saleem, R; Sedler, M; Shea, WP; Smith, A | 1 |
| Matsui-Sakata, A; Ohtani, H; Sawada, Y | 1 |
| Jansson, E; Melkersson, K | 1 |
| Christensen, JD; Garver, DL; Holcomb, JA | 1 |
| Carnahan, RM; Perry, PJ | 1 |
| Altschuler, EL; Kast, RE | 1 |
| Bruins Slot, LA; Kleven, MS; Newman-Tancredi, A | 1 |
| English, P; Ice, K; Keck, PE; Potkin, SG; Segal, S | 1 |
| Brown, FW; Greco, KE; Tune, LE; Van Horn, WA | 1 |
| Eckholdt, P; LoVecchio, F; Watts, D | 1 |
| Hwang, JP; Tsai, CF; Tsai, SJ | 1 |
| Murray, S; Pigott, T; Romano, SJ; Simpson, GM; Siu, CO; Weiden, P | 1 |
| Cohrs, S; Jordan, W; Meier, A; Neumann, AC; Rodenbeck, A; Rüther, E | 1 |
| Berk, M; Bourin, M; Dodd, S; Ivanovski, B; Lagopoulos, J; Malhi, GS; Mitchell, PB | 1 |
| Cohrs, S; Huether, G; Jordan, W; Meier, A; Neumann, AC; Rodenbeck, A; Rüther, E | 1 |
| Zaidi, AN | 1 |
| Geddes, J | 1 |
| Lin, CL; Luu, SU; Mao, WC; Shiah, IS | 1 |
| Rickels, K; Rynn, MA; Snyderman, SH | 1 |
| Cahill, CM; Hardiman, O; Murphy, KC | 1 |
| Aboul-Enein, HY; Al-Dirbashi, OY; Al-Odaib, A; Jacob, M; Rashed, MS | 1 |
| Grossi, P; Kanter, Rd; Monaci, S; Monshouwer, M; Turlizzi, E; Vignati, L | 1 |
| Davis, CE; Davis, SM; Hsiao, JK; Keefe, RS; Lebowitz, BD; Lieberman, JA; McEvoy, JP; Perkins, DO; Rosenheck, RA; Severe, J; Stroup, TS; Swartz, MS | 1 |
| Duggal, HS; Singh, I | 3 |
| Berg, PH; Breier, A; Cavazzoni, P; Gattaz, WF; Kane, JM; Naber, D; Roychowdhury, SM; Thakore, JH; Walker, DJ | 1 |
| Baser, O; Engelhart, L; Finkel, S; Greenspan, A; Kozma, C; Long, S; Mahmoud, R | 1 |
| Chen, Y; Hop, CE; Yu, LJ | 1 |
| Preskorn, SH | 2 |
| Ayani, I; Bernardo, M; Florez, Td; Gandía, R; Gómez-Criado, MS; Gutiérrez, JR | 1 |
| Allen, MH; Battaglia, J; Citrome, L; Fishkind, A; Francis, A; Herr, DL; Hughes, D; Martel, M; Preval, H; Ross, R; Zimbroff, DL | 1 |
| Mendhekar, DN | 1 |
| Papapetropoulos, S; Singer, C; Wheeler, S | 1 |
| Biros, M; Clinton, J; Martel, M; Miner, J; Sterzinger, A | 1 |
| Obach, RS; Walsky, RL | 1 |
| Clifton, PG; Hartfield, AW; Moore, NA | 1 |
| Howland, RH | 1 |
| Artigas, F; Bortolozzi, A; Celada, P; Díaz-Mataix, L; Scorza, MC; Toth, M | 1 |
| Jayathilake, K; Meltzer, HY; Roy, A; Sumiyoshi, C; Sumiyoshi, T | 1 |
| Giller, E; Kane, JM; Khanna, S; Rajadhyaksha, S | 1 |
| Bozikas, VP; Fokas, K; Garyfallos, G; Giouzepas, J; Nikolaidis, N; Xomalis, D | 1 |
| Chen, J; Cox, BF; Gintant, GA; Gopalakrishnan, M; Martin, RL; McDermott, JS; Su, Z | 1 |
| Bhatia, SC; Marcil, WA; Petty, F; Ramaswamy, S; Siddiqui, Z | 1 |
| Cilia, J; Cluderay, JE; Gartlon, J; Jennings, CA; Jones, DN; Lloyd, A; Southam, E | 1 |
| Bilal, L; Gasper, JJ; Ndlela, JC; Tsai, C | 1 |
| Bond, LC; Borovicka, MC; Gaughan, KM | 1 |
| Hwang, J; Kaufman, KR; Mohebati, A; Olsavsky, A; Stern, L | 1 |
| Annable, L; Beauclair, L; Chouinard, G; Kolivakis, TT; Margolese, HC; Miller, R | 1 |
| Adams, DH; Kinon, BJ; Liu-Seifert, H | 1 |
| Daniel, DG; Harvey, PD; Kilts, CD; Lieberman, JA; Nemeroff, CB; Newcomer, JW; Schatzberg, AF; Weiden, PJ | 1 |
| Blow, FC; Dalack, GW; Ignacio, RV; McCarthy, JF; Stavenger, T; Valenstein, M | 1 |
| Luchins, DJ | 1 |
| Hsiao, JK; Lieberman, JA | 1 |
| Banks, SM; Pandiani, JA | 1 |
| Anders, JL | 1 |
| Anghelescu, IG; Dettling, M | 1 |
| Correll, CU | 1 |
| Bossie, CA; Canuso, CM; Gharabawi, GM; Greenspan, A; Lasser, RA; Mahmoud, R; Turkoz, I | 1 |
| Bitter, I; Jones, RM; Thompson, C | 1 |
| Axelband, J; Fulton, JA; Heller, MB; Jacoby, JL | 1 |
| Francis, A; Kohen, I; Preval, H; Southard, R | 1 |
| Altinbas, K; Demirkiran, S; Oral, ET | 1 |
| Stone, AM | 1 |
| Bowie, CR; Harvey, PD; Loebel, A | 1 |
| Murray, S; Olié, JP; Spina, E; Yang, R | 1 |
| Canive, JM; Khan, A; Lieberman, JA; McEvoy, JP; McGee, M; Miller, DD; Reimherr, F; Rosenheck, RA; Stroup, TS; Swanson, JW; Swartz, MS; Van Dorn, R; Wagner, HR | 1 |
| Birinyi-Strachan, L; Davey, P; Kongsakon, R; Leelahanaj, T; Price, N | 1 |
| Kostulski, A; Rabe-Jabłońska, J; Wyszogrodzka-Kucharska, A | 1 |
| Carter, CT; Harrison, DJ; Joyce, AT; Loebel, AD; Ollendorf, DA | 1 |
| Harrison, DJ; Mullins, CD; Naradzay, J; Obeidat, N; Shaya, FT; Zito, JM | 1 |
| Gianfrancesco, FD; Rajagopalan, K; Sajatovic, M; Wang, RH | 2 |
| Adler, CM; Strakowski, SM; Weinstein, SK | 1 |
| Jones, DN; Kalinichev, M; Rourke, C | 1 |
| Savas, E; Savas, HA; Selek, S; Yumru, M | 1 |
| Chen, CK; Chen, HK; Hu, MC; Shiah, IS; Yeh, CB | 1 |
| Davis, CE; Davis, SM; Hsiao, JK; Keefe, RS; Lieberman, JA; McEvoy, JP; Meltzer, HY; Perkins, DO; Rosenheck, RA; Severe, J; Stroup, TS; Swartz, MS | 1 |
| Davis, CE; Davis, SM; Hsiao, JK; Keefe, RS; Lieberman, JA; McEvoy, JP; Perkins, DO; Rosenheck, RA; Severe, J; Stroup, TS; Swartz, MS | 1 |
| Boettger, S; Breitbart, W | 1 |
| Chou, YH; Ku, HL; Su, TP | 1 |
| Adams, DH; Ascher-Svanum, H; Edwards, SB; Kinon, BJ; Lipkovich, I; Siris, SG | 1 |
| Brook, S; Citrome, L; Czobor, P; Loebel, A; Mandel, FS; Volavka, J | 1 |
| Keck, PE; Strawn, JR | 1 |
| Friedman, AB; Li, X; Rosborough, KM; Roth, KA; Zhu, W | 1 |
| Gearhart, DA; Hohnadel, E; Mahadik, SP; Nasrallah, HA; Parikh, V; Pillai, A; Terry, AV; Warner, S | 1 |
| Doraiswamy, PM; Levine, JG; Szarfman, A; Tonning, JM | 1 |
| Calliess, IT; Ziegenbein, M | 1 |
| Chappell, P; Loebel, A; Miceli, J; Siu, C | 1 |
| Miceli, JJ; Patel, NC; Robarge, L; Sallee, FR; Tensfeldt, T; Wilner, K | 1 |
| Alvarez, E; Barrachina, J; Campins, MJ; Madre, M; Pascual, JC; Pérez, V; Soler, J | 1 |
| Versiani, M | 1 |
| de Beaurepaire, R; Even, PC; Lacroix, M; Minet-Ringuet, J; Tomé, D | 1 |
| Bowie, C; Green, MF; Harvey, PD; Loebel, A | 1 |
| Barak, Y; Baruch, Y; Mazeh, D; Plopski, I | 1 |
| Akkaya, C; Kirli, S; Kotan, Z; Sarandol, A; Sivrioglu, EY | 1 |
| Bates, JA; Burdick, KE; Kane, JM; Malhotra, AK; Razi, K; Sanders, M | 1 |
| Ehret, MJ; Levin, GM | 1 |
| Keck, PE; Patel, NC | 1 |
| Campbell, L; Cato, KJ; Clarke, K; Davies, CH; Gordon, L; Gribble, A; Heath, J; Jones, DN; Patel, N; Riley, G; Scott, C; Wood, MD; Worby, A | 1 |
| Bies, RR; Chew, ML; Gharabawi, G; Greenspan, A; Kapur, S; Kirshner, MA; Lehman, ME; Mulsant, BH; Pollock, BG | 1 |
| de Leon, J; Diaz, FJ; Markham-Abedi, C; McNeely, C; Villanueva, N | 1 |
| Schindehütte, J; Trenkwalder, C | 1 |
| Coffey, B; Jummani, R; Vito, J | 1 |
| de Oliveira Lança, G; Hara, C; Kascher, GG; Magalhães Scoralick, F; Ramos, MG; Rocha, FL; Santos, MA | 1 |
| Baumgartner, S; Ebenbichler, C; Edlinger, M; Fleischhacker, WW; Hofer, A; Hummer, M; Kemmler, G; Lechleitner, M; Rettenbacher, MA | 1 |
| Naber, D; Phillips, GA; Roychowdhury, SM; Van Brunt, DL; Xu, W | 1 |
| Calandre, EP; Hidalgo, J; Rico-Villademoros, F | 1 |
| Correll, CU; Frederickson, AM; Kane, JM; Manu, P | 1 |
| Aravagiri, M; Marder, SR; Pollock, B | 1 |
| Adams, DH; Citrome, L; Kinon, BJ; Liu-Seifert, H | 1 |
| Gil, R; Girgis, RR; Rosenfield, PJ | 1 |
| Balbo, E; Delgado, JF; Diez, T; Martin, E; Montes, JM; Rodriguez, JL; Sopelana, P; Soto, JA; Villardaga, I | 1 |
| Scott, LJ; Swainston Harrison, T | 1 |
| Domin, S; Kasper, S; Kudla, D; Lambert, M; Naber, D | 1 |
| Bernardo, M; Ramón Azanza, J; Rejas, J; Rubio-Terrés, C | 1 |
| De Oliveira, IR; Juruena, MF | 1 |
| Khan, SS; Mican, LM | 1 |
| Bartkó, G; Bitter, I; Degrell, I; Faludi, G; Füredi, J; Trixler, M | 1 |
| Carpéné, C; Daviaud, D; de Beaurepaire, R; Even, PC; Minet-Ringuet, J; Prévot, D; Quignard-Boulange, A; Tomé, D; Valet, P; Visentin, V | 1 |
| Citrome, L; Jaffe, A; Levine, J | 2 |
| Chahine, LM; Chemali, ZN | 1 |
| Karanti, A; Landén, M | 1 |
| Chirivella, J; Ferri, J; Noé, E; Trénor, C | 1 |
| Capuano, G; Davis, SM; Hsiao, JK; Keefe, RS; Lieberman, JA; McEvoy, JP; McGee, MF; Perkins, DO; Reimherr, F; Rosenheck, RA; Stroup, TS; Swartz, MS | 1 |
| Duggal, HS | 3 |
| Cansel, N; Herken, H; Ozen, ME; Savas, HA; Yumru, M | 1 |
| Gomberg, R | 1 |
| Mellacheruvu, S; Norton, JW; Schweinfurth, J | 1 |
| Gianfrancesco, F; Goldberg, JF; Rajagopalan, K; Wang, RH | 1 |
| Akkaya, C; Aydogan, K; Kirli, S; Sarandol, A | 1 |
| Altschuler, EL; Focosi, D; Kast, RE; Petrini, M | 1 |
| Aukst-Margetic, B; Margetic, B | 1 |
| Delgado, SV; Saldaña, SN | 1 |
| Bowie, CR; Buckley, PF; Harvey, PD; Loebel, A | 1 |
| Colasanti, A; Dragogna, F; Fiorentini, A; Mauri, MC; Papa, P; Rossattini, M; Valli, A; Volonteri, LS | 1 |
| Bilder, RM; Capuano, G; Davis, CE; Davis, SM; Gold, JM; Green, MF; Harvey, PD; Hsiao, JK; Keefe, RS; Lieberman, JA; McEvoy, JP; Meltzer, HY; Palmer, BW; Perkins, DO; Rosenheck, RA; Stroup, TS; Swartz, MS | 1 |
| Goodman, C; Silver, H | 1 |
| Jebaraj, P; Rajkumar, AP; Tharyan, P | 1 |
| Cleveland, NR; Heard, K; Krier, S | 1 |
| Anjum, N; Cheetham, S; Dickinson, K; Fell, MJ; Marshall, KM; Neill, JC; Peltola, LM; Vickers, S | 1 |
| Brophy, MH | 1 |
| Cuffel, BJ; Loebel, AD; Mullins, CD; Naradzay, J; Obeidat, NA | 1 |
| Citrome, L; Greenberg, WM | 1 |
| Lebovitz, HE; Loebel, AD; Newcomer, JW; Weiden, PJ; Yang, R | 1 |
| Arolt, V; Baune, BT; Dannlowski, U; Deckert, J; Evers, S; Hetzel, G; Moeller, O; Nguyen, DH | 1 |
| Gibel, A; Ratner, Y; Ritsner, MS; Soifer, P; Yorkov, V | 1 |
| Gibel, A; Ratner, Y; Ritsner, MS; Yorkov, V | 1 |
| Amsterdam, JD; Dunner, DL; Loebel, A; Romano, SJ; Shelton, RC | 1 |
| Dimpfel, W | 1 |
| Cañas, F; Díaz, S; Pérez-Solá, V; Rejas, J | 1 |
| Geiss-Granadia, T; Joukhadar, C; Kasper, S; Klein, N; Lackner, E; Mossaheb, N; Müller, M; Sacher, J; Sauermann, R; Spindelegger, C | 1 |
| Wooten, J | 1 |
| Bian, Q; Hashioka, S; Horikawa, H; Kanba, S; Kato, T; Mizoguchi, Y; Monji, A | 1 |
| Bartlett, MG; Terry, AV; Zhang, G | 2 |
| Barzman, DH; DelBello, MP; Forrester, JJ; Keck, PE; Strakowski, SM | 1 |
| Ice, K; Loebel, A; Lombardo, I; Warrington, L | 1 |
| Chua, SE; Chung, AK | 1 |
| Citrome, L | 5 |
| Giller, E; Khanna, S; Loebel, AD; Potkin, SG; Rajadhyaksha, S; Siu, CO | 1 |
| Loebel, A; Siu, C; Warrington, L; Yang, R; Zimbroff, D | 1 |
| Varma, A; Wickham, R | 1 |
| Allen, MH; Nordstrom, K | 1 |
| Jain, R; Skale, TG | 1 |
| Bick, P; Castle, D; Knoesen, N | 1 |
| Avorn, J; Brookhart, MA; Choudhry, NK; Mogun, H; Patrick, A; Schneeweiss, S; Setoguchi, S; Wang, PS | 1 |
| Alderman, J; Glue, P; Miceli, JJ; Wilner, K | 1 |
| Neill, JC; Snigdha, S | 1 |
| Perlis, RH | 1 |
| de Leon, J; Markham-Abedi, C; McNeely, C | 1 |
| Hoffman, RS; Manini, AF; Nelson, LS; Raspberry, D | 1 |
| Aleardi, M; Biederman, J; Dougherty, M; Mick, E; Spencer, T; Wozniak, J | 1 |
| Bilder, RM; Galluzzo, A; Gorini, B; Harvey, PD; Loebel, AD; Romeo, F; Sacchetti, E | 1 |
| Farina, C; Kenndler, E; Kremser, L; Raggi, MA | 1 |
| Papakostas, GI; Shelton, RC | 1 |
| Neill, JC; Reynolds, GP; Snigdha, S; Thumbi, C | 1 |
| Calabrese, JR; Gajwani, P; Ganocy, SJ; Gao, K; Kemp, DE; Muzina, DJ | 1 |
| Hoffman, RS; Manini, AF; Pearl-Davis, MS; Wu, S | 1 |
| Carpenter, LL; Philip, NS; Price, LH; Tyrka, AR | 1 |
| Alvarez, E; Pascual, JC; Pérez, V; Pérez-Egea, R; Puigdemont, D; Soler, J; Tiana, T | 1 |
| Citil, DY; Karlidağ, R; Selçuk, E; Unal, S | 1 |
| Anjum, N; Fell, MJ; Marshall, KM; Neill, JC; Peltola, LM | 1 |
| D'Agostino, RB; Eng, SM; Faich, GA; Kane, JM; Reynolds, RF; Ruskin, JN; Strom, BL | 1 |
| Cater, JR; Delaney, MA; Hyman, SB; Malone, RP | 1 |
| Clifton, PG; Davoodi, N; Kalinichev, M | 1 |
| Cutler, AJ; Hamilton, J; Kalali, AH; Weiden, PJ; Wolfgang, CD | 1 |
| Mech, AW | 1 |
| Boter, H; Davidson, M; Dollfus, S; Fleischhacker, WW; Gaebel, W; Galderisi, S; Gheorghe, MD; Grobbee, DE; Hranov, LG; Hummer, M; Kahn, RS; Keet, IP; Libiger, J; Lindefors, N; López-Ibor, JJ; Peuskens, J; Riecher-Rössler, A; Rybakowski, JK; Vergouwe, Y | 1 |
| Certa, K; Chism, LM; Mago, R; Pinninti, NR | 1 |
| Eidelman, P; Nierenberg, AA; Smoller, JW; Tilley, CA; Wu, YP | 1 |
| Allingham, B; Citrome, L; Jaffe, A; Levine, J; Martello, D | 1 |
| Davis, SM; Hsiao, JK; Keefe, RS; Lieberman, JA; McEvoy, JP; Rosenheck, RA; Stroup, TS; Swartz, MS | 1 |
| Bentley, ML; Biscardi, FH; Butcher, C; Levitov, A | 1 |
| Washburn, CF | 1 |
| Agid, O; Kapur, S; Loebel, A; Siu, C; Warrington, L | 1 |
| Hamilton, J; Heaton, C; Lannan, R; Lavedan, C; Licamele, L; Mack, K; Polymeropoulos, MH; Thompson, A; Volpi, S; Wolfgang, CD | 1 |
| Hamilton, JB; Heaton, C; Lannan, R; Lavedan, C; Licamele, L; Mack, K; Polymeropoulos, MH; Volpi, S; Wolfgang, CD | 1 |
| Chang, KD | 1 |
| Erickson, CA; McDougle, CJ; Posey, DJ; Stigler, KA | 1 |
| Sikich, L | 1 |
| Daumit, GL; Davis, SM; Davis, VG; Goff, DC; Hsiao, J; Lieberman, JA; McEvoy, JP; Meyer, JM; Nasrallah, HA; Stroup, TS; Swartz, MS | 1 |
| Ozen, ME; Savas, HA; Yumru, M | 1 |
| Romeo, F; Rossi, A; Tiradritti, P; Vita, A | 1 |
| Dressing, H; Krumm, B; Kuwilsky, A; Zink, M | 1 |
| Fusar-Poli, RR | 1 |
| Croarkin, PE; Emslie, GJ; Mayes, TL | 1 |
| Bastiaens, L | 1 |
| Chen, CK; Chen, HK; Tzeng, NS | 1 |
| Gibbons, GM; Paula, R; Wein, DA | 1 |
| Akkaya, C; Eker, SS; Kirli, S; Sarandol, A; Sivrioglu, EY | 1 |
| Aliaga, M; Assié, MB; Barbara, M; Bardin, L; Carilla-Durand, E; Malfètes, N; Maraval, M; Newman-Tancredi, A | 1 |
| Choi, SM; Kim, NR; Kim, YH; Lee, CH; Lee, JG; Lee, SJ; Park, SW | 2 |
| Forrester, MB | 1 |
| Alvarez, Jdo N; Carvalho, Rde C; Frussa-Filho, R; Fukushiro, DF; Ribeiro, LT; Ricardo, VP | 1 |
| Clement, HW; Heiser, P; Hemmeter, UM; Krieg, JC; Schmidt, AJ; Schulz, E; Vedder, H | 1 |
| Heard, K; Krier, S; Zahniser, NR | 1 |
| Montejo, AL; Rico-Villademoros, F | 1 |
| Haug, HJ; Kolb, SA; Koponen, H; Lublin, H; Sigmundsson, T | 1 |
| Ahlner, J; Bengtsson, F; Chermá, MD; Hägg, S; Reis, M | 1 |
| DelBello, MP; Ice, K; Keller, D; Miceli, J; Versavel, M | 1 |
| Katsigiannopoulos, K; Kouvelas, D; Papazisis, G; Saitis, M | 1 |
| Dietmaier, O; Gansmüller, R; Gründer, G; Hiemke, C; Leiblein, T; Vogel, F; Wassmuth, H | 1 |
| Loebel, A; O'Gorman, CJ; Simpson, GM; Yang, R | 1 |
| Bartenstein, P; Boy, C; Bröcheler, A; Buchholz, HG; Cumming, P; Fellows, C; Gründer, G; Hiemke, C; Janouschek, H; Landvogt, C; Rösch, F; Schäfer, W; Spreckelmeyer, K; Vernaleken, I; Veselinovic, T; Wong, DF | 1 |
| Kang, SG; Kim, H; Lee, HJ; Lee, KJ; Lee, SH; Park, YM | 1 |
| Alderman, JA; Gandelman, K; Glue, P; LaBadie, RR; Lombardo, I; Preskorn, SH; Versavel, M | 1 |
| Chen, CK; Chen, CL; Chen, YC; Feng, HM; Wang, TY; Yeh, YW | 1 |
| Benabarre, A; Comes, M; Cruz, N; Franco, C; Horga, G; Rosa, AR; Torrent, C; Vieta, E | 1 |
| English, PA; Keller, D; Loebel, AD; Miceli, J; Ramey, T; Vieta, E | 1 |
| Boora, K; Chiappone, K; Dubovsky, S; Xu, J | 1 |
| Addington, DE; Johnson, G; Kulkarni, J; Labelle, A; Loebel, A; Mandel, FS | 1 |
| Harvey, PD; Kremer, CM; Lombardo, I; Pappadopulos, E | 1 |
| Laroia, R; Samuels, D; Spiegel, DR | 1 |
| Gründer, G; Hiemke, C; Kircher, T; Leube, D; Saur, R; Schlotterbeck, P; Vehren, T | 1 |
| Buhl, D; Lamkin, S | 1 |
| Akhtar, J; Dunner, D; Johnson, AE; Liebowitz, MR; Mech, A; Pratap, R; Salmán, E | 1 |
| Blasey, C; Davis, JM; Kraemer, H; Lieberman, JA; Reaven, GM; Schatzberg, AF; Sethuraman, G; Tsuang, MT | 1 |
| Galluzzo, A; Gorini, B; Romeo, F; Sacchetti, E; Valsecchi, P; Warrington, L | 2 |
| Borba, CP; Boxill, R; Cather, C; Copeland, PM; Evins, AE; Fan, X; Forstbauer, SI; Freudenreich, O; Goff, DC; Henderson, DC; Miley, K; Sharma, B | 1 |
| Bogers, JP; Starrenburg, FC | 1 |
| Allison, DB; Giller, E; Loebel, A; Parsons, B; Romano, S; Siu, C; Williams, K | 1 |
| Ascher-Svanum, H; Ball, T; Conley, R; Liu, L; Stauffer, V | 1 |
| Díaz-Marsá, M; Rico-Villademoros, F; Sánchez, S | 1 |
| Fasano, CJ; Lares, C; O'Malley, GF; Rowden, AK | 1 |
| Citrome, L; Glue, P; Karayal, ON; Yang, R | 1 |
| Kumar, R; Sachdev, PS | 1 |
| Ayesa, R; Crespo-Facorro, B; Martínez-Garcia, O; Mata, I; Pérez-Iglesias, R; Ramirez-Bonilla, M; Rodríguez-Sánchez, JM; Vázquez-Barquero, JL | 1 |
| Loebel, AD; Potkin, SG; Siu, CO; Warrington, LE; Watsky, EJ; Weiden, PJ | 1 |
| Belloch, V; Cozar, R; Ojeda, E; Ordoño, F; Rueda, M; Salazar, J; Soriano, S | 1 |
| Price, LH | 1 |
| Auclair, AL; Barret-Grévoz, C; Barreto, M; Depoortère, R; Kleven, MS; Newman-Tancredi, A | 1 |
| Conrad, SA; Green, R; McCarthy, PJ; Scott, LK | 1 |
| Goldberg, TE; Gomar, JJ | 1 |
| Heard, K; Hoppe, J; Tan, HH | 1 |
| DeLorenze, G; L'Italien, G; McQuade, R; Newcomer, J; Oliveria, SA; Quesenberry, CP; Tsai, AL; Willey, VJ; Yood, MU | 1 |
| Jing, Y; Kim, E; Pikalov, A; Tran, QV; You, M | 1 |
| Akkaya, C; Alptekin, K; Brook, S; Danaci, AE; El Tallawy, H; Hafez, J; Karayal, ON; Lowe, W; Tzebelikos, E; Ucok, A | 1 |
| Buitelaar, JK; Grootens, KP; Kahn, RS; Peuskens, J; Sabbe, BG; Thys, E; van Veelen, NM; Verkes, RJ | 1 |
| Lin, YL; Tsai, GF; Wu, YC | 1 |
| Lavedan, C; Licamele, L; Malhotra, AK; Potkin, SG; Volpi, S | 1 |
| Horne, RL; Keck, PE; Loebel, AD; Versiani, M; Warrington, L | 1 |
| Barbui, C; Boso, M; Cipriani, A | 1 |
| Endicott, JM; Harvey, PD; Loebel, AD | 1 |
| Baumann, MR; MacVane, CZ | 1 |
| Loebel, A; Lombardo, I; Mandel, FS; Stahl, S | 1 |
| Coskun, O; Dalkiran, M; Duran, A; Emul, M; Keles, I; Tosun, M; Ugur, M; Yavuz, R | 1 |
| Bastiampillai, T; Dhillon, R; Mohan, T | 1 |
| Christodoulou, C; Douzenis, A; Gournellis, R; Lykouras, LP; Rizos, E | 1 |
| Agid, O; Kapur, S; Ketter, TA; Loebel, A; Romano, SJ; Siu, CO | 1 |
| Camargos, ST; Cardoso, FE; Prais, HA; Viana, Bde M | 1 |
| Aberg, K; Adkins, DE; Lieberman, JA; McClay, JL; Perkins, DO; Stroup, S; Sullivan, PF; van den Oord, EJ; Vladimirov, VI | 1 |
| Chen, QX; Huang, WQ; Liu, WZ; Wang, GF; Zhang, JJ | 1 |
| Baralatei, FT; Lauterbach, EC | 1 |
| Dadić-Hero, E; Knez, R; Medved, P; Petrić, D; Ruzić, K | 1 |
| Kaushik, S; Lindenmayer, JP; Maccabee, N | 1 |
| Bhoopathi, PS; Hunger, H; Kissling, W; Komossa, K; Leucht, S; Rummel-Kluge, C; Schwarz, S | 1 |
| Citrome, L; Cuffel, B; Harnett, J; Lenhart, G; Montejano, LB; Palmer, L; Reist, C; Sanders, KN | 1 |
| Werremeyer, A | 1 |
| Herman, BK; Lawson, WB; Lazariciu, I; Loebel, A; Malik, M | 1 |
| Laier, SA; Lang, UE; Lee, AH; Wertenauer, F; Willmund, G | 1 |
| Chandra, AB; Chandra, PA | 1 |
| DelBello, MP; Keller, D; Stewart, M; Versavel, M | 1 |
| Lavedan, C; Thompson, A; Volpi, S | 1 |
| Alipour, A; Cruz, R; Lott, RS | 1 |
| Balas, MC | 1 |
| Hunger, H; Kissling, W; Komossa, K; Leucht, S; Rummel-Kluge, C; Schmid, F; Schwarz, S; Silveira da Mota Neto, JI | 1 |
| Hunger, H; Kissling, W; Komossa, K; Leucht, S; Rummel-Kluge, C; Schmid, F; Schwarz, S; Srisurapanont, M | 1 |
| Bernard, GR; Canonico, AE; Carson, SS; Dittus, RS; Ely, EW; Girard, TD; Meltzer, HY; Pandharipande, PP; Pun, BT; Schmidt, GA; Shintani, AK; Thompson, JL; Wright, PE | 1 |
| Conley, Y; Davies, MA; Roth, BL | 1 |
| Anziano, R; Harrigan, RH; Miceli, JJ; O'Gorman, C; Shiovitz, T; Tensfeldt, TG | 1 |
| Baik, JH; Choi, SY; Noh, JS; Yoon, S | 1 |
| Bowden, CL; Ice, KS; Schwartz, JH; Versavel, M; Vieta, E; Wang, PP | 1 |
| Helm, ME; Henderson, C; Martin, BC; Pathak, P; West, D | 1 |
| Kelleher, KJ; Pajer, K; Penfold, RB; Strange, B; Wang, W | 1 |
| Ambesi-Impiombato, A; de Bartolomeis, A; Fiore, G; Iasevoli, F; Muscettola, G; Panariello, F | 1 |
| Pennell, K; Spiegel, DR; Turner, K; Weller, AL | 1 |
| Burns, T; Derks, EM; Fleischhacker, WW; Gaebel, W; Kahn, RS; Riesbeck, M; Rössler, W; von Wilmsdorff, M | 1 |
| Holdridge, KC; Houston, JP; Saunders, W; Sorsaburu, S | 1 |
| Gresham, C; Ruha, AM | 1 |
| Barth, KS; Garner, A; Phan, SV; Snarr, BS; VandenBerg, AM | 1 |
| Duggan, L; Hunger, H; Kissling, W; Komossa, K; Leucht, S; Rummel-Kluge, C; Schmid, F; Schwarz, S | 1 |
| Peitl, MV; Peitl, V; Petrić, D | 1 |
| Johnsen, E; Jørgensen, HA; Kroken, RA; Wentzel-Larsen, T | 1 |
| Benedetti, AM; Frazee, LA; Leung, JG; Myers, N | 1 |
| Florakis, A; Markatou, M; Masdrakis, VG; Oulis, P; Tzanoulinos, G | 1 |
| Anziano, RJ; Harrigan, RH; Miceli, JJ; O'Gorman, C; Shiovitz, T; Tensfeldt, TG | 1 |
| Bacalis, S; Chatziioannou, S; Douzenis, A; Fotiadis, C; Katsantoni, E; Lykouras, L; Mandrapilia, A; Rizos, EN; Siafakas, N | 1 |
| Elsom, SJ; Gurvich, C; Kulkarni, J; McCauley-Elsom, K | 1 |
| Potvin, S; Stip, E; Tourjman, V; Zhornitsky, S | 1 |
| Grootens, KP; Kahn, RS; Peuskens, J; Sabbe, BG; Salden, ME; Sitskoorn, MM; van Veelen, NM; Verkes, RJ | 1 |
| Albaugh, VL; Breazeale, S; Elich, TD; Ilkayeva, O; Joyal, JL; Lang, CH; Lynch, CJ; Maresca, KP; Vary, TC; Wenner, BR | 1 |
| Bae, KY; Kim, JM; Kim, SW; Shin, IS; Yang, SJ; Yoon, JS | 1 |
| Lincoln, J; Preskorn, SH; Stewart, ME | 1 |
| Etemad, B; Gallop, R; Lohoff, FW; Mandos, LA; Rickels, K | 1 |
| Tsai, AC | 1 |
| Bramness, JG; Gjerden, P; Slørdal, L | 1 |
| Harvey, PD; Loebel, A; Malla, A; Newcomer, JW; Potkin, SG; Romano, S; Siu, CO; Stahl, SM; Watsky, E; Weiden, PJ | 1 |
| Altun, NS; Budak, F; Dündar, S; Kutlu, A | 1 |
| Dressing, H; Englisch, S; Krumm, B; Kuwilsky, A; Zink, M | 1 |
| Grignon, S; Roy-Desruisseaux, J | 1 |
| Hong, CJ; Lin, PY; Tsai, SJ | 1 |
| Campeta, AM; Chekal, BP; Samas, B; Seadeek, C | 1 |
| Gitlin, MJ; Rim, CL | 1 |
| Kellner, M; Muhtz, C; Wiedemann, K | 1 |
| Abella, J; Aneiros, A; Casás-Martínez, A; Domínguez-Urbistondo, G; Llaneza, M; Macías, M; Salazar-Laya, B; Santos, H; Santos-García, D | 1 |
| Cañas, F; Fagiolini, A; Gallhofer, B; Larmo, I; Levy, P; Montes, JM; Papageorgiou, G; Rossi, A; Zink, M | 1 |
| Fasano, CJ; O'Malley, GF; Rowden, AK | 1 |
| Gumustas, M; Kul, D; Ozkan, SA; Uslu, B | 1 |
| Strawn, JR; Tambyraja, R | 1 |
| Davis, JM; Hunger, H; Kissling, W; Komossa, K; Leucht, S; Lobos, CA; Rummel-Kluge, C; Schmid, F; Schwarz, S | 1 |
| Jackson, CW; Lorenz, RA; Saitz, M | 1 |
| Campbell, EC; Caroff, SN; Chakos, MH; Davis, SM; Davis, VG; Keefe, RS; Lieberman, JA; McEvoy, JP; Miller, DD; Riggio, S; Rosenheck, RA; Saltz, BL; Stroup, TS; Swartz, MS | 1 |
| Harada, K; Irie, M; Kayama, Y; Kondo, Y; Matsuoka, N; Mihara, T; Ni, K; Shobo, M; Yamada, H | 1 |
| Buitelaar, JK; Grootens, KP; Kahn, RS; Peuskens, J; Sabbe, BG; Sitskoorn, MM; van Veelen, NM; Verkes, RJ | 1 |
| Deng, S; Gao, H; Obach, RS | 1 |
| Newman, M | 1 |
| D'Agostino, RB; Eng, SM; Faich, G; Kane, JM; Reynolds, RF; Ruskin, J; Strom, BL | 1 |
| Bouvier, ML; Gaebel, W; Henning, U; Schmitt, A; von Wilmsdorff, M | 1 |
| Angelopoulos, EK; Bergiannaki, JD; Corcondilas, M; Kioulos, KT; Kollias, CT; Papadimitriou, GN | 1 |
| Asenjo Lobos, C; Hunger, H; Komossa, K; Leucht, S; Rummel-Kluge, C; Schmid, F; Schwarz, S | 1 |
| Case, M; Conley, RR; Hoffmann, VP; Jacobson, JG; Stauffer, VL | 1 |
| Abi-Dargham, A; Cangiano, C; Frankle, WG; Gil, R; Huang, Y; Hwang, DR; Kegeles, LS; Laruelle, M; Lombardo, I; Martin, JH; Reich, E; Slifstein, M | 1 |
| Hasselstrøm, J | 1 |
| Celikyurt, IK; Erden, FB; Kayir, H; Ulak, G; Ulusoy, GK; Uzbay, TI | 1 |
| Mandel, FS; Masand, P; O'Gorman, C | 1 |
| Bies, RR; Coley, K; Kirshner, MM; Li, CH; Lieberman, JA; Marder, SR; Pollock, BG; Schneider, LS; Stroup, S; Wessels, AM | 1 |
| Kim, LW; Kim, YH; Lee, BJ; Lee, CH; Lee, JG; Park, SW; Shin, BS | 1 |
| Hunger, H; Kissling, W; Komossa, K; Leucht, S; Rummel-Kluge, C; Schmid, F; Schwarz, S | 1 |
| Adrjanowicz, K; Grzybowska, K; Hawelek, L; Kaminski, K; Mazgalski, J; Paluch, M; Wojnarowska, Z; Zakowiecki, D | 1 |
| Cucchiaro, J; Harvey, PD; Keefe, RS; Loebel, A; Ogasa, M | 1 |
| Karayal, ON; Keohane, D; Pappadopulos, E; Vanderburg, D | 1 |
| Hong, J; Mcgonagle, MD; Shah, JC | 1 |
| Cañas, F; Correll, CU; Fagiolini, A; Larmo, I; Levy, P; Montes, JM; Papageorgiou, G; Rossi, A; Sturlason, R; Zink, M | 1 |
| Stroup, TS | 1 |
| Bobo, WV; Crystal, S; Gerhard, T; Huang, C; Lieberman, JA; Olfson, M | 1 |
| Belal, F; Eid, M; El-Enany, N; El-Shaheny, RN; Walash, MI | 1 |
| Chandler, RA; Childers, ME; Hill, SJ; Ketter, TA; Rasgon, NL; Wang, PW | 1 |
| Dubovsky, AN; Dubovsky, SL | 1 |
| Baek, M; Ha, DJ; Kim, SJ; Koo, TS; Lee, J; Moon, H | 1 |
| Lombardo, I; Mandel, FS; Pappadopulos, E; Vieta, E | 1 |
| Bachinsky, M; Cavus, I; Chappell, P; Glue, P; Karayal, ON; Kolluri, S; Stewart, M | 1 |
| Montes, JM | 1 |
| Dadić-Hero, E; Grahovac, T; Knez, R; Kosec, T; Ružić, K; Sabljić, V | 1 |
| Dadić-Hero, E; Grahovac, T; Palijan, TZ; Petranović, D; Ružić, K; Sepić-Grahovac, D | 1 |
| Dadić-Hero, E; Grahovac, T; Ružić, K; Sabljić, V; Sepić-Grahovac, D | 1 |
| Anway, SD; Batzar, E; Karayal, ON; Vanderburg, DG | 1 |
| Correll, CU; Figen, V; Kane, JM; Lops, JD; Malhotra, AK; Manu, P | 1 |
| Nielsen, J | 1 |
| Baldaçara, L; Cordeiro, DC; Jackoswski, AP; Sanches, M | 1 |
| Mycyk, MB; Witsil, JC; Zell-Kanter, M | 1 |
| Hasnain, M; Vieweg, WV | 1 |
| Ayyanar, S; Kattimani, S; Menon, V | 1 |
| Chappell, PB; Gurtovaya, O; Ice, KS; Kasuba, B; Sachs, GS; Schwartz, JH; Vanderburg, DG | 1 |
| Alderman, JA; Herbig, SM; Thombre, AG | 1 |
| Mautone, A; Scarone, S | 1 |
| Camm, JA; Eng, S; Geier, JL; Karayal, ON; Keane, M; Kolluri, S; Kremer, CM; Lewis, M; Reynolds, R; Strom, BL | 1 |
| Calabrese, JR; Ice, KS; Karayal, ON; Kemp, DE; Pappadopulos, E; Sachs, GS; Siu, CO; Vieta, E | 1 |
| Cañas, F; Correll, CU; Fagiolini, A; Larmo, I; Levy, P; Montes, JM; Papageorgiou, G; Rossi, A; Zink, M | 1 |
| Alvir, JM; Crabtree, BL; Cuffel, BJ; Dostrow, VG; Evans, CJ; Sanders, KN | 1 |
| Berling, I; Calver, L; Clunas, S; Isbister, GK | 1 |
| Bitter, I; Czobor, P; Derks, EM; Fleischhacker, WW; Kahn, RS; Libiger, J; Volavka, J | 1 |
| Chae, YJ; Koo, TS; Lee, KR | 1 |
| Andreotti, S; Gattaz, WF; Lima, FB; Passos-Bueno, MR; Sertié, AL; Sertié, RA; Suzuki, AM | 1 |
| Abdel-Baki, A; Dubreucq, S; Granger, B; Létourneau, G; Mahone, M | 1 |
| Johnsen, E; Jørgensen, HA; Kjelby, E; Kroken, RA; Løberg, EM | 1 |
| Cucchiaro, J; Loebel, A; Ogasa, M; Potkin, SG | 1 |
| Akritopoulou, K; Anestakis, D; Ekonomopoulou, MT; Iakovidou-Kritsi, Z; Karapidaki, I | 1 |
| English, C; Harrington, CA | 1 |
| Jakovljevic, M; Mihaljevic-Peles, A; Muck-Seler, D; Mustapic, M; Nedic, G; Nikolac, M; Pivac, N; Sagud, M; Vuksan Cusa, B | 1 |
| Galluzzo, A; Sacchetti, E; Valsecchi, P | 1 |
| Létourneau, G; Moteshafi, H; Potvin, S; Stikarovska, I; Stip, E; Tourjman, V; Zhornitsky, S | 1 |
| Lerner, V; Miodownik, C; Witztum, E | 1 |
| Johnsen, E; Jørgensen, HA; Kroken, RA; Løberg, EM | 1 |
| Citrome, L; Hochfeld, M; Meng, X; Stahl, SM | 1 |
| Abuherba, MS; Cuartero, M; García, MS; Ortuño, JA | 1 |
| Dudova, I; Hrdlicka, M; Urbanek, T; Zedkova, I | 1 |
| Kaushik, S; Khan, A; Lindenmayer, JP; Parakadavil, M; Smith, RC; Tedeschi, F; Yusim, A | 1 |
| Hong, JP; Kim, MS; Namkoong, C; Park, MH; Park, S | 1 |
| Berkowitz, RL; Docherty, JP; Ni, Q; Parks, JJ; Patel, U | 1 |
| Bobo, WV; Chen, Y; Jayathilake, K; Meltzer, HY; Tang, T; Watts, K | 1 |
| Ash, P; Craighead, WE; Jacob, MK | 1 |
| Ascher-Svanum, H; Bruhn, D; Graham, CN; Lawson, AH; Mauskopf, JA | 1 |
| Li, YM; Ou, JJ; Wu, RR; Zhao, JP | 1 |
| Bies, RR; Keefe, RS; Mamo, DC; Mimura, M; Pollock, BG; Rajji, TK; Sakurai, H; Stroup, ST; Suzuki, T; Uchida, H; Watanabe, K | 1 |
| Ghaemi, SN; Gilmer, W; Holtzman, N; Pae, CU; Patkar, AA; Thommi, SB | 1 |
| Burkey, MD; Coffey, BJ; Howell, C; Riddle, MA | 1 |
| Caldwell, WB; Sagawa, K; Shah, JC; Thombre, AG | 1 |
| Chung, YC; Huang, GB; Kim, MG; Lee, KH; Park, TW; Yang, JC; Zhao, T | 1 |
| Hu, SH; Tao, J; Wang, JH; Wu, XL | 1 |
| Camm, AJ; Kane, JM; Karayal, ON; Kolluri, S; Meltzer, H; Miceli, J; O'Gorman, C; Tensfeldt, T | 1 |
| Filkowski, MM; Ghaemi, SN; Gilmer, W; Holtzman, NS; Loebel, A; Logvinenko, T; Masand, P; Mulligan, M; Pae, CU; Patkar, A; Pirok, E; Thommi, SB; Vöhringer, PA; Whitham, EA; Ziffra, M | 1 |
| Kamel, AM; Obach, RS; Prakash, C | 1 |
| Sun, J; Xu, H; Zhao, Z | 1 |
| Benninghoff, J; Dehning, S; Genius, J; Grunze, H; Möller, HJ; Rujescu, D; Schindler, C; Schloesser, RJ; van der Ven, A; Wiltfang, J | 1 |
| Mencacci, C | 1 |
| Chen, SC; Gordon, JS; Neyman, KM; Wells, RD | 1 |
| Choi, YW; Jalin, AM; Kaengkan, P; Kam, KY; Kang, SG; Kim, YH; Park, SW | 1 |
| Bitter, I; Bucci, P; Fleischhacker, WW; Galderisi, S; Kahn, RS; Libiger, J; Mucci, A | 1 |
| Kolluri, S; Kremer, C; Lombardo, I; Sachs, G; Yang, R | 1 |
| Bahadur, S; Pathak, K | 1 |
| Kolluri, S; Newcomer, JW; Pappadopulos, E | 1 |
| Adler, CM; Bitter, SM; DelBello, MP; Eliassen, J; Mills, NP; Schneider, MR; Strakowski, SM; Weber, W; Whitsel, R | 1 |
| Cho, YM; Jeong, SW; Jung, H; Kim, JH; Kwak, SN; Kwon, OJ; Lee, KW; Oh, JE | 1 |
| Beszlej, A; Bieńkowski, P; Frydecka, D; Grzywacz, A; Mak, M; Mierzejewski, P; Potemkowski, A; Samochowiec, A; Samochowiec, J; Tybura, P | 1 |
| Alvir, JM; Berger, A; Edelsberg, J; Mychaskiw, MA; Oster, G; Sanders, KN | 1 |
| Moteshafi, H; Stip, E | 1 |
| Chen, HH; Fan, X; Gao, K; Guo, XF; Ou, JJ; Wang, J; Wu, RR; Xu, Y; Zhao, JP | 1 |
| Agbaba, D; Nikolic, K; Pavlovic, M; Smolinski, A | 1 |
| Alvarez, E; Arranz, B; Corripio, I; Dueñas, R; Perez, V; Ramirez, N; Safont, G; San, L | 1 |
| Bowden, CL; Gundapaneni, BK; Karayal, ON; O'Gorman, C; Schwartz, JH | 1 |
| Mandel, FS; Masand, PS; O'Gorman, C; Pae, CU | 1 |
| Caldwell, WB; Friesen, DT; McCray, SB; Sutton, SC; Thombre, AG | 1 |
| Li, RM; Liu, ZW; Wang, C; Zhao, B | 1 |
| Capapey, J; Colom, F; Goikolea, JM; Grande, I; Sanchez-Moreno, J; Torres, I; Undurraga, J; Valentí, M; Vieta, E | 1 |
| Blagojević, D; Lečić-Toševski, D; Miljević, Č; Niketić, V; Nikolić, M; Nikolić-Kokić, A; Spasić, MB | 1 |
| Childers, ME; Hill, SJ; Ittasakul, P; Ketter, TA; Miller, S; Rasgon, N; Wang, PW | 1 |
| Agid, O; Pappadopulos, E; Remington, G; Siu, CO; Vanderburg, D | 1 |
| Adams, CE; Jones, H; Powney, MJ | 1 |
| Bachinsky, M; Cavus, I; Karayal, ON; Kolluri, S; Sachs, GS; Vanderburg, DG | 1 |
| Bachinsky, M; Cavus, I; Edman, S; Karayal, ON; Kolluri, S; Sachs, GS; Vanderburg, DG | 1 |
| Tohen, M | 1 |
| Eng, SM; Faich, G; Kane, JM; Kolitsopoulos, FM; Reynolds, RF; Strom, BL | 1 |
| Erdur, B; Ergin, A; Kortunay, S; Yuksel, A | 1 |
| Buchmann, J; Häßler, F; Höppner, J; Pohl, B; Reis, O; Weirich, S | 1 |
| Hochfeld, M; Meng, X; Potkin, SG; Preskorn, S | 1 |
| Piazzi, G; Sciarretta, A | 1 |
| Raghunath, A | 1 |
| Abrams, J; Bari, MA; Fava, M; Hails, KA; Ishak, WW; Kinrys, G; Lipkin, SH; Meisner, A; Mischoulon, D; Okasha, MS; Papakostas, GI; Rapaport, MH; Schoenfeld, DA; Shelton, RC; Vitolo, OV; Ward, SG; Winokur, A; Zajecka, JM | 1 |
| Akintola, M; Messerschmidt, C; Morewitz, J; Spiegel, DR | 1 |
| Cutler, AJ; Kalali, AH; Kunovac, J; Mattingly, GW; Meng, X | 1 |
| Chen, Y; Kuang, F; Liu, L; Peng, Z; Tan, Q; Wang, H; Wang, L; Xue, F; Yang, F; Zhang, R | 1 |
| Borlido, C; Caravaggio, F; Deluca, V; Graff-Guerrero, A; Ismail, Z; Mamo, D; Mulsant, B; Pollock, B; Remington, G; Suzuki, T; Uchida, H | 1 |
| Crespo-Facorro, B; Martínez-Garcia, O; Mata, I; Ortiz-Garcia de la Foz, V; Pérez-Iglesias, R; Valdizan, EM; Vazquez-Barquero, JL | 1 |
| Deng, H; Gao, C; Karayal, ON; Li, K; Pan, S; Shi, J; Shu, L; Tang, H; Vanderburg, D; Wang, G; Wang, X; Xie, S; Xu, X; Zhang, H; Zhao, J | 1 |
| Brixner, DI; Ghate, SR; Hashibe, M; Joy, E; Porucznik, CA; Said, Q | 1 |
| Nakagawa, T; Nishimuta, H; Nomura, N; Yabuki, M | 1 |
| El-Sayeh, HG; Hunger, H; Khanna, P; Komossa, K; Leucht, S; Rummel-Kluge, C; Schwarz, S | 1 |
| Arnold, JG; Cañive, JM; Miller, AL; Mintz, J; Rosenheck, RA; Swartz, MS | 1 |
| Crittenden, NE; Jortani, SA; Middleberg, RA; Shaw, MA; Truscott, SM | 1 |
| Bruni, C | 1 |
| Calabrese, JR; Gao, K; Karayal, ON; Kolluri, S; Pappadopulos, E | 1 |
| Dietrich-Muszalska, A; Kopka, J; Kwiatkowska, A | 1 |
| Erbas, O; Yilmaz, M | 1 |
| Ayesa-Arriola, R; Crespo-Facorro, B; Mata, I; Ortiz-García de la Foz, V; Pérez-Iglesias, R; Suarez-Pinilla, P; Valdizan, EM; Vázquez-Barquero, JL | 1 |
| Chen, AP; Juang, YY; Lee, CP | 1 |
| Chen, H; Fang, M; Ou, J; Shao, P; Wu, R; Xu, Y; Zhao, J | 1 |
| Rossi, A; Stratta, P | 1 |
| Eisman, J; Palekar, N | 1 |
| Bies, RR; Graff-Guerrero, A; Mamo, DC; Mimura, M; Pollock, BG; Suzuki, T; Tsuboi, T; Uchida, H | 1 |
| Frisch, J; Hiemke, C; Holthoewer, D; Kirschbaum, KM; Schmitt, U | 1 |
| Achtyes, ED; Buckley, P; Bustillo, JR; Citrome, L; Gil, R; Goff, DC; Macklin, EA; Manschreck, TC; McEvoy, JP; Mech, AW | 1 |
| Fernandes, JC; Mota, T; Teixeira, J | 1 |
| Bahk, WM; Wang, HR; Woo, YS | 1 |
| Hong, JP; Kim, MS; Park, S; Yi, KK | 1 |
| Li, CH; Rao, SZ; Shi, L; Zhan, GL; Zhang, H | 1 |
| Bies, RR; Mamo, DC; Mimura, M; Moriguchi, S; Pollock, BG; Remington, G; Suzuki, T; Uchida, H; Watanabe, K | 1 |
| Sebestyén, Z; Szabó, B; Szepesi, K | 1 |
| Ayyanar, S; Menon, V; Ramamourthy, P | 1 |
| Ayesa-Arriola, R; Crespo-Facorro, B; de la Foz, VO; Martinez-Garcia, O; Mata, I; Pérez-Iglesias, R; Suarez-Pinilla, P; Valdizan, EM | 1 |
| Bobes García, J; de la Gándara Martín, JJ; Gutiérrez Fraile, M | 1 |
| Bahk, WM; Kim, MD; Kwon, YJ; Lee, HB; Lee, JG; Woo, YS; Yoon, BH | 1 |
| Altamura, AC; Buoli, M; Serati, M | 1 |
| Aguiar, GC; Barros, AG; Bridi, JC; Gubert, P; Mourão, T; Romano-Silva, MA; Soares, FA | 1 |
| Feifel, D; MacDonald, K; Ronquillo, L; Vilke, GM; Wilson, MP | 1 |
| Hugdahl, K; Johnsen, E; Jørgensen, HA; Kroken, RA; Løberg, EM; Sinkeviciute, I | 1 |
| Cavuş, I; DelBello, MP; Findling, RL; Gundapaneni, BK; Pappadopulos, E; Schwartz, JH; Vanderburg, DG | 2 |
| Han, TY; Kim, EJ; Kim, MS; Kim, SW; Lee, JH; Son, SJ | 1 |
| Koplewicz, HS | 1 |
| Abenavoli, E; Bruno, A; Lamberti Castronuovo, E; Micò, U; Muscatello, MR; Pandolfo, G; Scimeca, G; Spina, E; Zoccali, R | 1 |
| Conca, A; Fulgenzi, G; Ghedini, N; Mandrioli, R; Mercolini, L; Protti, M; Raggi, MA | 1 |
| Asmal, L; Flegar, SJ; Komossa, K; Leucht, S; Rummel-Kluge, C; Wang, J | 1 |
| Citrome, L; Czobor, P; Van Dorn, RA; Volavka, J | 1 |
| Baek, SE; Do, BR; Kaengkan, P; Kam, KY; Kang, SG; Kim, JY; Lee, ES | 1 |
| Baldaia, MA; Berro, LF; Frussa-Filho, R; Hollais, AW; Longo, BM; Marinho, EA; Oliveira-Lima, AJ; Santos, R; Wuo-Silva, R | 1 |
| Cosgrove, VE; Feldman, NS; Gwizdowski, IS; Hidalgo, RB; McElroy, SL; Sheehan, DV; Suppes, T | 1 |
| Lin, H; Rosenheck, R | 1 |
| Aida, SA; Hatim, A; Mohamed, Z; Reynolds, GP; Roffeei, SN; Said, MA; Zainal, NZ | 1 |
| Dai, G; Zhang, Y | 1 |
| Berro, LF; Carvalho, RC; Frussa-Filho, R; Fukushiro, DF; Hollais, AW; Kameda, SR; Patti, CL; Zanin, KA | 1 |
| Shrestha, R | 1 |
| Awad, G; Hassan, M; Hsu, J; Loebel, A; Pikalov, A; Rajagopalan, K | 1 |
| Chue, P; Mandel, FS; Therrien, F | 1 |
| Chennoufi, L; Cheour, M; Ouanes, S | 1 |
| Bahramzi, M; Campillo, A; Minassian, A; Vilke, GM; Wilson, MP | 1 |
| Eng, SM; Fleischhacker, WW; Geier, J; Kane, JM; Karayal, O; Kolluri, S; Reynolds, RF; Strom, BL | 1 |
| Aguglia, E; Bianchini, O; Cannavò, D; De Ronchi, D; Nespeca, C; Porcelli, S; Serretti, A; Trappoli, A | 1 |
| Baer, L; Cardoos, A; Clain, A; DiPierro, M; Doorley, J; Fava, M; Jeon, HJ; Mischoulon, D; Papakostas, GI | 1 |
| Jiang, Y; McGinnis, JJ; Ni, W | 1 |
| Choi, SH; Jung, BJ; Jung, WY; Kang, DH; Kim, SG; Lee, JS; Lee, YM; Shin, DH | 1 |
| Beszlej, A; Bienkowski, P; Frydecka, D; Grzywacz, A; Mierzejewski, P; Samochowiec, A; Samochowiec, J; Trześniowska-Drukała, B; Tybura, P | 1 |
| Kuntz, KM; Park, T | 1 |
| Calandre, EP; Rico-Villademoros, F; Slim, M | 1 |
| Albers, LJ; Conca, A; Mandrioli, R; Mercolini, L; Protti, M; Raggi, MA | 1 |
| Bond, M; Darwish, M; Hellriegel, ET; Robertson, P; Yang, R | 1 |
| Balaban, E; Cwikel-Hamzany, S; Fostick, L; Juven-Wetzler, A; Zohar, J | 1 |
| Buckley, PF | 1 |
| Morrissette, DA; Stahl, SM | 1 |
| Guoguang, C; Lili, R; Pingkai, O; Yanfei, M | 1 |
| Chen, G; Miao, Y; Pingkai, O; Ren, L | 1 |
| Amado, JA; Ayesa-Arriola, R; Crespo-Facorro, B; Garcia-Unzueta, MT; Martínez García, O; Ortiz-Garcia de la Foz, V; Pérez-Iglesias, R; Suarez-Pinilla, P; Tabares-Seisdedos, R | 1 |
| Cornelius, V; Smith, L; Taylor, DM; Young, AH | 1 |
| Andersen, CU; Dabrowski, K; Hansen, KB; Høimark, L; Sædder, E | 2 |
| Fujita, M; Hagino, Y; Hashimoto, M; Ikeda, K; Kasai, S; Kobayashi, K; Meltzer, HY; Setogawa, S; Yamaura, H; Yanagihara, D | 1 |
| Brennan, MD; Ramsey, TL | 1 |
| Mandrioli, R; Mercolini, L; Protti, M | 1 |
| Crespo-Facorro, B; Prieto, C; Sainz, J | 1 |
| Caravaggio, F; Chung, JK; Fervaha, G; Gerretsen, P; Graff-Guerrero, A; Iwata, Y; Mihashi, Y; Mulsant, B; Nakajima, S; Plitman, E; Remington, G; Takeuchi, H | 1 |
| Adrjanowicz, K; Cal, K; Garbacz, G; Kaminska, E; Kaminski, K; Swinder, L; Zakowiecki, D | 1 |
| Brown, JB; Kadoyama, K; Kimura, G; Miki, I; Nakamura, T; Nisiguchi, K; Okuno, Y; Sakaeda, T | 1 |
| Baer, L; Clain, A; Doorley, J; Fava, M; Heo, JY; Jeon, HJ; Mischoulon, D; Papakostas, GI; Pisoni, A | 1 |
| Geerts, H; Potkin, S; Roberts, P; Spiros, A | 1 |
| Connolly, JG; Schneeweiss, MC; Toomey, TJ | 1 |
| Álamo, C; Bernardo, M; Bobes, J; Hidalgo, D; Murru, A; Saiz-Ruiz, J; Vieta, E | 1 |
| Iskandar, JW; Kablinger, A; Kavuru, B; Vance, JE | 1 |
| Dalley, S; Ghaemi, SN; Loebel, A; Masand, PS; Mauer, S; Narasimhan, M; Pae, CU; Patkar, AA; Vöhringer, PA | 1 |
| Brooks, KR; Kram, BL; Kram, SJ | 1 |
| Lin, H; McEvoy, J; Mohamed, S; Rosenheck, RA; Stroup, S; Swartz, M | 1 |
| Baer, L; Bobo, WV; Fava, M; Jaeger, A; Papakostas, GI; Shelton, RC; Swee, MB | 1 |
| Dominick, K; Erickson, CA; McDougle, CJ; Wink, LK | 1 |
| Fleischhacker, WW; Karayal, ON; Kemmler, G; Kolluri, S; Vanderburg, D; Widschwendter, CG | 1 |
| Bean, JR; Lister, JF; Thimothy, L; Voinov, B | 1 |
| Caldwell, WB; Connor, AL; Malhotra, BK; Shamblin, SL; Thombre, AG; Wilding, IR | 1 |
| Banerjee, S; Prasad Y, R; Shankar, KR | 1 |
| Bera, H; Boddupalli, S; Nayak, AK | 1 |
| Al-Jadiri, A; Azzo, S; Carbon, M; Correll, CU; Kane, JM; Kapoor, S; Saito, E; Sarkaria, T; Sheridan, E | 1 |
| Chen, X; Liu, ZX; Song, Y; Tang, MQ; Yuan, W; Zhang, ZH | 1 |
| Akar, FY; Buyukokuroglu, ME; Celikyurt, IK; Erden, BF; Mutlu, O; Tanyeri, P; Ulak, G | 1 |
| Chan, VC; Diak, IL; La Grenade, L; Levin, RL | 1 |
| Nelson, JC | 1 |
| Chen, G; Miao, Y; Ouyang, P; Ren, L | 1 |
| Dening, TJ; Prestidge, CA; Rao, S; Thomas, N | 1 |
| Khouzam, HR | 1 |
| Brugnoli, R; Carlino, N; D'Andreagiovanni, M; De Giorgi, R; Del Casale, A; Giardini, M; Girardi, P; Kotzalidis, GD; Rapinesi, C; Sacco, M | 1 |
| Eddings, W; Franklin, JM; Kesselheim, AS; Landon, J; Wang, B | 1 |
| Alessandra, A; Daniela, C; Elisa, M; Giuseppina, D; Maria, N; Paolo, C; Perna, G; Raffaele, B | 1 |
| Barbosa, DS; Bonifácio, KL; Brinholi, FF; Casagrande, R; Farias, CC; Higachi, L; Moreira, EG | 1 |
| Das, P | 1 |
| Baer, L; Fava, M; Ionescu, DF; Meade, KH; Papakostas, GI; Shelton, RC; Swee, MB | 1 |
| Alonso-Martín, C; Arias-Loste, MT; Crespo, J; Crespo-Facorro, B; Fábrega, E; Martínez-García, O; Morlán-Coarasa, MJ; Ortiz-García de la Foz, V; Romero-Gómez, M | 1 |
| Blagojević, D; Mijušković, A; Miler, M; Miljević, Č; Milošević, V; Nestorov, J; Nikolić, M; Nikolić-Kokić, A; Oreščanin-Dušić, Z; Spasić, M; Tatalović, N | 1 |
| Cross, ES; Davies, W; Guerrero, S; Humby, T; Messer, L | 1 |
| Álvarez-García, R; Baca-García, E; Barrigón, ML; Berrouiguet, S; Brandt, SA; Carballo, JJ; Courtet, P; Lenca, P; Ovejero-García, S | 1 |
| Baldaia, MA; Berro, LF; Frussa-Filho, R; Hollais, AW; Marinho, E; Oliveira-Lima, AJ; Ribeiro, LT; Santos-Baldaia, R; Talhati, F; Wuo-Silva, R | 1 |
| Baer, L; Bobo, WV; Curren, L; Fava, M; Mischoulon, D; Papakostas, GI; Shelton, RC | 1 |
| Bai, YH; Cai, M; Chen, YC; Guo, L; McAlonan, GM; Tan, QR; Wang, HH; Wang, HN; Wang, Y; Wu, WJ; Zhang, RG; Zhang, YH; Zhang, ZJ | 1 |
| Atlı Şekeroğlu, Z; Coşguner, G; Kefelioğlu, H; Kontaş Yedier, S; Şekeroğlu, V | 1 |
| Hamera, L; Khishfe, BF | 1 |
| Lee, Y; Mansur, RB; McIntyre, RS | 1 |
| Guina, J; Pennington, JG | 1 |
| Li, Y; Wang, ST | 1 |
| Loebel, A; Meyer, N; Rajagopalan, K; Wade, S | 1 |
| Foster, R; Nguyen, T; Stanton, J | 1 |
| Bentaleb, LA; Cherbal, A; Luck, D; Lungu, O; Stip, E; Zhornitsky, S | 1 |
| Amado-Señaris, JA; Ayesa-Arriola, R; Correll, C; Crespo-Facorro, B; Labad, J; Ortiz-Garcia de la Foz, V; Pérez-Iglesias, R; Suarez-Pinilla, P; Teresa Garcia-Unzueta, M; Valdizan, EM | 1 |
| Gandelman, K; Nause, R; Sutton, SC | 1 |
| Ensom, MHH; Johnson, EG; Johnson, HE; Wilby, KJ | 1 |
| Crespo-Facorro, B; Gomez-Arnau, J; Juncal-Ruiz, M; Martinez-Garcia, O; Neergaard, KD; Ortiz-Garcia de la Foz, V; Ramirez-Bonilla, M; Suarez-Pinilla, P; Tabares-Seisdedos, R | 1 |
| Grabe, HJ; Janowitz, D; Schomerus, G; Speerforck, S | 1 |
| Hetrick, SE; Loy, JH; Merry, SN; Stasiak, K | 1 |
| Cao, D; Kang, B; Meng, Y; Ning, H; Wang, H; Xie, S | 1 |
| Chui, SJ; Harbourt, K; Pajoumand, M; Pruskowski, KA; Reynolds, HN | 1 |
| Crespo-Facorro, B; Díaz Martínez, Á; Ortiz-García de la Foz, V; Pérez-Iglesias, R; Suárez Pinilla, P; Vázquez-Bourgon, J | 1 |
| Azzolin, VF; Barbisan, F; da Cruz Jung, IE; da Cruz, IBM; do Prado-Lima, PAS; Duarte, MMMF; Duarte, T; Mastella, MH; Teixeira, CF | 1 |
| Kou, C; Liu, X; Liu, Y; Ma, Y; Song, Y; Su, Y; Wang, M; Yang, G; You, Y; Zhang, L; Zhang, Y | 1 |
| Dietrich-Muszalska, A; Kolińska-Łukaszuk, J | 1 |
| Dang, NL; Hughes, TB; Miller, GP; Swamidass, SJ | 1 |
| Siegfried, N; Stein, DJ; Temmingh, HS; Williams, T | 1 |
| Banchs, JE; Copeland, LA; McNeal, CJ; Stock, EM; Zeber, JE | 1 |
| Bateman, BT; Cohen, JM; Cohen, LS; Desai, RJ; Glynn, RJ; Hernandez-Diaz, S; Huybrechts, KF; Mogun, H; Park, Y; Patorno, E | 1 |
| Carvalho, AF; Hidalgo-Mazzei, D; Murru, A; Pacchiarotti, I; Samalin, L; Verdolini, N; Vieta, E; Young, AH | 1 |
| Dening, TJ; Meola, TR; Prestidge, CA | 1 |
| Cole, JB; Collins, JD; Driver, BE; Fagerstrom, E; Hessel, M; Horton, GB; Klein, LR; Martel, ML; Miner, JR; Satpathy, R | 1 |
| Ferrando, S; Munjal, S; Schultheis, G | 1 |
| Bogers, JPAM; Broekman, TG; de Haan, L; Moleman, P; Schulte, PFJ | 1 |
| Dickert, NW; Sugarman, J | 2 |
| Blagojević, D; Mijović, M; Mijusković, A; Miler, M; Miljević, Č; Milošević, V; Nestorov, J; Nikolić, M; Nikolić-Kokić, A; Oreščanin-Dušić, Z; Spasić, M; Tatalović, N | 1 |
| Giri, P; Giri, S; Gupta, L; Joshi, V; Naidu, S; Patel, N; Srinivas, NR | 1 |
| Crespo-Facorro, B; Gómez-Revuelta, M; González-Pinto, A; Juncal-Ruiz, M; Ortiz-García de la Foz, V; Pelayo-Terán, JM; Vázquez-Bourgon, J | 1 |
| Agbaba, D; Čarapić, M; Marković, B; Nikolic, K; Pavlovic, M; Petković, M | 1 |
| Bottlender, R; Jäger, M; Laux, G; Möller, HJ; Musil, R; Obermeier, M; Riedel, M; Schennach, R; Schmauss, M; Spellmann, I | 1 |
| Bleck, TP | 1 |
| Bernard, GR; Boehm, LM; Bowton, DL; Brummel, NE; Carson, SS; Chandrasekhar, R; Dittus, RS; Douglas, IS; Ely, EW; Exline, MC; Feinstein, DJ; Girard, TD; Gong, MN; Hite, RD; Hough, CL; Hughes, CG; Hyzy, RC; Jackson, JC; Khan, B; Malhotra, A; Masica, AL; Owens, RL; Pandharipande, PP; Patel, MB; Pisani, MA; Pun, BT; Rock, P; Schmidt, GA; Schweickert, WD; Stollings, JL; Strength, C; Thompson, JL | 1 |
| Gokden, M; Harada, Y; Stefans, V; Virmani, T | 1 |
| Black, KJ; Davis, AA; Younce, JR | 1 |
| Azzolin, VF; Barbisan, F; da Cruz Jung, IE; da Cruz, IBM; da Cunha, BSN; do Prado-Lima, PA; Duarte, MMMF; Duarte, T; Ribeiro, EE; Turra, BO | 1 |
| Bellavia, A; Centorrino, F; Fitzmaurice, G; Jackson, JW; Valeri, L | 1 |
| Chen, G; Ren, L; Wang, J; Xu, X; Xue, X | 1 |
| Biesdorf, C; Diniz, A; Martins, FS; Sy, SKB | 1 |
| Abbasi, YF; Ahmmed, SKM; Bera, H; Bhatnagar, P; Kakoti, BB; Seng, PM; Yoke, FF | 1 |
| Adams, CE; Kwong, JS; Nyakyoma, K; Qi, F; Sinclair, DJ; Zhao, S | 1 |
| Nordstrom, K; Wilson, M; Zeller, S | 1 |
| Cole, JB; Driver, BE; Klein, LR; Martel, ML; Miner, JR | 2 |
| Tenser, RB | 1 |
| Lee, HB; Neufeld, KJ; Oldham, MA | 1 |
| Ishiki, H; Satomi, E; Shimizu, K | 1 |
| Ely, EW; Girard, TD | 1 |
| April, MD; De Lorenzo, RA; Schauer, SG; Wheeler, AR | 1 |
| Jovanović, VB; Mačvanin, MT; Mandić, LM; Nikolić, MR; Nikolić-Kokić, AL; Spasić, SD; Uzelac, TN | 1 |
| Bernhard, M; Beynon, C; Brenner, T; Dietrich, M; Hecker, A; Jungk, C; Michalski, D; Nusshag, C; Reuß, CJ; Schmidt, K; Weigand, MA | 1 |
| Crippa, A; Davis, JM; Leucht, S; Orsini, N; Patel, MX; Siafis, S | 1 |
| Cheng, Z; Jiang, N; Liu, W; Lu, W; Wang, S | 1 |
| Rojo-Moreno, J; Rojo-Valdemoro, C; Santolaya-Ochando, F | 1 |
| Broder, MS; Chang, E; Greene, M; Houle, CR; Tarbox, MH; Waters, HC; Yan, T | 1 |
| Ayesa-Arriola, R; Crespo-Facorro, B; Gómez-Revuelta, M; Juncal-Ruiz, M; Pelayo-Terán, JM; Romero-Jiménez, R; Setién Suero, E; Suárez-Pinilla, P; Vázquez-Bourgon, J | 1 |
| Madden, K; Mahgoub, Y; Xia, T | 1 |
| Banks, CD; Deeter, J; Langley, P; Rollins, MR | 1 |
| Correll, CU; DiPetrillo, L; Jiang, Y; Liu, Y; Pathak, S; Todtenkopf, MS | 1 |
| Chen, Q; Coid, J; Deng, W; Guo, W; Hu, X; Li, K; Li, L; Li, T; Li, X; Li, Y; Lu, T; Lv, L; Ma, X; Ren, H; Reynolds, GP; Tan, L; Tan, Q; Tian, Y; Wang, C; Wang, H; Wang, L; Wang, Q; Wei, W; Yan, H; Yang, F; Yang, G; Yang, J; Yu, H; Yue, W; Zhang, D; Zhang, F; Zhang, H; Zhang, Y; Zhao, L | 1 |
| Celebi, N; Karakucuk, A; Tashan, E | 1 |
| Buchmann, J; Dück, A; Grözinger, M; Häßler, F; Hofmockel, R; Höppner, J; Reinhardt, M; Weirich, S | 1 |
| Ahmad, FJ; Ahmed, MZ; Hasan, N; Jain, GK; Khan, UA; Parveen, U; Saad, S | 1 |
| Ishigooka, J; Masukawa, D; Moriya, S; Nishimura, K; Takahashi, H; Yamada, M | 1 |
| An, JR; Ha, KS; Heo, R; Jung, HS; Kang, M; Park, H; Park, WS; Seo, MS | 1 |
| Claro, A; Corte-Real, F; Franco, J; Monteiro, C; Mustra, C; Proença, P | 1 |
| Biros, MH; Cole, JB; Driver, BE; Martel, ML; Miner, JR | 1 |
| Ayesa Arriola, R; Crespo Facorro, B; Gómez Revuelta, M; Ibáñez Alario, M; Juncal Ruiz, M; Mayoral-van Son, J; Ortiz-García de la Foz, V; Vázquez-Bourgon, J | 1 |
| Goto, S; Karube, Y; Koga, M; Matsunaga, K; Murata, A; Setoguchi, S; Takata, J; Terada, K; Toki, E; Watase, D; Yamakawa, H | 1 |
| Alexander, KM; Caposole, MZ; Ficarino, HM; Kinnard, CM; McGowin, EF; N Krebsbach, M; Noelle Davis, S; Simmons, JD | 1 |
| Blagojević, D; Brkljačić, J; Miler, M; Miljević, Č; Milošević, V; Nikolić, M; Nikolić-Kokić, A; Oreščanin-Dušić, Z; Platanić Arizanović, L; Spasić, S; Tatalović, N; Vidonja Uzelac, T | 1 |
| Atreya, A; Basnyat, S; Phuyal, P; Pokhrel, S; Sedhai, YR | 1 |
| Abuzeid, MY; Alamiri, B; Allami, S; Naguy, A | 1 |
| Emami Riedmaier, A; Kesisoglou, F; Parrott, N; Pepin, XJH; Wagner, C | 1 |
| Alisauskiene, R; Gjestad, R; Johnsen, E; Jørgensen, HA; Kroken, RA; Løberg, EM | 1 |
| Bhat, K; Godbole, HM; Murkute, SR; Singh, GP; Trivedi, A; Upadhyay, PR; Vasantharaju, SG | 1 |
| Chen, L; Gu, X; Han, F; Li, H; Li, M; Shang, L; Yang, Y; Zheng, M | 1 |
| Coralic, Z; Rader, ES; Vinson, DR; Wilson, MP | 1 |
| Guan, X; Kosten, TR; Liu, J; Wang, Y; Wu, F; Xiu, M; Zhang, X; Zhu, C | 1 |
| Biederman, J; Cook, E; DiSalvo, M; Faraone, SV; Farrell, A; Joshi, G; Wozniak, J; Yule, A | 1 |
| Cao, D; Hong, Y; Huang, W; Wang, L; Wei, H; Xu, J; Zhang, J | 1 |
| Bai, L; Guo, Y; Li, J; Li, K; Li, Y; Liang, W; Liu, L; Liu, Z; Wang, J; Wang, X; Wu, Y; Xu, J; Yang, F; Yu, J; Zhang, C; Zhang, Y | 1 |
147 review(s) available for ziprasidone and thiazoles
| Article | Year |
|---|---|
The new generation of antipsychotic drugs.
Topics: Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Schizophrenia; Thiazoles | 1996 |
[New antipsychotic drugs].
Topics: Antipsychotic Agents; Benzodiazepines; Benzothiazoles; Clinical Trials as Topic; Dibenzothiazepines; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Pirenzepine; Pramipexole; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Thiazoles | 1997 |
Tardive dyskinesia in affective disorders.
Topics: Adult; Affective Disorders, Psychotic; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Controlled Clinical Trials as Topic; Dibenzothiazepines; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Humans; Imidazoles; Indoles; Male; Olanzapine; Piperazines; Pirenzepine; Psychotic Disorders; Quetiapine Fumarate; Risk Assessment; Risk Factors; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome | 1999 |
Antipsychotic-induced weight gain: a comprehensive research synthesis.
Topics: Antipsychotic Agents; Clinical Trials as Topic; Clozapine; Confidence Intervals; Drug Administration Schedule; Humans; Molindone; Piperazines; Placebos; Psychotic Disorders; Research Design; Thiazoles; Treatment Outcome; Weight Gain | 1999 |
[New antipsychotic agents].
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Pirenzepine; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Sulpiride; Thiazoles | 1999 |
The efficacy of atypical antipsychotics in the treatment of depressive symptoms, hostility, and suicidality in patients with schizophrenia.
Topics: Aggression; Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Clozapine; Depression; Depressive Disorder; Dibenzothiazepines; Hostility; Humans; Multicenter Studies as Topic; Olanzapine; Piperazines; Pirenzepine; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Suicide; Thiazoles; Treatment Outcome | 2000 |
Ziprasidone for schizophrenia and severe mental illness.
Topics: Antipsychotic Agents; Humans; Piperazines; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Thiazoles | 2000 |
[New i.e. atypical neuroleptic agents for negative symptoms of schizophrenia: results and methodological problems of evaluation].
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Dibenzothiepins; Double-Blind Method; Dyskinesia, Drug-Induced; Humans; Imidazoles; Indoles; Neurotransmitter Agents; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Schizophrenic Psychology; Sulpiride; Thiazoles | 2000 |
Atypical antipsychotics and weight gain--a systematic review.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Dibenzothiepins; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Risperidone; Sulpiride; Thiazoles; Weight Gain | 2000 |
Ziprasidone for schizophrenia and severe mental illness.
Topics: Antipsychotic Agents; Humans; Piperazines; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Thiazoles | 2000 |
Ziprasidone: comprehensive overview and clinical use of a novel antipsychotic.
Topics: Animals; Antipsychotic Agents; Clinical Trials as Topic; Humans; Piperazines; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Serotonin Antagonists; Thiazoles | 2000 |
Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Dibenzothiepins; Dopamine Antagonists; Drug Monitoring; Haloperidol; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Receptors, Dopamine D2; Receptors, Dopamine D4; Risperidone; Schizophrenia; Schizophrenic Psychology; Serotonin Antagonists; Sulpiride; Thiazoles; Treatment Outcome | 2001 |
[Atypical neuroleptics: new approaches to drug therapy of schizophrenic disorders].
Topics: Aged; Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Controlled Clinical Trials as Topic; Dibenzothiazepines; Dibenzothiepins; Haloperidol; Humans; Imidazoles; Indoles; Multicenter Studies as Topic; Olanzapine; Piperazines; Pirenzepine; Placebos; Quetiapine Fumarate; Risperidone; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sulpiride; Thiazoles | 2000 |
The pharmacology of weight gain with antipsychotics.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Eating; Humans; Olanzapine; Piperazines; Pirenzepine; Psychotic Disorders; Quetiapine Fumarate; Rats; Receptors, Neurotransmitter; Schizophrenia; Thiazoles; Weight Gain | 2001 |
Ziprasidone, a new atypical antipsychotic drug.
Topics: Antipsychotic Agents; Bipolar Disorder; Clinical Trials as Topic; Drug Interactions; Humans; Piperazines; Psychotic Disorders; Schizophrenia; Thiazoles; Tourette Syndrome | 2001 |
Ziprasidone: a new atypical antipsychotic.
Topics: Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Dibenzothiazepines; Dopamine Antagonists; Drug Interactions; Guidelines as Topic; Humans; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Risperidone; Schizophrenia; Serotonin Antagonists; Thiazoles; Time Factors; Tourette Syndrome | 2001 |
Review of atypical antipsychotics and weight gain.
Topics: Ambulatory Care; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Clinical Trials as Topic; Clozapine; Dibenzothiazepines; Dose-Response Relationship, Drug; Hospitalization; Humans; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Research Design; Schizophrenia; Thiazoles; Weight Gain | 2001 |
Use of atypical antipsychotics in mood disorders.
Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clinical Trials as Topic; Clozapine; Depressive Disorder, Major; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Risperidone; Thiazoles | 2001 |
Focus on ziprasidone.
Topics: Antipsychotic Agents; Clinical Trials as Topic; Dopamine Antagonists; Humans; Piperazines; Psychotic Disorders; Schizophrenia; Serotonin Antagonists; Thiazoles; Treatment Outcome | 2001 |
Ziprasidone: profile on safety.
Topics: Antipsychotic Agents; Blood Glucose; Electrocardiography; Humans; Lipids; Piperazines; Prolactin; Psychotic Disorders; Thiazoles; Weight Gain | 2001 |
Ziprasidone: an atypical antipsychotic drug for the treatment of schizophrenia.
Topics: Administration, Oral; Antipsychotic Agents; Bipolar Disorder; Clinical Trials as Topic; Drug Interactions; Drug Overdose; Humans; Injections, Intramuscular; Piperazines; Psychotic Disorders; Schizophrenia; Thiazoles; Tourette Syndrome | 2002 |
Advances in atypical antipsychotics for the treatment of schizophrenia: new formulations and new agents.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clinical Trials as Topic; Clozapine; Dosage Forms; Humans; Isoxazoles; Olanzapine; Piperazines; Piperidines; Pirenzepine; Quinolones; Risperidone; Schizophrenia; Thiazoles | 2002 |
Ziprasidone: the fifth atypical antipsychotic.
Topics: Acute Disease; Antipsychotic Agents; Basal Ganglia Diseases; Body Weight; Headache; Humans; Injections, Intramuscular; Long QT Syndrome; Nausea; Piperazines; Randomized Controlled Trials as Topic; Schizophrenia; Thiazoles; Treatment Outcome; Weight Gain | 2002 |
Ziprasidone: a review of its use in schizophrenia and schizoaffective disorder.
Topics: Administration, Oral; Antipsychotic Agents; Clinical Trials as Topic; Drug Interactions; Humans; Injections, Intramuscular; Piperazines; Psychotic Disorders; Schizophrenia; Thiazoles; Treatment Outcome | 2002 |
Spotlight on ziprasidone in schizophrenia and schizoaffective disorder.
Topics: Antipsychotic Agents; Humans; Piperazines; Psychotic Disorders; Randomized Controlled Trials as Topic; Schizophrenia; Thiazoles; Treatment Outcome | 2002 |
Continuum of care: stabilizing the acutely agitated patient.
Topics: Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Continuity of Patient Care; Cost-Benefit Analysis; Drug Therapy, Combination; Economics, Pharmaceutical; Humans; Olanzapine; Piperazines; Pirenzepine; Psychomotor Agitation; Schizophrenia; Thiazoles; Treatment Outcome | 2002 |
Brief report on Ziprasidone.
Topics: Antipsychotic Agents; Humans; Mental Disorders; Piperazines; Thiazoles | 2002 |
Ziprasidone and the QTc interval: pharmacokinetic and pharmacodynamic considerations.
Topics: Animals; Antipsychotic Agents; Electrocardiography; Humans; Long QT Syndrome; Piperazines; Thiazoles | 2001 |
Recent developments in pharmacotherapy for the acutely psychotic patient.
Topics: Anti-Dyskinesia Agents; Antipsychotic Agents; Benzodiazepines; Haloperidol; Humans; Injections, Intramuscular; Olanzapine; Piperazines; Pirenzepine; Psychomotor Agitation; Psychotic Disorders; Thiazoles | 2002 |
[Schizoaffective disorder: clinical symptoms and present-day approach to treatment].
Topics: Adolescent; Amisulpride; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Carbamazepine; Child; Diagnosis, Differential; Dibenzothiazepines; Dogs; Female; Humans; Imidazoles; Indoles; Lithium Carbonate; Male; Mianserin; Middle Aged; Mirtazapine; Olanzapine; Piperazines; Pirenzepine; Placebos; Prognosis; Psychotic Disorders; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Sulpiride; Thiazoles; Time Factors | 2002 |
Ziprasidone in the management of schizophrenia : the QT interval issue in context.
Topics: Antipsychotic Agents; Electrocardiography; Female; Humans; Long QT Syndrome; Male; Piperazines; Risk Assessment; Risk Factors; Schizophrenia; Sex Factors; Thiazoles; Torsades de Pointes | 2003 |
Atypical psychotropic medications and their adverse effects: a review for the African-American primary care physician.
Topics: Adult; Aged; Antipsychotic Agents; Arrhythmias, Cardiac; Benzodiazepines; Black or African American; Bone Marrow Diseases; Child; Dibenzothiazepines; Endocrine System Diseases; Humans; Mental Disorders; Nervous System Diseases; Olanzapine; Piperazines; Pirenzepine; Primary Health Care; Quetiapine Fumarate; Risperidone; Thiazoles | 2003 |
Alternatives to lithium and divalproex in the maintenance treatment of bipolar disorder.
Topics: Acetates; Amines; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Calcium Channel Blockers; Carbamazepine; Clozapine; Cyclohexanecarboxylic Acids; Dibenzothiazepines; Donepezil; Fatty Acids, Omega-3; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Indans; Lamotrigine; Lithium Carbonate; Olanzapine; Piperazines; Piperidines; Pirenzepine; Quetiapine Fumarate; Risperidone; Thiazoles; Topiramate; Treatment Outcome; Triazines; Valproic Acid | 2003 |
Chlorpromazine equivalent doses for the newer atypical antipsychotics.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chlorpromazine; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Administration Schedule; Haloperidol; Humans; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Therapeutic Equivalency; Thiazoles | 2003 |
Ziprasidone metabolism, aldehyde oxidase, and clinical implications.
Topics: Aldehyde Oxidase; Aldehyde Oxidoreductases; Animals; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Humans; Piperazines; Thiazoles | 2003 |
Antipsychotic medication and seizures: a review.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clinical Trials as Topic; Clozapine; Dibenzothiazepines; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Quinolones; Risperidone; Seizures; Thiazoles | 2003 |
The psychopharmacology of ziprasidone: receptor-binding properties and real-world psychiatric practice.
Topics: Animals; Antipsychotic Agents; Brain; Clinical Trials as Topic; Dopamine; Humans; Membrane Glycoproteins; Membrane Transport Proteins; Neuropeptides; Piperazines; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Schizophrenia; Schizophrenic Psychology; Serotonin; Serotonin Antagonists; Thiazoles; Vesicular Biogenic Amine Transport Proteins | 2003 |
Intramuscular ziprasidone: moving beyond the conventional in the treatment of acute agitation in schizophrenia.
Topics: Acute Disease; Antipsychotic Agents; Brief Psychiatric Rating Scale; Dose-Response Relationship, Drug; Humans; Injections, Intramuscular; Piperazines; Psychomotor Agitation; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology; Serotonin Antagonists; Thiazoles; Treatment Outcome | 2003 |
Oral ziprasidone in the treatment of schizophrenia: a review of short-term trials.
Topics: Administration, Oral; Antipsychotic Agents; Double-Blind Method; Humans; Piperazines; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology; Serotonin Antagonists; Thiazoles; Treatment Outcome | 2003 |
Maintaining symptom control: review of ziprasidone long-term efficacy data.
Topics: Antipsychotic Agents; Clinical Trials as Topic; Humans; Long-Term Care; Piperazines; Schizophrenia; Schizophrenic Psychology; Serotonin Antagonists; Thiazoles; Treatment Outcome | 2003 |
Tolerability of ziprasidone: an expanding perspective.
Topics: Administration, Oral; Antipsychotic Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Humans; Injections, Intramuscular; Long-Term Care; Piperazines; Schizophrenia; Schizophrenic Psychology; Serotonin Antagonists; Thiazoles | 2003 |
Atypical antipsychotics: pharmacokinetics, therapeutic drug monitoring and pharmacological interactions.
Topics: Antipsychotic Agents; Benzodiazepines; Chemistry, Pharmaceutical; Clinical Trials as Topic; Clozapine; Cytochrome P-450 Enzyme System; Dibenzothiazepines; Drug Interactions; Drug Monitoring; Humans; Molecular Structure; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles | 2004 |
Naturalistic studies of second generation antipsychotics in the treatment of schizophrenia.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clinical Trials as Topic; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Patient Compliance; Piperazines; Polypharmacy; Quetiapine Fumarate; Quinolones; Research Design; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome | 2004 |
New antipsychotics and schizophrenia: a review on efficacy and side effects.
Topics: Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Cognition; Dibenzothiazepines; Drug Interactions; Humans; Olanzapine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome | 2004 |
Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies.
Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Benzodiazepines; Child; Dibenzothiazepines; Double-Blind Method; Dyskinesia, Drug-Induced; Haloperidol; Humans; Middle Aged; Neurologic Examination; Olanzapine; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risk; Sulpiride; Thiazoles | 2004 |
[Current pharmacotherapy of schizophrenia].
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Serotonin Antagonists; Sulpiride; Thiazoles | 2004 |
[Ziprasidone. A new second-generation antipsychotic agent].
Topics: Administration, Oral; Antipsychotic Agents; Dopamine Antagonists; Humans; Injections, Intramuscular; Piperazines; Psychotic Disorders; Schizophrenia; Serotonin Antagonists; Thiazoles | 2004 |
Atypical antipsychotics in the treatment of children and adolescents: clinical applications.
Topics: Adolescent; Age Factors; Antipsychotic Agents; Attention Deficit and Disruptive Behavior Disorders; Benzodiazepines; Bipolar Disorder; Child; Child Development Disorders, Pervasive; Clozapine; Dibenzothiazepines; Humans; Mental Disorders; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Tic Disorders | 2004 |
The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2003 update.
Topics: Algorithms; Ambulatory Care; Ambulatory Care Facilities; Antipsychotic Agents; Aripiprazole; Clozapine; Decision Trees; Drug Administration Schedule; Drug Therapy, Combination; Humans; Piperazines; Practice Guidelines as Topic; Quinolones; Schizophrenia; Schizophrenic Psychology; Texas; Thiazoles; Treatment Outcome | 2004 |
[Paralytic ileus during haloperidol therapy].
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Fatal Outcome; Haloperidol; Humans; Intestinal Pseudo-Obstruction; Male; Piperazines; Schizophrenia; Schizophrenic Psychology; Thiazoles | 2004 |
Atypical antipsychotics and diabetes mellitus.
Topics: Antipsychotic Agents; Benzodiazepines; Diabetes Mellitus; Dibenzothiazepines; Glucose; Humans; Insulin Resistance; Islets of Langerhans; Obesity; Olanzapine; Pancreas; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles | 2004 |
[Psychotropics and weight gain].
Topics: Adolescent; Adult; Amisulpride; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Mass Index; Child; Clozapine; Dibenzothiazepines; Double-Blind Method; Female; Fructose; Haloperidol; Humans; Imidazoles; Indoles; Male; Obesity; Olanzapine; Piperazines; Placebos; Psychotropic Drugs; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Socioeconomic Factors; Sulpiride; Thiazoles; Time Factors; Topiramate; Valproic Acid; Weight Gain | 2004 |
The promise of atypical antipsychotics: fewer side effects mean enhanced compliance and improved functioning.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Diabetes Mellitus, Type 2; Dibenzothiazepines; Drug Administration Schedule; Humans; Hyperprolactinemia; Mental Disorders; Olanzapine; Patient Compliance; Piperazines; Practice Guidelines as Topic; Prescription Fees; Quetiapine Fumarate; Quinolones; Risk Assessment; Risperidone; Thiazoles; Torsades de Pointes; Treatment Outcome; Weight Gain | 2004 |
Pharmacology of antipsychotics in the elderly: a focus on atypicals.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Risperidone; Serotonin Antagonists; Thiazoles; Treatment Outcome; United States | 2004 |
Optimizing atypical antipsychotic treatment strategies in the elderly.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Controlled Clinical Trials as Topic; Dementia; Dibenzothiazepines; Humans; Olanzapine; Parkinson Disease; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles; Treatment Outcome | 2004 |
An analysis of the effect of funding source in randomized clinical trials of second generation antipsychotics for the treatment of schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Double-Blind Method; Drug Industry; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Research Support as Topic; Retrospective Studies; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome | 2004 |
Ziprasidone: efficacy, tolerability, and emerging data on wide-ranging effectiveness.
Topics: Antipsychotic Agents; Chemistry, Pharmaceutical; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Tolerance; Humans; Piperazines; Schizophrenia; Thiazoles | 2005 |
The treatment of mixed states and the risk of switching to depression.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Electroconvulsive Therapy; Haloperidol; Health Education; Humans; Lithium Carbonate; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Thiazoles | 2005 |
Toxicology and overdose of atypical antipsychotic medications in children: does newer necessarily mean safer?
Topics: Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Benzodiazepines; Cardiomyopathies; Child; Clozapine; Diabetes Mellitus; Dibenzothiazepines; Drug Interactions; Drug Overdose; Dry Eye Syndromes; Humans; Hyperlipidemias; Hypotension; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Seizures; Thiazoles | 2005 |
Ziprasidone: a novel psychotropic with unique properties.
Topics: Antipsychotic Agents; Clinical Trials as Topic; Humans; Mental Disorders; Piperazines; Schizophrenia; Thiazoles | 2004 |
Atypical antipsychotics: newer options for mania and maintenance therapy.
Topics: Acute Disease; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Humans; Lithium Carbonate; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Thiazoles | 2005 |
Efficacy of olanzapine and ziprasidone for the treatment of schizophrenia: a systematic review.
Topics: Antipsychotic Agents; Benzodiazepines; Drug Evaluation; Humans; Meta-Analysis as Topic; Olanzapine; Piperazines; Schizophrenia; Thiazoles | 2005 |
A typical mood stabilizers: a "typical role for atypical antipsychotics.
Topics: Affect; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Clozapine; Dibenzothiazepines; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Secondary Prevention; Sulpiride; Thiazoles | 2005 |
Bipolar disorder.
Topics: Antidepressive Agents; Antimanic Agents; Benzodiazepines; Bipolar Disorder; Chlorpromazine; Cognitive Behavioral Therapy; Humans; Lithium Carbonate; Olanzapine; Piperazines; Thiazoles; Valproic Acid | 2005 |
Pharmacokinetics and therapeutics of acute intramuscular ziprasidone.
Topics: Antipsychotic Agents; Humans; Injections, Intramuscular; Molecular Structure; Piperazines; Thiazoles | 2005 |
Ziprasidone overdose: cases recorded in the database of Pfizer-Spain and literature review.
Topics: Adult; Antipsychotic Agents; Databases as Topic; Drug Overdose; Electrocardiography; Female; Humans; Male; Middle Aged; Piperazines; Thiazoles | 2005 |
Best clinical practice with ziprasidone IM: update after 2 years of experience.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Critical Care; Emergency Medical Services; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Piperazines; Psychomotor Agitation; Psychotic Disorders; Severity of Illness Index; Thiazoles | 2005 |
Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 2: Incidence and management strategies in patients with schizophrenia.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Dyskinesia, Drug-Induced; Humans; Incidence; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Thiazoles | 2005 |
Discontinuation of treatment of schizophrenic patients is driven by poor symptom response: a pooled post-hoc analysis of four atypical antipsychotic drugs.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Female; Humans; Male; Middle Aged; Olanzapine; Patient Dropouts; Piperazines; Psychiatric Status Rating Scales; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Failure; Treatment Refusal | 2005 |
A systematic review of the efficacy and safety of second generation antipsychotics in the treatment of mania.
Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Thiazoles; Treatment Outcome | 2006 |
[Mechanisms of the body weight gain induced by novel antipsychotic drugs and concomitant lipid abnormalities].
Topics: Antipsychotic Agents; Body Weight; Clozapine; Dibenzothiazepines; Humans; Hyperlipidemias; Leptin; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Thiazoles; Weight Gain | 2005 |
Atypical antipsychotics in the management of delirium: a review of the empirical literature.
Topics: Antipsychotic Agents; Benzodiazepines; Delirium; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Thiazoles; Treatment Outcome | 2005 |
Long-term use of atypical antipsychotics in bipolar disorder.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Drug Administration Schedule; Drug Costs; Humans; Olanzapine; Piperazines; Practice Guidelines as Topic; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Thiazoles; United States | 2006 |
Ziprasidone: efficacy and safety in patients with bipolar disorder.
Topics: Bipolar Disorder; Dopamine Antagonists; Humans; Piperazines; Thiazoles | 2006 |
Differential rates of treatment discontinuation in clinical trials as a measure of treatment effectiveness for olanzapine and comparator atypical antipsychotics for schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Double-Blind Method; Female; Humans; Male; Olanzapine; Patient Dropouts; Piperazines; Psychiatric Status Rating Scales; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Research Design; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Failure; Treatment Outcome | 2006 |
Ziprasidone: a review of its use in schizophrenia and schizoaffective disorder.
Topics: Antipsychotic Agents; Area Under Curve; Humans; Injections, Intramuscular; Long QT Syndrome; Piperazines; Psychotic Disorders; Schizophrenia; Tablets; Thiazoles; Treatment Outcome | 2006 |
Treatment of psychosis: 30 years of progress.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Receptors, Dopamine; Receptors, Serotonin; Risperidone; Schizophrenia; Thiazoles | 2006 |
Ziprasidone for schizophrenia and bipolar disorder: a review of the clinical trials.
Topics: Affective Symptoms; Antipsychotic Agents; Bipolar Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Longitudinal Studies; Piperazines; Randomized Controlled Trials as Topic; Schizophrenia; Thiazoles; Treatment Outcome | 2007 |
Metabolic effects of the atypical antipsychotics.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Diabetes Mellitus; Dibenzothiazepines; Dyslipidemias; Glucose Metabolism Disorders; Humans; Insulin Resistance; Mental Disorders; Obesity; Olanzapine; Phenothiazines; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Thiazoles | 2007 |
Ziprasidone for the treatment of acute manic or mixed episodes associated with bipolar disorder.
Topics: Acute Disease; Administration, Oral; Antipsychotic Agents; Bipolar Disorder; Dopamine D2 Receptor Antagonists; Humans; Piperazines; Serotonin 5-HT2 Receptor Antagonists; Thiazoles; Treatment Outcome | 2007 |
Managing the acutely agitated and psychotic patient.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Dibenzothiazepines; Emergencies; Humans; Olanzapine; Piperazines; Psychomotor Agitation; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Thiazoles | 2007 |
Clinical relevance of relative receptor binding affinity: quetiapine and ziprasidone as examples.
Topics: Antipsychotic Agents; Area Under Curve; Dibenzothiazepines; Dose-Response Relationship, Drug; Humans; Piperazines; Protein Binding; Quetiapine Fumarate; Receptors, Neurotransmitter; Thiazoles | 2007 |
Treatment of bipolar disorder: the evolving role of atypical antipsychotics.
Topics: Antipsychotic Agents; Aripiprazole; Arrhythmias, Cardiac; Benzodiazepines; Bipolar Disorder; Diabetes Mellitus, Type 2; Dibenzothiazepines; Drug Evaluation; Drug Interactions; Drug Therapy, Combination; Dyslipidemias; Humans; Hyperprolactinemia; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles; Treatment Outcome; Weight Gain | 2007 |
Comparison of intramuscular ziprasidone, olanzapine, or aripiprazole for agitation: a quantitative review of efficacy and safety.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Double-Blind Method; Humans; Injections, Intramuscular; Olanzapine; Piperazines; Psychomotor Agitation; Quinolones; Randomized Controlled Trials as Topic; Schizophrenia; Thiazoles; Treatment Outcome | 2007 |
Augmentation of antidepressants with atypical antipsychotics for treatment-resistant major depressive disorder.
Topics: Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Depressive Disorder, Major; Dibenzothiazepines; Dopamine D2 Receptor Antagonists; Drug Resistance; Drug Therapy, Combination; Fluoxetine; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Serotonin 5-HT2 Receptor Antagonists; Thiazoles; Trazodone; Triazoles | 2008 |
A review of sensitivity and tolerability of antipsychotics in patients with bipolar disorder or schizophrenia: focus on somnolence.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Double-Blind Method; Haloperidol; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Research Design; Risperidone; Schizophrenia; Sleep Stages; Thiazoles; Treatment Outcome | 2008 |
Augmentation of antidepressants with atypical antipsychotics: a review of the current literature.
Topics: Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Clozapine; Depressive Disorder, Major; Dibenzothiazepines; Drug Synergism; Drug Therapy, Combination; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Thiazoles | 2008 |
Problems with CATIE. Phase 1: Looking back--what the clinician needs to know.
Topics: Antidepressive Agents, Second-Generation; Basal Ganglia Diseases; Benzodiazepines; Clinical Trials, Phase I as Topic; Cost-Benefit Analysis; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risk; Risperidone; Schizophrenia; Thiazoles | 2008 |
The use of atypical antipsychotics in pediatric bipolar disorder.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Bipolar Disorder; Child; Comorbidity; Dibenzothiazepines; Disorders of Excessive Somnolence; Humans; Obesity; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles; Weight Gain | 2008 |
Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders.
Topics: Adolescent; Aggression; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Benzodiazepines; Child; Child Development Disorders, Pervasive; Child, Preschool; Clozapine; Dibenzothiazepines; Disorders of Excessive Somnolence; Humans; Obesity; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles | 2008 |
Efficacy of atypical antipsychotics in early-onset schizophrenia and other psychotic disorders.
Topics: Adolescent; Adult; Age of Onset; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Brain Diseases; Child; Chronic Disease; Clozapine; Comorbidity; Disease Progression; Humans; Magnetic Resonance Imaging; Olanzapine; Piperazines; Prognosis; Psychotic Disorders; Quinolones; Schizophrenia; Thiazoles; Treatment Failure | 2008 |
Neuroleptic malignant syndrome associated with atypical antipsychotics in pediatric patients: a review of published cases.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Child; Child, Preschool; Clozapine; Dibenzothiazepines; Humans; Neuroleptic Malignant Syndrome; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Retrospective Studies; Risperidone; Thiazoles | 2008 |
Ziprasidone in the treatment of affective disorders: a review.
Topics: Antipsychotic Agents; Bipolar Disorder; Humans; Piperazines; Randomized Controlled Trials as Topic; Thiazoles | 2008 |
How can antipsychotics cause Diabetes Mellitus? Insights based on receptor-binding profiles, humoral factors and transporter proteins.
Topics: Adiponectin; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Blood Glucose; Clozapine; Diabetes Mellitus; Humans; Leptin; Obesity; Olanzapine; Piperazines; Quinolones; Receptor, Muscarinic M3; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D2; Receptors, Histamine; Serotonin 5-HT1 Receptor Agonists; Thiazoles; Weight Gain | 2009 |
Akathisia and second-generation antipsychotic drugs.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Isoxazoles; Olanzapine; Piperazines; Piperidines; Prevalence; Psychomotor Agitation; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Risk Factors; Risperidone; Sulpiride; Thiazoles | 2009 |
A systematic review of cardiovascular effects after atypical antipsychotic medication overdose.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Cardiovascular System; Dibenzothiazepines; Drug Overdose; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles | 2009 |
Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Clozapine; Dibenzothiazepines; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Sulpiride; Thiazoles | 2009 |
Using oral ziprasidone effectively: the food effect and dose-response.
Topics: Administration, Oral; Antipsychotic Agents; Biological Availability; Bipolar Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Energy Intake; Food-Drug Interactions; Humans; Injections, Intramuscular; Intestinal Absorption; Piperazines; Safety; Schizophrenia; Thiazoles; Treatment Outcome | 2009 |
Ziprasidone versus other atypical antipsychotics for schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Sulpiride; Thiazoles | 2009 |
Amisulpride versus other atypical antipsychotics for schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Humans; Olanzapine; Piperazines; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Sulpiride; Thiazoles | 2010 |
Quetiapine versus other atypical antipsychotics for schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Medication Adherence; Olanzapine; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Thiazoles | 2010 |
Olanzapine versus other atypical antipsychotics for schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Sulpiride; Thiazoles | 2010 |
Antipsychotics in pregnancy.
Topics: Abnormalities, Drug-Induced; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Diabetes, Gestational; Dibenzothiazepines; Female; Humans; Infant, Newborn; Olanzapine; Piperazines; Pregnancy; Pregnancy Complications; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles | 2010 |
Ziprasidone HCl capsules for the adjunctive maintenance treatment of bipolar disorder in adults.
Topics: Antipsychotic Agents; Bipolar Disorder; Humans; Piperazines; Randomized Controlled Trials as Topic; Thiazoles | 2010 |
Strategies for successful clinical management of schizophrenia with ziprasidone.
Topics: Antipsychotic Agents; Comorbidity; Humans; Piperazines; Randomized Controlled Trials as Topic; Risk Factors; Schizophrenia; Thiazoles; Treatment Outcome | 2010 |
Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Blood Glucose; Cholesterol; Clinical Trials as Topic; Clozapine; Dibenzothiazepines; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Sulpiride; Thiazoles; Weight Gain | 2010 |
Adjunctive use of atypical antipsychotics for treatment-resistant generalized anxiety disorder.
Topics: Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Benzodiazepines; Clinical Trials as Topic; Dibenzothiazepines; Drug Resistance; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Selective Serotonin Reuptake Inhibitors; Thiazoles | 2010 |
Clozapine versus other atypical antipsychotics for schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Dibenzothiepins; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Thiazoles | 2010 |
Risperidone versus other atypical antipsychotics for schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Sulpiride; Thiazoles | 2011 |
Drug safety evaluation of ziprasidone.
Topics: Antipsychotic Agents; Bipolar Disorder; Clinical Trials as Topic; Drug-Related Side Effects and Adverse Reactions; Humans; Long QT Syndrome; Piperazines; Schizophrenia; Thiazoles | 2011 |
Practical guidance for prescribing ziprasidone in acute manic or mixed episodes of bipolar I disorder.
Topics: Acute Disease; Antipsychotic Agents; Bipolar Disorder; Humans; Molecular Structure; Piperazines; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Thiazoles | 2011 |
Adverse Drug Events Related to Ziprasidone: A Meta-analysis of Randomized, Placebo-Controlled Trials.
Topics: Antipsychotic Agents; Dose-Response Relationship, Drug; Humans; Piperazines; Placebos; Randomized Controlled Trials as Topic; Risk; Thiazoles | 2011 |
Oral ziprasidone in the treatment of patients with bipolar disorders: a critical review.
Topics: Administration, Oral; Antipsychotic Agents; Bipolar Disorder; Humans; Piperazines; Randomized Controlled Trials as Topic; Thiazoles; Treatment Outcome | 2011 |
Ziprasidone for psychotic disorders: a meta-analysis and systematic review of the relationship between pharmacokinetics, pharmacodynamics, and clinical profile.
Topics: Antipsychotic Agents; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Evidence-Based Medicine; Food-Drug Interactions; Humans; Patient Selection; Piperazines; Psychotic Disorders; Receptors, Dopamine D2; Risk Assessment; Thiazoles; Treatment Outcome | 2011 |
Ziprasidone and the corrected QT interval: a comprehensive summary of clinical data.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Bipolar Disorder; Child; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Clinical Trials, Phase IV as Topic; Dose-Response Relationship, Drug; Electrocardiography; Humans; Long QT Syndrome; Piperazines; Randomized Controlled Trials as Topic; Schizophrenia; Thiazoles | 2012 |
Changes in weight, plasma lipids, and glucose in adults treated with ziprasidone: a comprehensive analysis of pfizer-initiated clinical trials.
Topics: Antipsychotic Agents; Bipolar Disorder; Blood Glucose; Body Mass Index; Body Weight; Clinical Trials as Topic; Drug Industry; Fasting; Humans; Lipids; Piperazines; Psychotic Disorders; Randomized Controlled Trials as Topic; Schizophrenia; Thiazoles; Time Factors | 2012 |
Comparing tolerability profile of quetiapine, risperidone, aripiprazole and ziprasidone in schizophrenia and affective disorders: a meta-analysis.
Topics: Adult; Affective Disorders, Psychotic; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Dibenzothiazepines; Humans; Hypercholesterolemia; Incidence; Pharmacovigilance; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Thiazoles | 2012 |
Lower rate of depressive switch following antimanic treatment with second-generation antipsychotics versus haloperidol.
Topics: Acute Disease; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Depression; Depressive Disorder; Dibenzothiazepines; Double-Blind Method; Drug Industry; Haloperidol; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Research Support as Topic; Risperidone; Thiazoles | 2013 |
Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation).
Topics: Aggression; Antipsychotic Agents; Aripiprazole; Clopenthixol; Dystonia; Haloperidol; Humans; Lorazepam; Piperazines; Psychomotor Agitation; Psychotic Disorders; Quinolones; Randomized Controlled Trials as Topic; Sleep; Thiazoles | 2012 |
Aripiprazole versus other atypical antipsychotics for schizophrenia.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Humans; Olanzapine; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Thiazoles | 2013 |
Risk for adverse events and discontinuation due to adverse events of ziprasidone monotherapy relative to placebo in the acute treatment of bipolar depression, mania, and schizophrenia.
Topics: Antipsychotic Agents; Bipolar Disorder; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Humans; Piperazines; Randomized Controlled Trials as Topic; Schizophrenia; Sleep Stages; Thiazoles; Weight Gain | 2013 |
Atypical antipsychotics in the treatment of delirium.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Delirium; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Sulpiride; Thiazoles | 2013 |
[Pharmaceutical applications of sulfobuthylether-beta-cyclodextrin].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Antiemetics; Antifungal Agents; Antipsychotic Agents; Aripiprazole; beta-Cyclodextrins; Chemistry, Pharmaceutical; Dosage Forms; Drug Stability; Humans; Hungary; Multiple Myeloma; Oligopeptides; Piperazines; Pyrimidines; Quinolones; Quinuclidines; Solubility; Thiazoles; Triazoles; Voriconazole | 2013 |
The efficacy and safety of switching to ziprasidone from olanzapine in patients with bipolar I disorder: an 8-week, multicenter, open-label study.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Drug Substitution; Drug Therapy, Combination; Dyslipidemias; Female; Humans; Lithium; Male; Middle Aged; Olanzapine; Piperazines; Prospective Studies; Thiazoles; Treatment Outcome; Valproic Acid; Young Adult | 2013 |
Is the combination of a mood stabilizer plus an antipsychotic more effective than mono-therapies in long-term treatment of bipolar disorder? A systematic review.
Topics: Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Drug Therapy, Combination; Humans; Long-Term Care; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles; Treatment Outcome | 2014 |
Quetiapine versus other atypical antipsychotics for schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Medication Adherence; Olanzapine; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Thiazoles | 2013 |
An update on the treatment of mixed bipolar states: what is new in 2013?
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Calcitonin; Dibenzocycloheptenes; Heterocyclic Compounds, 4 or More Rings; Humans; Olanzapine; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Thiazoles; Treatment Outcome | 2014 |
Current status of atypical antipsychotics for the treatment of fibromyalgia.
Topics: Amisulpride; Antipsychotic Agents; Anxiety; Benzodiazepines; Comorbidity; Depression; Dibenzothiazepines; Fibromyalgia; Humans; Olanzapine; Patient Selection; Piperazines; Quetiapine Fumarate; Sulpiride; Thiazoles; Treatment Outcome | 2014 |
Treating the violent patient with psychosis or impulsivity utilizing antipsychotic polypharmacy and high-dose monotherapy.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Brain; Clozapine; Dibenzocycloheptenes; Drug Therapy, Combination; Heterocyclic Compounds, 4 or More Rings; Humans; Impulsive Behavior; Isoxazoles; Lurasidone Hydrochloride; Olanzapine; Paliperidone Palmitate; Piperazines; Piperidines; Polypharmacy; Psychotic Disorders; Quetiapine Fumarate; Receptors, Dopamine D2; Risperidone; Thiazoles; Violence | 2014 |
Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple-treatments meta-analysis.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Depression; Dibenzothiazepines; Drug Therapy, Combination; Fluoxetine; Humans; Isoindoles; Lamotrigine; Lithium Compounds; Lurasidone Hydrochloride; Monoamine Oxidase Inhibitors; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Selective Serotonin Reuptake Inhibitors; Thiazoles; Treatment Outcome; Triazines; Valproic Acid | 2014 |
[Sparse evidence of antipsychotic drugs for the treatment of delirium].
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Delirium; Evidence-Based Medicine; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Sulpiride; Thiazoles | 2014 |
[Sparse evidence of antipsychotic drugs for the treatment of delirium].
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Delirium; Evidence-Based Medicine; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Sulpiride; Thiazoles | 2014 |
Evaluation of the pharmacokinetics, safety and clinical efficacy of ziprasidone for the treatment of schizophrenia and bipolar disorder.
Topics: Animals; Antipsychotic Agents; Bipolar Disorder; Disorders of Excessive Somnolence; Dizziness; Drug Evaluation; Humans; Piperazines; Schizophrenia; Thiazoles; Treatment Outcome | 2015 |
Antipsychotic switching in schizoaffective disorder: A systematic review.
Topics: Antipsychotic Agents; Aripiprazole; Drug Substitution; Humans; Piperazines; Psychotic Disorders; Randomized Controlled Trials as Topic; Risperidone; Thiazoles | 2016 |
Psychopharmacology of chronic pain: a focus on antidepressants and atypical antipsychotics.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bupropion; Chronic Pain; Humans; Mianserin; Mirtazapine; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Thiazoles; Trazodone; Triazoles | 2016 |
Is There Room for Second-Generation Antipsychotics in the Pharmacotherapy of Panic Disorder? A Systematic Review Based on PRISMA Guidelines.
Topics: Antipsychotic Agents; Bipolar Disorder; Humans; Panic Disorder; Piperazines; Quetiapine Fumarate; Risperidone; Thiazoles | 2016 |
A pragmatic approach to the diagnosis and treatment of mixed features in adults with mood disorders.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Cognitive Behavioral Therapy; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Humans; Lithium Compounds; Mood Disorders; Piperazines; Thiazoles | 2016 |
Evidence-Based Review of Pharmacotherapy Used for Parkinson's Disease Psychosis.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Evidence-Based Medicine; Humans; Olanzapine; Parkinson Disease; Piperazines; Piperidines; Practice Guidelines as Topic; Psychotic Disorders; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Thiazoles; Urea | 2017 |
Atypical antipsychotics for disruptive behaviour disorders in children and youths.
Topics: Adolescent; Aggression; Antipsychotic Agents; Anxiety Disorders; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Conduct Disorder; Depressive Disorder, Major; Dibenzothiazepines; Humans; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Thiazoles; Weight Gain | 2017 |
The metabolic side effects of 12 antipsychotic drugs used for the treatment of schizophrenia on glucose: a network meta-analysis.
Topics: Antipsychotic Agents; Benzodiazepines; Blood Glucose; Humans; Insulin; Lurasidone Hydrochloride; Network Meta-Analysis; Olanzapine; Piperazines; Risperidone; Schizophrenia; Thiazoles | 2017 |
Risperidone versus other antipsychotics for people with severe mental illness and co-occurring substance misuse.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Diagnosis, Dual (Psychiatry); Humans; Mental Disorders; Olanzapine; Patient Dropouts; Perphenazine; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Substance-Related Disorders; Thiazoles | 2018 |
Mixed states in bipolar and major depressive disorders: systematic review and quality appraisal of guidelines.
Topics: Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Therapy, Combination; Electroconvulsive Therapy; Humans; Lithium; Lurasidone Hydrochloride; Olanzapine; Paliperidone Palmitate; Piperazines; Practice Guidelines as Topic; Quetiapine Fumarate; Thiazoles; Valproic Acid | 2018 |
A Systematic Review and Case Series of Ziprasidone for Psychosis in Parkinson's Disease.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Female; Humans; Lewy Body Disease; Male; Parkinson Disease; Piperazines; Thiazoles | 2019 |
Electroconvulsive therapy for treatment-resistant schizophrenia.
Topics: Adult; Antipsychotic Agents; Brief Psychiatric Rating Scale; Electroconvulsive Therapy; Female; Flupenthixol; Humans; Male; Memory Disorders; Patient Readmission; Piperazines; Randomized Controlled Trials as Topic; Schizophrenia; Standard of Care; Thiazoles; Treatment Outcome | 2019 |
Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia.
Topics: Acute Disease; Administration, Oral; Antipsychotic Agents; Aripiprazole; Clozapine; Delayed-Action Preparations; Dose-Response Relationship, Drug; Haloperidol; Humans; Imidazoles; Indoles; Isoxazoles; Lurasidone Hydrochloride; Olanzapine; Paliperidone Palmitate; Piperazines; Piperidines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Thiophenes | 2020 |
Haloperidol Versus Ziprasidone With Concomitant Medications and Other Predictors of Physical Restraint Duration in the Emergency Department.
Topics: Antipsychotic Agents; Emergency Service, Hospital; Haloperidol; Humans; Piperazines; Psychomotor Agitation; Restraint, Physical; Retrospective Studies; Thiazoles | 2022 |
A cumulative Bayesian network meta-analysis on the comparative efficacy of pharmacotherapies for mania over the last 40 years.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Carbamazepine; Dibenzocycloheptenes; Haloperidol; Humans; Lithium; Mania; Network Meta-Analysis; Olanzapine; Paliperidone Palmitate; Pharmaceutical Preparations; Piperazines; Quetiapine Fumarate; Risperidone; Tamoxifen; Thiazoles; Valproic Acid | 2022 |
237 trial(s) available for ziprasidone and thiazoles
| Article | Year |
|---|---|
Dose dependent occupancy of central dopamine D2 receptors by the novel neuroleptic CP-88,059-01: a study using positron emission tomography and 11C-raclopride.
Topics: Adult; Brain; Cerebrovascular Circulation; Dopamine Antagonists; Dose-Response Relationship, Drug; Humans; Image Processing, Computer-Assisted; Male; Neostriatum; Piperazines; Prolactin; Raclopride; Receptors, Dopamine D2; Salicylamides; Spiro Compounds; Thiazoles; Tomography, Emission-Computed | 1993 |
The time course of binding to striatal dopamine D2 receptors by the neuroleptic ziprasidone (CP-88,059-01) determined by positron emission tomography.
Topics: Adult; Antipsychotic Agents; Corpus Striatum; Humans; Male; Piperazines; Prolactin; Raclopride; Receptors, Dopamine D2; Salicylamides; Thiazoles; Time Factors; Tomography, Emission-Computed | 1996 |
Metabolism and excretion of a new antipsychotic drug, ziprasidone, in humans.
Topics: Adult; Antipsychotic Agents; Area Under Curve; Biotransformation; Chromatography, High Pressure Liquid; Chromatography, Liquid; Circular Dichroism; Feces; Humans; Hydrolysis; Mass Spectrometry; Piperazines; Reference Standards; Thiazoles | 1997 |
An exploratory haloperidol-controlled dose-finding study of ziprasidone in hospitalized patients with schizophrenia or schizoaffective disorder.
Topics: Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Haloperidol; Hospitalization; Humans; Male; Middle Aged; Neurologic Examination; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome | 1998 |
Ziprasidone 40 and 120 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 4-week placebo-controlled trial.
Topics: Acute Disease; Adolescent; Adult; Aged; Antipsychotic Agents; Double-Blind Method; Electrocardiography; Female; Humans; Male; Middle Aged; Piperazines; Psychotic Disorders; Schizophrenia; Thiazoles | 1998 |
Ziprasidone 80 mg/day and 160 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 6-week placebo-controlled trial. Ziprasidone Study Group.
Topics: Acute Disease; Adolescent; Adult; Aged; Antipsychotic Agents; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Thiazoles | 1999 |
Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study.
Topics: Adolescent; Antipsychotic Agents; Child; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Pilot Projects; Piperazines; Thiazoles; Tourette Syndrome | 2000 |
Single- and multiple-dose pharmacokinetics of ziprasidone under non-fasting conditions in healthy male volunteers.
Topics: Adolescent; Adult; Antipsychotic Agents; Area Under Curve; Double-Blind Method; Humans; Male; Middle Aged; Piperazines; Prolactin; Reference Values; Sleep; Sleep Stages; Thiazoles | 2000 |
Single- and multiple-dose pharmacokinetics of ziprasidone in healthy young and elderly volunteers.
Topics: Adolescent; Adult; Aged; Aging; Antipsychotic Agents; Area Under Curve; Female; Humans; Male; Middle Aged; Piperazines; Thiazoles | 2000 |
The pharmacokinetics of ziprasidone in subjects with normal and impaired hepatic function.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Antipyrine; Area Under Curve; Female; Humans; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Male; Middle Aged; Piperazines; Reference Values; Saliva; Thiazoles | 2000 |
The pharmacokinetics of ziprasidone in subjects with normal and impaired renal function.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Area Under Curve; Creatinine; Double-Blind Method; Female; Half-Life; Humans; Kidney Diseases; Male; Middle Aged; Piperazines; Reference Values; Renal Dialysis; Thiazoles | 2000 |
Ziprasidone and the activity of cytochrome P450 2D6 in healthy extensive metabolizers.
Topics: Adolescent; Adult; Antipsychotic Agents; Area Under Curve; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Dextromethorphan; Drug Interactions; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Thiazoles | 2000 |
Ziprasidone and the pharmacokinetics of a combined oral contraceptive.
Topics: Adolescent; Adult; Antipsychotic Agents; Area Under Curve; Contraceptives, Oral, Synthetic; Cross-Over Studies; Double-Blind Method; Drug Interactions; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Piperazines; Prolactin; Thiazoles | 2000 |
The pharmacokinetics of ziprasidone in healthy volunteers treated with cimetidine or antacid.
Topics: Adult; Antacids; Anti-Ulcer Agents; Antipsychotic Agents; Area Under Curve; Cimetidine; Cross-Over Studies; Drug Interactions; Female; Half-Life; Humans; Male; Piperazines; Thiazoles | 2000 |
The effects of ziprasidone on steady-state lithium levels and renal clearance of lithium.
Topics: Adult; Antipsychotic Agents; Drug Interactions; Humans; Lithium; Male; Middle Aged; Piperazines; Thiazoles | 2000 |
The effect of carbamazepine on the steady-state pharmacokinetics of ziprasidone in healthy volunteers.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Area Under Curve; Carbamazepine; Drug Interactions; Female; Half-Life; Humans; Male; Piperazines; Thiazoles | 2000 |
The effects of ketoconazole on ziprasidone pharmacokinetics--a placebo-controlled crossover study in healthy volunteers.
Topics: Adolescent; Adult; Antifungal Agents; Antipsychotic Agents; Area Under Curve; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Female; Humans; Ketoconazole; Male; Mixed Function Oxygenases; Piperazines; Thiazoles | 2000 |
Ziprasidone in the short-term treatment of patients with schizoaffective disorder: results from two double- blind, placebo-controlled, multicenter studies.
Topics: Adolescent; Adult; Antipsychotic Agents; Double-Blind Method; Female; Humans; Male; Middle Aged; Movement Disorders; Piperazines; Psychotic Disorders; Thiazoles; Treatment Outcome | 2001 |
Intramuscular ziprasidone compared with intramuscular haloperidol in the treatment of acute psychosis. Ziprasidone I.M. Study Group.
Topics: Acute Disease; Adult; Aged; Antipsychotic Agents; Brief Psychiatric Rating Scale; Drug Administration Schedule; Female; Haloperidol; Hospitalization; Humans; Injections, Intramuscular; Male; Middle Aged; Piperazines; Psychotic Disorders; Severity of Illness Index; Thiazoles; Treatment Outcome | 2000 |
Intramuscular ziprasidone, 2 mg versus 10 mg, in the short-term management of agitated psychotic patients.
Topics: Antipsychotic Agents; Area Under Curve; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Injections, Intramuscular; Male; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Thiazoles; Treatment Outcome | 2001 |
Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Double-Blind Method; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Psychomotor Agitation; Psychotic Disorders; Thiazoles | 2001 |
The apparent effects of ziprasidone on plasma lipids and glucose.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Blood Glucose; Body Mass Index; Body Weight; Cholesterol; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Lipids; Male; Outcome Assessment, Health Care; Piperazines; Psychotic Disorders; Schizophrenia; Thiazoles; Triglycerides | 2001 |
The anxiolytic effect of the novel antipsychotic ziprasidone compared with diazepam in subjects anxious before dental surgery.
Topics: Adolescent; Adult; Anti-Anxiety Agents; Antipsychotic Agents; Arousal; Dental Anxiety; Diazepam; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Premedication; Thiazoles; Treatment Outcome | 2002 |
A 28-week comparison of ziprasidone and haloperidol in outpatients with stable schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Female; Haloperidol; Humans; Male; Middle Aged; Nausea; Piperazines; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Sleep Initiation and Maintenance Disorders; Thiazoles; Treatment Outcome; Vomiting | 2002 |
A 1-year, double-blind, placebo-controlled trial of ziprasidone 40, 80 and 160 mg/day in chronic schizophrenia: the Ziprasidone Extended Use in Schizophrenia (ZEUS) study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Chronic Disease; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Recurrence; Schizophrenia; Thiazoles; Time Factors; Treatment Outcome | 2002 |
Weight, lipids, glucose, and behavioral measures with ziprasidone treatment in a population with mental retardation.
Topics: Antipsychotic Agents; Blood Glucose; Body Weight; Cholesterol; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Intellectual Disability; Lipids; Male; Mental Disorders; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Thiazoles; Treatment Outcome; Triglycerides | 2003 |
Ziprasidone augmentation of clozapine in 11 patients.
Topics: Adult; Antipsychotic Agents; Clozapine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Piperazines; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome; Weight Gain | 2003 |
Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial.
Topics: Acute Disease; Administration, Oral; Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Piperazines; Placebos; Psychiatric Status Rating Scales; Severity of Illness Index; Thiazoles; Treatment Outcome | 2003 |
Effectiveness of switching to ziprasidone for stable but symptomatic outpatients with schizophrenia.
Topics: Adolescent; Adult; Ambulatory Care; Antipsychotic Agents; Benzodiazepines; Cross-Over Studies; Female; Humans; Male; Middle Aged; Olanzapine; Piperazines; Pirenzepine; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Thiazoles; Treatment Outcome | 2003 |
Pharmacodynamics of ziprasidone in children and adolescents: impact on dopamine transmission.
Topics: Adolescent; Antipsychotic Agents; Child; Chronic Disease; Dopamine; Dopamine D2 Receptor Antagonists; Drug Administration Schedule; Female; Humans; Male; Piperazines; Prefrontal Cortex; Thiazoles; Tourette Syndrome | 2003 |
Randomized, controlled, double-blind, multicenter comparison of the cognitive effects of ziprasidone versus olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cognition; Double-Blind Method; Female; Hospitalization; Humans; Male; Memory; Middle Aged; Olanzapine; Piperazines; Psychotic Disorders; Schizophrenia; Thiazoles | 2004 |
Improvement in indices of health status in outpatients with schizophrenia switched to ziprasidone.
Topics: Adolescent; Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Body Weight; Female; Health Status Indicators; Humans; Male; Middle Aged; Olanzapine; Piperazines; Prolactin; Psychotic Disorders; Risperidone; Schizophrenia; Thiazoles; Withholding Treatment | 2003 |
The effect of a switch to ziprasidone in an adult population with autistic disorder: chart review of naturalistic, open-label treatment.
Topics: Adult; Age Factors; Antipsychotic Agents; Autistic Disorder; Cholesterol; Female; Humans; Male; Middle Aged; Piperazines; Retrospective Studies; Thiazoles; Treatment Outcome; Weight Gain | 2004 |
Ziprasidone augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant major depressive disorder.
Topics: Adult; Antipsychotic Agents; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Personality Assessment; Personality Inventory; Piperazines; Psychometrics; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Agonists; Thiazoles; Treatment Outcome | 2004 |
Improvement in cognitive function following a switch to ziprasidone from conventional antipsychotics, olanzapine, or risperidone in outpatients with schizophrenia.
Topics: Adolescent; Adult; Ambulatory Care; Arousal; Attention; Benzodiazepines; Cognition; Drug Administration Schedule; Drug Tolerance; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Olanzapine; Piperazines; Risperidone; Schizophrenia; Thiazoles; Verbal Behavior | 2004 |
The tolerability of intramuscular ziprasidone and haloperidol treatment and the transition to oral therapy.
Topics: Administration, Oral; Adult; Aged; Antipsychotic Agents; Dose-Response Relationship, Drug; Drug Interactions; Endpoint Determination; Female; Haloperidol; Humans; Injections, Intramuscular; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Thiazoles; Time Factors | 2004 |
A PET study of dopamine D2 and serotonin 5-HT2 receptor occupancy in patients with schizophrenia treated with therapeutic doses of ziprasidone.
Topics: Adult; Antipsychotic Agents; Brain; Corpus Striatum; Drug Administration Schedule; Female; Humans; Male; Piperazines; Psychotic Disorders; Pyrimidinones; Raclopride; Receptors, Dopamine D2; Receptors, Serotonin, 5-HT2; Schizophrenia; Thiazoles; Tomography, Emission-Computed | 2004 |
Ziprasidone in the acute treatment of borderline personality disorder in psychiatric emergency services.
Topics: Acute Disease; Administration, Oral; Adult; Antipsychotic Agents; Borderline Personality Disorder; Drug Administration Schedule; Emergency Services, Psychiatric; Female; Humans; Male; Piperazines; Psychiatric Status Rating Scales; Thiazoles; Treatment Outcome | 2004 |
Randomized, controlled, double-blind multicenter comparison of the efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lorazepam; Male; Metabolic Syndrome; Middle Aged; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Thiazoles; Treatment Outcome; Weight Gain | 2004 |
[QTc-interval prolongation in therapy with atypical antipsychotics--results of an open, non-randomized survey].
Topics: Antipsychotic Agents; Electrocardiography; Germany; Hospitalization; Hospitals, Psychiatric; Humans; Long QT Syndrome; Piperazines; Prospective Studies; Psychotic Disorders; Risk Assessment; Thiazoles; Torsades de Pointes | 2004 |
Economic consequences of the adverse reactions related with antipsychotics: an economic model comparing tolerability of ziprasidone, olanzapine, risperidone, and haloperidol in Spain.
Topics: Antipsychotic Agents; Benzodiazepines; Cost-Benefit Analysis; Dyskinesia, Drug-Induced; Follow-Up Studies; Haloperidol; Hospitalization; Humans; Mental Disorders; Models, Econometric; Olanzapine; Outpatients; Patient Compliance; Piperazines; Psychiatric Status Rating Scales; Retrospective Studies; Risperidone; Sensitivity and Specificity; Spain; Survival Analysis; Thiazoles; Treatment Outcome; Weight Gain | 2004 |
Electrocardiographic changes in children and adolescents treated with ziprasidone: a prospective study.
Topics: Adolescent; Antipsychotic Agents; Child; Child Development Disorders, Pervasive; Electrocardiography; Female; Humans; Long QT Syndrome; Male; Obsessive-Compulsive Disorder; Piperazines; Prospective Studies; Psychotic Disorders; Thiazoles; Tourette Syndrome | 2005 |
Striatal dopaminergic D2 receptor occupancy and clinical efficacy in psychosis exacerbation: a 123I-IBZM study with ziprasidone and haloperidol.
Topics: Adult; Antipsychotic Agents; Benzamides; Drug Resistance; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Male; Neostriatum; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Pyrrolidines; Radiopharmaceuticals; Receptors, Dopamine D2; Single-Blind Method; Thiazoles; Tomography, Emission-Computed, Single-Photon; Treatment Failure | 2005 |
Efficacy and tolerability of ziprasidone versus risperidone in patients with acute exacerbation of schizophrenia or schizoaffective disorder: an 8-week, double-blind, multicenter trial.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Double-Blind Method; Female; Follow-Up Studies; Humans; Hyperprolactinemia; Male; Patient Dropouts; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Sexual Dysfunctions, Psychological; Sleep Initiation and Maintenance Disorders; Thiazoles; Treatment Outcome | 2004 |
Ziprasidone and haloperidol in the treatment of acute exacerbation of schizophrenia and schizoaffective disorder: comparison of intramuscular and oral formulations in a 6-week, randomized, blinded-assessment study.
Topics: Acute Disease; Administration, Oral; Adult; Affective Disorders, Psychotic; Brief Psychiatric Rating Scale; Demography; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Haloperidol; Humans; Injections, Intramuscular; Male; Manifest Anxiety Scale; Piperazines; Schizophrenia; Severity of Illness Index; Thiazoles; Time Factors; Treatment Outcome; Withholding Treatment | 2005 |
Parenteral ziprasidone: a new atypical neuroleptic for emergency treatment of psychosis in Parkinson's disease?
Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Electrocardiography; Emergency Medical Services; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Parkinson Disease; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Psychotic Disorders; Thiazoles | 2005 |
Pharmacokinetics, safety, and tolerability of intramuscular ziprasidone in healthy volunteers.
Topics: Adult; Antipsychotic Agents; Blood Pressure; Cross-Over Studies; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Half-Life; Heart Rate; Humans; Injections, Intramuscular; Injections, Intravenous; Kidney; Male; Middle Aged; Piperazines; Thiazoles; Time Factors | 2005 |
Cerebral cortical gray expansion associated with two second-generation antipsychotics.
Topics: Adult; Antipsychotic Agents; Atrophy; Cerebral Cortex; Cognition Disorders; Female; Follow-Up Studies; Haloperidol; Humans; Magnetic Resonance Imaging; Male; Nerve Growth Factors; Piperazines; Psychiatric Status Rating Scales; Quality of Life; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome | 2005 |
Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial.
Topics: Acute Disease; Adult; Aged; Antipsychotic Agents; Bipolar Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Hospitalization; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Thiazoles; Treatment Outcome | 2005 |
Six-month, blinded, multicenter continuation study of ziprasidone versus olanzapine in schizophrenia.
Topics: Ambulatory Care; Antipsychotic Agents; Benzodiazepines; Brief Psychiatric Rating Scale; Double-Blind Method; Drug Administration Schedule; Follow-Up Studies; Humans; Obesity; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Thiazoles; Treatment Outcome; Weight Gain | 2005 |
Improved sleep continuity and increased slow wave sleep and REM latency during ziprasidone treatment: a randomized, controlled, crossover trial of 12 healthy male subjects.
Topics: Acoustic Stimulation; Antipsychotic Agents; Cross-Over Studies; Double-Blind Method; Electroencephalography; Humans; Male; Piperazines; Placebos; Polysomnography; Sleep; Sleep Stages; Sleep, REM; Stress, Psychological; Surveys and Questionnaires; Thiazoles | 2005 |
Ziprasidone decreases cortisol excretion in healthy subjects.
Topics: Acoustic Stimulation; Adult; Antipsychotic Agents; Double-Blind Method; Humans; Hydrocortisone; Male; Piperazines; Stress, Physiological; Thiazoles | 2005 |
Open-label pilot study of ziprasidone for refractory generalized anxiety disorder.
Topics: Adult; Aged; Antipsychotic Agents; Anxiety Disorders; Drug Resistance; Female; Humans; Male; Middle Aged; Pilot Projects; Piperazines; Psychiatric Status Rating Scales; Thiazoles | 2005 |
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Dibenzothiazepines; Double-Blind Method; Female; Humans; Lipids; Male; Olanzapine; Patient Compliance; Perphenazine; Piperazines; Proportional Hazards Models; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome; Weight Gain | 2005 |
Olanzapine versus ziprasidone: results of a 28-week double-blind study in patients with schizophrenia.
Topics: Adult; Age of Onset; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Blood Glucose; Double-Blind Method; Drug Administration Schedule; Fasting; Female; Humans; Lipids; Male; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Quality of Life; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Thiazoles; Treatment Outcome | 2005 |
Management of acute undifferentiated agitation in the emergency department: a randomized double-blind trial of droperidol, ziprasidone, and midazolam.
Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Antipsychotic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Droperidol; Emergency Service, Hospital; Female; Humans; Length of Stay; Male; Mental Status Schedule; Midazolam; Middle Aged; Piperazines; Prospective Studies; Psychomotor Agitation; Respiratory Insufficiency; Thiazoles; Treatment Outcome | 2005 |
Efficacy and tolerability of ziprasidone in patients with treatment-resistant schizophrenia.
Topics: Adult; Antipsychotic Agents; Brief Psychiatric Rating Scale; Chlorpromazine; Double-Blind Method; Drug Resistance; Female; Haloperidol; Humans; Male; Piperazines; Prolactin; Schizophrenia; Thiazoles; Time Factors | 2006 |
Neuropsychological normalization with long-term atypical antipsychotic treatment: results of a six-month randomized, double-blind comparison of ziprasidone vs. olanzapine.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cognition Disorders; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Olanzapine; Patient Admission; Piperazines; Psychometrics; Psychotic Disorders; Schizophrenia; Thiazoles | 2006 |
Ziprasidone and amisulpride effectively treat negative symptoms of schizophrenia: results of a 12-week, double-blind study.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Amisulpride; Antipsychotic Agents; Behavioral Symptoms; Double-Blind Method; Female; Hospitalization; Humans; Ketones; Male; Middle Aged; Movement Disorders; Piperazines; Psychiatric Status Rating Scales; Schizophrenia; Sulpiride; Thiazoles; Time Factors; Treatment Outcome; Weight Gain; Weight Loss | 2006 |
Effect of initial ziprasidone dose on length of therapy in schizophrenia.
Topics: Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Piperazines; Proportional Hazards Models; Psychiatric Status Rating Scales; Retrospective Studies; Risk; Schizophrenia; Thiazoles; Time Factors; Treatment Outcome | 2006 |
Effect of initial ziprasidone dose on treatment persistence in schizophrenia.
Topics: Adult; Antipsychotic Agents; Chi-Square Distribution; Demography; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Middle Aged; Piperazines; Proportional Hazards Models; Psychiatric Status Rating Scales; Retrospective Studies; Schizophrenia; Sensitivity and Specificity; Thiazoles; Treatment Outcome | 2006 |
Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment.
Topics: Adult; Agranulocytosis; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Clozapine; Cross-Over Studies; Dibenzothiazepines; Drug Monitoring; Drug Resistance; Eosinophilia; Female; Follow-Up Studies; Humans; Male; Olanzapine; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome | 2006 |
Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Body Weight; Chronic Disease; Cross-Over Studies; Dibenzothiazepines; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Olanzapine; Patient Dropouts; Piperazines; Proportional Hazards Models; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Survival Analysis; Thiazoles; Time Factors; Treatment Outcome | 2006 |
A 24-week randomized study of olanzapine versus ziprasidone in the treatment of schizophrenia or schizoaffective disorder in patients with prominent depressive symptoms.
Topics: Antipsychotic Agents; Benzodiazepines; Depression; Glycated Hemoglobin; Humans; Olanzapine; Patient Dropouts; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Thiazoles; Treatment Outcome; Triglycerides; United States; Weight Gain | 2006 |
Efficacy of ziprasidone against hostility in schizophrenia: Post hoc analysis of randomized, open-label study data.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antipsychotic Agents; Female; Haloperidol; Hospitalization; Hostility; Humans; Injections, Intramuscular; Male; Middle Aged; Piperazines; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome | 2006 |
Single-dose pharmacokinetics and safety of ziprasidone in children and adolescents.
Topics: Adolescent; Antipsychotic Agents; Child; Cluster Analysis; Dose-Response Relationship, Drug; Electrocardiography; Female; Humans; Male; Piperazines; Thiazoles; Tourette Syndrome | 2006 |
Intramuscular ziprasidone treatment of acute psychotic agitation in elderly patients with schizophrenia.
Topics: Acute Disease; Aged; Aged, 80 and over; Antipsychotic Agents; Drug Administration Schedule; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Piperazines; Psychomotor Agitation; Psychotic Disorders; Schizophrenia; Thiazoles | 2006 |
Ziprasidone-induced cognitive enhancement in schizophrenia: specificity or pseudospecificity?
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Brief Psychiatric Rating Scale; Cognition; Cognition Disorders; Female; Humans; Male; Memory; Middle Aged; Neuropsychological Tests; Piperazines; Schizophrenia; Severity of Illness Index; Thiazoles | 2006 |
An exploratory open-label trial of ziprasidone for the treatment of behavioral and psychological symptoms of dementia.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Dementia; Disorders of Excessive Somnolence; Drug Administration Schedule; Female; Gastrointestinal Diseases; Humans; Male; Mental Disorders; Middle Aged; Parkinson Disease, Secondary; Piperazines; Thiazoles | 2006 |
Early changes of plasma lipids during treatment with atypical antipsychotics.
Topics: Adolescent; Adult; Aged; Amisulpride; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Body Weight; Cholesterol; Clozapine; Humans; Lipids; Middle Aged; Olanzapine; Piperazines; Prospective Studies; Schizophrenia; Sulpiride; Thiazoles; Time Factors; Triglycerides | 2006 |
The relationship between quality of life and clinical efficacy from a randomized trial comparing olanzapine and ziprasidone.
Topics: Antipsychotic Agents; Benzodiazepines; Double-Blind Method; Health Status; Humans; Longitudinal Studies; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Quality of Life; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome | 2006 |
Use of ziprasidone in patients with fibromyalgia: a case series.
Topics: Adult; Aged; Antipsychotic Agents; Female; Fibromyalgia; Humans; Male; Middle Aged; Pain; Piperazines; Severity of Illness Index; Thiazoles; Treatment Outcome | 2007 |
[Switching patients with schizophrenia to ziprasidone from conventional or other atypical antipsychotics].
Topics: Adult; Aged; Antipsychotic Agents; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Thiazoles; Treatment Outcome | 2006 |
Efficacy of ziprasidone in controlling agitation during post-traumatic amnesia.
Topics: Adolescent; Adult; Amnesia; Antipsychotic Agents; Brain Injuries; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Glasgow Coma Scale; Humans; Male; Piperazines; Psychomotor Agitation; Thiazoles | 2007 |
Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE study.
Topics: Adaptation, Psychological; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Clozapine; Dibenzothiazepines; Follow-Up Studies; Health Status; Humans; National Institute of Mental Health (U.S.); Olanzapine; Patient Dropouts; Perphenazine; Piperazines; Quality of Life; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Social Adjustment; Thiazoles; Treatment Outcome; United States | 2007 |
Ziprasidone outcome and tolerability: a practical clinical trial with plasma drug levels.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Body Weight; Chromatography, High Pressure Liquid; Electrocardiography; Female; Humans; Male; Middle Aged; Piperazines; Schizophrenia; Thiazoles | 2007 |
Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cognition Disorders; Cohort Studies; Dibenzothiazepines; Double-Blind Method; Female; Humans; Male; Neuropsychological Tests; Olanzapine; Perphenazine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome | 2007 |
Long-term changes in weight and plasma lipids during maintenance treatment with ziprasidone.
Topics: Antipsychotic Agents; Benzodiazepines; Body Mass Index; Body Weight; Brief Psychiatric Rating Scale; Cross-Sectional Studies; Female; Follow-Up Studies; Humans; Lipids; Male; Mental Disorders; Olanzapine; Piperazines; Retrospective Studies; Single-Blind Method; Thiazoles; Time Factors | 2008 |
Effectiveness, safety, and tolerability of ziprasidone for treating schizophrenia patients undergoing usual care: a 12-month, open-label, flexible-dose, naturalistic observational trial.
Topics: Adult; Antipsychotic Agents; Body Weight; Chronic Disease; Female; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Schizophrenia; Thiazoles | 2007 |
Efficacy and tolerability of adjunctive ziprasidone in treatment-resistant depression: a randomized, open-label, pilot study.
Topics: Adult; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pilot Projects; Piperazines; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sertraline; Thiazoles; Treatment Outcome | 2007 |
Cost-effectiveness analysis of ziprasidone versus haloperidol in sequential intramuscular/oral treatment of exacerbation of schizophrenia: economic subanalysis of the ZIMO trial.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Brief Psychiatric Rating Scale; Cost of Illness; Cost-Benefit Analysis; Drug Costs; Drug Therapy, Combination; Female; Haloperidol; Hospital Costs; Humans; Injections, Intramuscular; Length of Stay; Male; Piperazines; Quality of Life; Research Design; Schizophrenia; Spain; Thiazoles; Treatment Outcome | 2007 |
Effects of olanzapine and ziprasidone on glucose tolerance in healthy volunteers.
Topics: Administration, Oral; Adult; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Drug Administration Schedule; Female; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Insulin; Male; Microdialysis; Middle Aged; Olanzapine; Piperazines; Single-Blind Method; Thiazoles; Time Factors | 2008 |
Ziprasidone in treatment-resistant schizophrenia: a 52-week, open-label continuation study.
Topics: Adult; Antipsychotic Agents; Brief Psychiatric Rating Scale; Chlorpromazine; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Administration Schedule; Drug Resistance, Multiple; Female; Humans; Male; Piperazines; Schizophrenia; Thiazoles; Treatment Outcome | 2007 |
Comparison of ziprasidone and aripiprazole in acutely ill patients with schizophrenia or schizoaffective disorder: a randomized, double-blind, 4-week study.
Topics: Acute Disease; Adult; Affective Disorders, Psychotic; Antipsychotic Agents; Aripiprazole; Blood Glucose; Diagnostic and Statistical Manual of Mental Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Dyspepsia; Electrocardiography; Fasting; Humans; Lipids; Nausea; Piperazines; Prolactin; Quinolones; Schizophrenia; Severity of Illness Index; Thiazoles; Time Factors; Treatment Outcome; Weight Loss | 2007 |
Clinical implications of the CATIE schizophrenia trials: day-to-day management lessons for Australasian psychiatrists.
Topics: Antipsychotic Agents; Australia; Benzodiazepines; Dibenzothiazepines; Double-Blind Method; Humans; Olanzapine; Perphenazine; Piperazines; Psychiatry; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Time Factors | 2007 |
The effect of food on the absorption of oral ziprasidone.
Topics: Absorption; Administration, Oral; Adolescent; Adult; Antipsychotic Agents; Biological Availability; Cross-Over Studies; Dietary Fats; Female; Food-Drug Interactions; Humans; Male; Middle Aged; Piperazines; Thiazoles | 2007 |
A prospective open-label treatment trial of ziprasidone monotherapy in children and adolescents with bipolar disorder.
Topics: Antipsychotic Agents; Bipolar Disorder; Body Weight; Evaluation Studies as Topic; Female; Humans; Male; Pediatrics; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Severity of Illness Index; Thiazoles | 2007 |
A randomized double-blind comparison of ziprasidone vs. clozapine for cognition in patients with schizophrenia selected for resistance or intolerance to previous treatment.
Topics: Adult; Antipsychotic Agents; Clozapine; Cognition Disorders; Double-Blind Method; Drug Resistance; Drug Tolerance; Female; Humans; Italy; Male; Memory Disorders; Neuropsychological Tests; Piperazines; Placebos; Schizophrenia; Schizophrenic Psychology; Thiazoles; Trail Making Test; Treatment Outcome | 2008 |
Ziprasidone in the treatment of borderline personality disorder: a double-blind, placebo-controlled, randomized study.
Topics: Adolescent; Adult; Antipsychotic Agents; Bipolar Disorder; Borderline Personality Disorder; Comorbidity; Depressive Disorder, Major; Disruptive, Impulse Control, and Conduct Disorders; Double-Blind Method; Humans; Middle Aged; Neurocognitive Disorders; Piperazines; Psychoses, Substance-Induced; Schizophrenia; Substance-Related Disorders; Surveys and Questionnaires; Thiazoles | 2008 |
The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC): design and baseline subject characteristics.
Topics: Adult; Antipsychotic Agents; Body Mass Index; Dyslipidemias; Female; Glycated Hemoglobin; Humans; Hypertension; Long QT Syndrome; Male; Observation; Piperazines; Prevalence; Research Design; Schizophrenia; Severity of Illness Index; Surveys and Questionnaires; Thiazoles; Triglycerides | 2008 |
Four-week, double-blind, placebo- and ziprasidone-controlled trial of iloperidone in patients with acute exacerbations of schizophrenia.
Topics: Acute Disease; Adolescent; Adult; Aged; Antipsychotic Agents; Double-Blind Method; Drug Administration Schedule; Female; Humans; Isoxazoles; Male; Middle Aged; Piperazines; Piperidines; Prospective Studies; Schizophrenia; Thiazoles; Treatment Outcome | 2008 |
Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial.
Topics: Adolescent; Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Female; Haloperidol; Humans; Linear Models; Male; Olanzapine; Patient Compliance; Piperazines; Proportional Hazards Models; Quetiapine Fumarate; Schizophrenia; Sulpiride; Thiazoles; Treatment Outcome | 2008 |
What CATIE found: results from the schizophrenia trial.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Cost-Benefit Analysis; Dibenzothiazepines; Double-Blind Method; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Olanzapine; Perphenazine; Piperazines; Psychology; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles | 2008 |
Early onset of antipsychotic response in the treatment of acutely agitated patients with psychotic disorders.
Topics: Acute Disease; Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Female; Hospitalization; Humans; Male; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Psychotic Disorders; Thiazoles; Time Factors; Treatment Outcome | 2008 |
Association of the NPAS3 gene and five other loci with response to the antipsychotic iloperidone identified in a whole genome association study.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Basic Helix-Loop-Helix Transcription Factors; Double-Blind Method; Female; Genome-Wide Association Study; Glial Cell Line-Derived Neurotrophic Factor Receptors; Humans; Isoxazoles; Male; Middle Aged; Nerve Tissue Proteins; Pharmacogenetics; Piperazines; Piperidines; Polymorphism, Single Nucleotide; Pseudogenes; Receptors, AMPA; Schizophrenia; Tenascin; Thiazoles; Transcription Factors; Young Adult | 2009 |
Whole genome association study identifies polymorphisms associated with QT prolongation during iloperidone treatment of schizophrenia.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Carrier Proteins; CELF Proteins; Cytoskeletal Proteins; Double-Blind Method; Electrocardiography; Female; Follow-Up Studies; Gene Frequency; Genome-Wide Association Study; Genotype; Humans; Intracellular Signaling Peptides and Proteins; Isoxazoles; Linear Models; Linkage Disequilibrium; Long QT Syndrome; Male; Middle Aged; Neuregulins; Organic Anion Transporters; Pharmacogenetics; Phosphoproteins; Phosphotransferases (Alcohol Group Acceptor); Piperazines; Piperidines; Polymorphism, Single Nucleotide; RNA-Binding Proteins; Schizophrenia; Thiazoles; Young Adult | 2009 |
Impact of antipsychotic treatment on nonfasting triglycerides in the CATIE Schizophrenia Trial phase 1.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cardiovascular Diseases; Dibenzothiazepines; Female; Humans; Male; Middle Aged; Olanzapine; Perphenazine; Piperazines; Quetiapine Fumarate; Risk Factors; Risperidone; Schizophrenia; Thiazoles; Triglycerides | 2008 |
Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial.
Topics: Adolescent; Adult; Antipsychotic Agents; Clozapine; Drug Therapy, Combination; Female; Humans; Long QT Syndrome; Male; Middle Aged; Piperazines; Prolactin; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Thiazoles; Treatment Outcome; Young Adult | 2009 |
A non-randomized, open study with aripiprazole and ziprasidone for the treatment of aggressive behavior in youth in a community clinic.
Topics: Adolescent; Aggression; Antipsychotic Agents; Aripiprazole; Child; Community Mental Health Centers; Female; Humans; Male; Piperazines; Quinolones; Thiazoles; Treatment Outcome | 2009 |
Changes in sexual function for outpatients with schizophrenia or other psychotic disorders treated with ziprasidone in clinical practice settings: a 3-month prospective, observational study.
Topics: Adolescent; Adult; Antipsychotic Agents; Female; Humans; Male; Piperazines; Prospective Studies; Psychotic Disorders; Schizophrenia; Sexual Dysfunction, Physiological; Thiazoles | 2008 |
Ziprasidone versus olanzapine, risperidone or quetiapine in patients with chronic schizophrenia: a 12-week open-label, multicentre clinical trial.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Cholesterol; Chronic Disease; Dibenzothiazepines; Drug Tolerance; Female; Humans; Male; Middle Aged; Olanzapine; Piperazines; Prolactin; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Triglycerides; Young Adult | 2009 |
Therapeutic drug monitoring of ziprasidone in a clinical treatment setting.
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Antipsychotic Agents; Child; Drug Interactions; Drug Monitoring; Female; Humans; Male; Middle Aged; Piperazines; Product Surveillance, Postmarketing; Sex Characteristics; Smoking; Thiazoles | 2008 |
Tolerability of oral ziprasidone in children and adolescents with bipolar mania, schizophrenia, or schizoaffective disorder.
Topics: Adolescent; Antipsychotic Agents; Bipolar Disorder; Child; Dose-Response Relationship, Drug; Electrocardiography; Female; Humans; Male; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Severity of Illness Index; Thiazoles | 2008 |
Long-term improvement in efficacy and safety after switching to ziprasidone in stable outpatients with schizophrenia.
Topics: Adolescent; Adult; Ambulatory Care; Antipsychotic Agents; Female; Follow-Up Studies; Humans; Long-Term Care; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Thiazoles; Treatment Outcome; Young Adult | 2008 |
Striatal and extrastriatal D2/D3-receptor-binding properties of ziprasidone: a positron emission tomography study with [18F]Fallypride and [11C]raclopride (D2/D3-receptor occupancy of ziprasidone).
Topics: Adult; Antipsychotic Agents; Basal Ganglia; Benzamides; Binding, Competitive; Carbon Radioisotopes; Dopamine Antagonists; Dose-Response Relationship, Drug; Female; Fluorine Radioisotopes; Humans; Male; Piperazines; Positron-Emission Tomography; Pyrrolidines; Raclopride; Radiopharmaceuticals; Receptors, Dopamine D2; Receptors, Dopamine D3; Schizophrenia; Thiazoles; Time Factors; Young Adult | 2008 |
The impact of calories and fat content of meals on oral ziprasidone absorption: a randomized, open-label, crossover trial.
Topics: Adult; Antipsychotic Agents; Biological Availability; Bipolar Disorder; Cross-Over Studies; Dietary Fats; Drug Administration Schedule; Energy Intake; Female; Food-Drug Interactions; Humans; Male; Middle Aged; Piperazines; Psychotic Disorders; Schizophrenia; Thiazoles; Young Adult | 2009 |
Ziprasidone in the treatment of acute mania: a 12-week, placebo-controlled, haloperidol-referenced study.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Double-Blind Method; Female; Haloperidol; Humans; India; Male; Middle Aged; Patient Dropouts; Piperazines; Placebo Effect; Psychiatric Status Rating Scales; Russia; Thiazoles; Time Factors; Treatment Outcome; United States; Young Adult | 2010 |
A comparison of ziprasidone and risperidone in the long-term treatment of schizophrenia: a 44-week, double-blind, continuation study.
Topics: Adult; Antipsychotic Agents; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Humans; Male; Piperazines; Risperidone; Schizophrenia; Severity of Illness Index; Thiazoles | 2009 |
Reduction of functional disability with atypical antipsychotic treatment: a randomized long term comparison of ziprasidone and haloperidol.
Topics: Adult; Antipsychotic Agents; Chi-Square Distribution; Cognition Disorders; Double-Blind Method; Female; Haloperidol; Humans; Longitudinal Studies; Male; Middle Aged; Neuropsychological Tests; Piperazines; Psychiatric Status Rating Scales; Schizophrenia; Thiazoles; Time Factors; Treatment Outcome | 2009 |
Ziprasidone monotherapy in bipolar II depression: an open trial.
Topics: Adult; Affect; Antipsychotic Agents; Bipolar Disorder; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Humans; Interview, Psychological; Male; Middle Aged; Personality Inventory; Piperazines; Psychometrics; Thiazoles; Treatment Outcome | 2009 |
In search of moderators and mediators of hyperglycemia with atypical antipsychotic treatment.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Blood Pressure; Body Mass Index; Body Weight; Dose-Response Relationship, Drug; Female; Humans; Hyperglycemia; Lipid Metabolism; Lipoproteins, HDL; Male; Middle Aged; Olanzapine; Piperazines; Prediabetic State; Predictive Value of Tests; Randomized Controlled Trials as Topic; Schizophrenia; Thiazoles; Time Factors; Treatment Outcome | 2009 |
Ziprasidone vs clozapine in schizophrenia patients refractory to multiple antipsychotic treatments: the MOZART study.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Body Weight; Clozapine; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Glucose; Humans; Italy; Lipids; Male; Middle Aged; Patient Compliance; Piperazines; Psychiatric Status Rating Scales; Quality of Life; Schizophrenia; Schizophrenic Psychology; Thiazoles; Young Adult | 2009 |
Ziprasidone as an adjuvant for clozapine- or olanzapine-associated medical morbidity in chronic schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Body Mass Index; Body Weight; Chronic Disease; Clozapine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hyperglycemia; Insulin Resistance; Male; Middle Aged; Morbidity; Olanzapine; Piperazines; Schizophrenia; Thiazoles; Time Factors | 2009 |
Effectiveness and tolerability of oral ziprasidone in psychiatric inpatients with an acute exacerbation of schizophrenia or schizoaffective disorder: a multicenter, prospective, and naturalistic study.
Topics: Acute Disease; Adult; Antipsychotic Agents; Brief Psychiatric Rating Scale; Drug Administration Schedule; Female; Hospitalization; Humans; In Vitro Techniques; Length of Stay; Piperazines; Prospective Studies; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Thiazoles; Treatment Outcome | 2009 |
Effect of ziprasidone dose on all-cause discontinuation rates in acute schizophrenia and schizoaffective disorder: a post-hoc analysis of 4 fixed-dose randomized clinical trials.
Topics: Acute Disease; Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Piperazines; Proportional Hazards Models; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Thiazoles; Time Factors; Treatment Outcome | 2009 |
Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Brain; Clozapine; Cognition Disorders; Female; Follow-Up Studies; Haloperidol; Humans; Male; Neuropsychological Tests; Olanzapine; Perphenazine; Piperazines; Prospective Studies; Psychotic Disorders; Risperidone; Severity of Illness Index; Sulpiride; Thiazoles | 2009 |
Remission in schizophrenia: 196-week, double-blind treatment with ziprasidone vs. haloperidol.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Double-Blind Method; Female; Haloperidol; Humans; Male; Middle Aged; Patient Dropouts; Piperazines; Psychiatric Status Rating Scales; Quality of Life; Remission Induction; Schizophrenia; Schizophrenic Psychology; Thiazoles; Time Factors; Treatment Outcome; Young Adult | 2009 |
Efficacy and tolerability of switching to ziprasidone from olanzapine, risperidone or haloperidol: an international, multicenter study.
Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Drug Administration Schedule; Female; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Thiazoles | 2009 |
Ziprasidone vs olanzapine in recent-onset schizophrenia and schizoaffective disorder: results of an 8-week double-blind randomized controlled trial.
Topics: Adult; Alanine Transaminase; Antipsychotic Agents; Aspartate Aminotransferases; Basal Ganglia Diseases; Benzodiazepines; Biperiden; Blood Glucose; Body Weight; Cholesterol; Chronic Disease; Electrocardiography; Female; Humans; Male; Muscarinic Antagonists; Olanzapine; Piperazines; Prolactin; Psychiatric Status Rating Scales; Psychometrics; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Thiazoles; Triglycerides; Young Adult | 2011 |
Applicability of a genetic signature for enhanced iloperidone efficacy in the treatment of schizophrenia.
Topics: Adult; Alleles; Antipsychotic Agents; Double-Blind Method; Female; Genetic Markers; Genotype; Humans; Isoxazoles; Likelihood Functions; Male; Middle Aged; Odds Ratio; Pharmacogenetics; Piperazines; Piperidines; Polymorphism, Single Nucleotide; Probability; Psychiatric Status Rating Scales; Psychometrics; Schizophrenia; Thiazoles; Treatment Outcome | 2009 |
Long-term safety and efficacy of ziprasidone in subpopulations of patients with bipolar mania.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Cohort Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Long-Term Care; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Thiazoles | 2009 |
The factor structure of clinical symptoms in mixed and manic episodes prior to and after antipsychotic treatment.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Bipolar Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Haloperidol; Humans; Male; Middle Aged; Patient Admission; Piperazines; Psychiatric Status Rating Scales; Psychometrics; Thiazoles | 2008 |
Ziprasidone vs clozapine in schizophrenia patients refractory to multiple antipsychotic treatments: the MOZART study.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Body Weight; Clozapine; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Glucose; Humans; Italy; Lipids; Male; Middle Aged; Patient Compliance; Piperazines; Psychiatric Status Rating Scales; Quality of Life; Schizophrenia; Schizophrenic Psychology; Thiazoles; Young Adult | 2009 |
Rapid antipsychotic response with ziprasidone predicts subsequent acute manic/mixed episode remission.
Topics: Adult; Antipsychotic Agents; Area Under Curve; Bipolar Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Predictive Value of Tests; Psychiatric Status Rating Scales; ROC Curve; Secondary Prevention; Thiazoles; Time Factors; Treatment Outcome | 2010 |
Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics.
Topics: Antipsychotic Agents; Benzodiazepines; Chromosomes, Human, Pair 4; Dibenzothiazepines; Double-Blind Method; Follow-Up Studies; Genome-Wide Association Study; Humans; Olanzapine; Perphenazine; Pharmacogenetics; Piperazines; Polymorphism, Single Nucleotide; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome | 2011 |
[Pharmacokinetics and relative bioavailability of ziprasidone tablets in Chinese healthy volunteers].
Topics: Administration, Oral; Asian People; Biological Availability; Drug-Related Side Effects and Adverse Reactions; Health; Humans; Piperazines; Tablets; Therapeutic Equivalency; Thiazoles; Time Factors; Young Adult | 2009 |
Ziprasidone in Black patients with schizophrenia: analysis of four short-term, double-blind studies.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Black People; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Thiazoles; Treatment Outcome; Young Adult | 2009 |
Psychosocial functioning and health-related quality of life in children and adolescents treated with open-label ziprasidone for bipolar mania, schizophrenia, or schizoaffective disorder.
Topics: Adolescent; Antipsychotic Agents; Bipolar Disorder; Child; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Health Status; Humans; Male; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quality of Life; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Social Behavior; Thiazoles; Treatment Outcome | 2009 |
Absence of weight gain association with the HTR2C -759C/T polymorphism in patients with schizophrenia treated with iloperidone.
Topics: Analysis of Variance; Antipsychotic Agents; Female; Follow-Up Studies; Gene Frequency; Genotype; Humans; Isoxazoles; Male; Piperazines; Piperidines; Polymorphism, Genetic; Receptor, Serotonin, 5-HT2C; Schizophrenia; Thiazoles; Weight Gain | 2010 |
Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: the MIND randomized, placebo-controlled trial.
Topics: Adult; Aged; Antipsychotic Agents; Delirium; Double-Blind Method; Female; Haloperidol; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Piperazines; Postoperative Complications; Psychiatric Status Rating Scales; Respiration, Artificial; Thiazoles; Treatment Outcome | 2010 |
Effects of Oral Ziprasidone and Oral Haloperidol on QTc interval in patients with Schizophrenia or Schizoaffective disorder.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Electrocardiography; Female; Haloperidol; Humans; Male; Middle Aged; Piperazines; Psychotic Disorders; Schizophrenia; Thiazoles | 2010 |
Ziprasidone plus a mood stabilizer in subjects with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind trial.
Topics: Adolescent; Adult; Aged; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lithium Compounds; Male; Middle Aged; Piperazines; Placebos; Psychiatric Status Rating Scales; Severity of Illness Index; Thiazoles; Treatment Outcome; Valproic Acid | 2010 |
Drug attitude as predictor for effectiveness in first-episode schizophrenia: Results of an open randomized trial (EUFEST).
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Female; Haloperidol; Humans; Male; Medication Adherence; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Quetiapine Fumarate; ROC Curve; Schizophrenia; Schizophrenic Psychology; Sulpiride; Surveys and Questionnaires; Thiazoles; Treatment Outcome | 2010 |
Effectiveness of second-generation antipsychotics: a naturalistic, randomized comparison of olanzapine, quetiapine, risperidone, and ziprasidone.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Galactorrhea; Hospitalization; Humans; Length of Stay; Male; Olanzapine; Patient Readmission; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Severity of Illness Index; Thiazoles; Treatment Outcome | 2010 |
Effects of high-dose ziprasidone and haloperidol on the QTc interval after intramuscular administration: a randomized, single-blind, parallel-group study in patients with schizophrenia or schizoaffective disorder.
Topics: Adult; Aged; Antipsychotic Agents; Blood Pressure; Dose-Response Relationship, Drug; Electrocardiography; Female; Haloperidol; Heart Rate; Humans; Male; Middle Aged; Piperazines; Psychotic Disorders; Schizophrenia; Single-Blind Method; Thiazoles; Young Adult | 2010 |
Switching from conventional antipsychotics to ziprasidone: a randomized, open-label comparison of regimen strategies.
Topics: Adult; Aged; Antipsychotic Agents; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Piperazines; Schizophrenia; Thiazoles; Treatment Outcome | 2010 |
Short term neurocognitive effects of treatment with ziprasidone and olanzapine in recent onset schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cognition Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Neuropsychological Tests; Olanzapine; Piperazines; Quality of Life; Schizophrenia; Statistics as Topic; Thiazoles; Verbal Learning; Young Adult | 2010 |
Effectiveness of switching from aripiprazole to ziprasidone in patients with schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Blood Glucose; Body Size; Body Weight; Diagnostic and Statistical Manual of Mental Disorders; Female; Hip; Humans; Hyperprolactinemia; Liver Function Tests; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Quinolones; Schizophrenia; Thiazoles; Treatment Outcome; Waist Circumference; Wakefulness; Young Adult | 2010 |
Ziprasidone treatment of refractory generalized anxiety disorder: a placebo-controlled, double-blind study.
Topics: Adult; Anxiety Disorders; Dizziness; Double-Blind Method; Female; Humans; Male; Pilot Projects; Piperazines; Sleep Stages; Thiazoles; Treatment Outcome | 2010 |
A post hoc analysis of negative symptoms and psychosocial function in patients with schizophrenia: a 40-week randomized, double-blind study of ziprasidone versus haloperidol followed by a 3-year double-blind extension trial.
Topics: Antipsychotic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Follow-Up Studies; Haloperidol; Humans; Piperazines; Psychiatric Status Rating Scales; Quality of Life; Remission Induction; Schizophrenia; Schizophrenic Psychology; Thiazoles; Time Factors; Treatment Outcome | 2010 |
Long-term efficacy and tolerability of clozapine combined with ziprasidone or risperidone.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Clozapine; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Humans; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Risperidone; Serotonin Antagonists; Thiazoles; Time Factors; Treatment Outcome; Young Adult | 2010 |
Treatment outcomes of patients with tardive dyskinesia and chronic schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Chi-Square Distribution; Dibenzothiazepines; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Movement Disorders; Olanzapine; Perphenazine; Piperazines; Proportional Hazards Models; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Severity of Illness Index; Thiazoles; Treatment Outcome | 2011 |
Effects on cognitive functioning after olanzapine-ziprasidone crossover in recent-onset schizophrenia.
Topics: Acute Disease; Adolescent; Adult; Benzodiazepines; Cognition; Cross-Over Studies; Double-Blind Method; Drug Substitution; Female; Follow-Up Studies; Humans; Male; Neuropsychological Tests; Olanzapine; Piperazines; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome; Young Adult | 2010 |
Comparative mortality associated with ziprasidone and olanzapine in real-world use among 18,154 patients with schizophrenia: The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC).
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cause of Death; Cross-Sectional Studies; Death, Sudden, Cardiac; Diabetic Ketoacidosis; Female; Hospitalization; Humans; Incidence; Kaplan-Meier Estimate; Long QT Syndrome; Male; Middle Aged; Myocardial Infarction; Olanzapine; Piperazines; Product Surveillance, Postmarketing; Prospective Studies; Risk; Schizophrenia; Suicide; Thiazoles | 2011 |
Predictive value of early changes in triglycerides and weight for longer-term changes in metabolic measures during olanzapine, ziprasidone or aripiprazole treatment for schizophrenia and schizoaffective disorder post hoc analyses of 3 randomized, controll
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Blood Glucose; Cholesterol; Drug Monitoring; Female; Humans; Male; Middle Aged; Olanzapine; Piperazines; Quinolones; Schizophrenia; Thiazoles; Time Factors; Triglycerides; Weight Gain | 2010 |
Population pharmacokinetic modeling of ziprasidone in patients with schizophrenia from the CATIE study.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Schizophrenia; Thiazoles; Young Adult | 2011 |
Performance and interview-based assessments of cognitive change in a randomized, double-blind comparison of lurasidone vs. ziprasidone.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Cognition Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Interview, Psychological; Isoindoles; Lurasidone Hydrochloride; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Thiazoles; Young Adult | 2011 |
Switching from quetiapine to ziprasidone: a sixteen-week, open-label, multicenter study evaluating the effectiveness and safety of ziprasidone in outpatient subjects with schizophrenia or schizoaffective disorder.
Topics: Adolescent; Adult; Antipsychotic Agents; Blood Glucose; Body Weight; Cholesterol; Cognition; Dibenzothiazepines; Drug Administration Schedule; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Outpatients; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Schizophrenia; Thiazoles; Treatment Outcome; Triglycerides; Young Adult | 2011 |
Rapid tranquilization for agitated patients in emergency psychiatric rooms: a randomized trial of olanzapine, ziprasidone, haloperidol plus promethazine, haloperidol plus midazolam and haloperidol alone.
Topics: Adult; Aggression; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Double-Blind Method; Drug Therapy, Combination; Emergency Services, Psychiatric; Female; Haloperidol; Humans; Hypnotics and Sedatives; Injections, Intramuscular; Male; Midazolam; Olanzapine; Piperazines; Promethazine; Psychomotor Agitation; Psychotic Disorders; Thiazoles; Tranquilizing Agents | 2011 |
Efficacy and safety of adjunctive oral ziprasidone for acute treatment of depression in patients with bipolar I disorder: a randomized, double-blind, placebo-controlled trial.
Topics: Acute Disease; Adolescent; Adult; Aged; Antimanic Agents; Bipolar Disorder; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lamotrigine; Lithium; Male; Middle Aged; Piperazines; Serotonin Antagonists; Thiazoles; Treatment Outcome; Triazines; Valproic Acid; Young Adult | 2011 |
Transition from ziprasidone im to oral formulation in agitated patients with acute exacerbation of schizophrenia: an open trial.
Topics: Administration, Oral; Adolescent; Adult; Antipsychotic Agents; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Schizophrenia; Thiazoles | 2011 |
Methodological challenges in the coding and adjudication of sudden deaths in a large simple trial with observational follow-up: the ziprasidone observational study of cardiac outcomes (ZODIAC).
Topics: Antipsychotic Agents; Benzodiazepines; Cause of Death; Clinical Coding; Death, Sudden; Death, Sudden, Cardiac; Endpoint Determination; Follow-Up Studies; Heart; Humans; Incidence; International Classification of Diseases; Olanzapine; Piperazines; Product Surveillance, Postmarketing; Research Design; Risk; Schizophrenia; Sensitivity and Specificity; Surveys and Questionnaires; Thiazoles; Time Factors; United States; United States Food and Drug Administration | 2011 |
Ziprasidone with adjunctive mood stabilizer in the maintenance treatment of bipolar I disorder: long-term changes in weight and metabolic profiles.
Topics: Adjuvants, Immunologic; Antipsychotic Agents; Bipolar Disorder; Body Weight; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lithium Chloride; Longitudinal Studies; Male; Metabolic Diseases; Metabolome; Piperazines; Psychiatric Status Rating Scales; Thiazoles; Valproic Acid | 2012 |
Efficacy of antipsychotic drugs against hostility in the European First-Episode Schizophrenia Trial (EUFEST).
Topics: Adult; Aggression; Amisulpride; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Haloperidol; Hostility; Humans; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Schizophrenia; Schizophrenic Psychology; Sulpiride; Thiazoles; Treatment Outcome | 2011 |
Anti-depressive effectiveness of olanzapine, quetiapine, risperidone and ziprasidone: a pragmatic, randomized trial.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Benzodiazepines; Depression; Dibenzothiazepines; Female; Humans; Male; Middle Aged; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Thiazoles | 2011 |
Double-blind comparison of the safety and efficacy of lurasidone and ziprasidone in clinically stable outpatients with schizophrenia or schizoaffective disorder.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Body Weight; Cholesterol; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Humans; Isoindoles; Lurasidone Hydrochloride; Male; Middle Aged; Outpatients; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Thiazoles; Time Factors; Treatment Outcome; Triglycerides; Young Adult | 2011 |
The lack of effect of ziprasidone on platelet serotonin concentration in schizophrenic patients.
Topics: Antipsychotic Agents; Blood Platelets; Dose-Response Relationship, Drug; Female; Humans; Male; Piperazines; Psychotic Disorders; Schizophrenia; Serotonin; Serotonin Antagonists; Thiazoles; Time Factors | 2012 |
Neurocognitive effectiveness of quetiapine, olanzapine, risperidone, and ziprasidone: a pragmatic, randomized trial.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Cognition; Dibenzothiazepines; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Olanzapine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Thiazoles; Treatment Outcome; Young Adult | 2013 |
Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antipsychotic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Labeling; Female; Haloperidol; Humans; Isoxazoles; Male; Middle Aged; Piperazines; Piperidines; Prospective Studies; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome; Young Adult | 2012 |
Comparative effectiveness of switching antipsychotic drug treatment to aripiprazole or ziprasidone for improving metabolic profile and atherogenic dyslipidemia: a 12-month, prospective, open-label study.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Atherosclerosis; Bipolar Disorder; Cohort Studies; Diagnostic and Statistical Manual of Mental Disorders; Drug Monitoring; Dyslipidemias; Female; Humans; Intention to Treat Analysis; Male; Middle Aged; North America; Patient Dropouts; Piperazines; Psychotic Disorders; Quinolones; Risk Factors; Schizophrenia; Severity of Illness Index; Thiazoles; Weight Loss | 2012 |
Efficacy and tolerability of ziprasidone vs. olanzapine in naive first-episode schizophrenia: a 6-week, randomized, open-label, flexible-dose study.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Comparative Effectiveness Research; Dose-Response Relationship, Drug; Drug Monitoring; Episode of Care; Female; Humans; Male; Middle Aged; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Thiazoles; Time Factors; Treatment Outcome; Weight Gain | 2012 |
Dopamine D2 receptor occupancy and cognition in schizophrenia: analysis of the CATIE data.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Cognition Disorders; Dopamine D2 Receptor Antagonists; Female; Humans; Linear Models; Male; Middle Aged; Olanzapine; Piperazines; Receptors, Dopamine D2; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Young Adult | 2013 |
Predictors of response to ziprasidone: results from a 6-week randomized double-blind, placebo-controlled trial for acute depressive mixed state.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antipsychotic Agents; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Predictive Value of Tests; Prospective Studies; Psychiatric Status Rating Scales; Thiazoles; Treatment Outcome; Young Adult | 2012 |
Efficacy and safety of ziprasidone in the treatment of first-episode psychosis: an 8-week, open-label, multicenter trial.
Topics: Adolescent; Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Body Weight; Female; Humans; Lipids; Male; Middle Aged; Patient Dropouts; Piperazines; Prolactin; Psychiatric Status Rating Scales; Psychotic Disorders; Thiazoles | 2012 |
A 6 week randomized double-blind placebo-controlled trial of ziprasidone for the acute depressive mixed state.
Topics: Acute Disease; Adult; Antipsychotic Agents; Bipolar Disorder; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Thiazoles; Treatment Outcome | 2012 |
Efficacy and tolerability of switching to ziprasidone in italian patients with acute exacerbation of schizophrenia: an open-label trial.
Topics: Adult; Antipsychotic Agents; Female; Humans; Long QT Syndrome; Male; Middle Aged; Patient Preference; Piperazines; Psychiatric Status Rating Scales; Schizophrenia; Thiazoles | 2012 |
Persistent negative symptoms in first episode patients with schizophrenia: results from the European First Episode Schizophrenia Trial.
Topics: Adolescent; Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Cognition Disorders; Dibenzothiazepines; Female; Haloperidol; Humans; Male; Neuropsychological Tests; Olanzapine; Piperazines; Psychomotor Disorders; Psychotic Disorders; Quetiapine Fumarate; Schizophrenia; Schizophrenic Psychology; Sulpiride; Thiazoles; Treatment Outcome; Young Adult | 2013 |
Two 6-week, randomized, double-blind, placebo-controlled studies of ziprasidone in outpatients with bipolar I depression: did baseline characteristics impact trial outcome?
Topics: Adolescent; Adult; Antipsychotic Agents; Bipolar Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Outpatients; Piperazines; Psychiatric Status Rating Scales; Thiazoles; Treatment Outcome | 2012 |
The effects of ziprasidone on prefrontal and amygdalar activation in manic youth with bipolar disorder.
Topics: Adolescent; Amygdala; Antipsychotic Agents; Bipolar Disorder; Child; Female; Humans; Magnetic Resonance Imaging; Male; Piperazines; Prefrontal Cortex; Thiazoles | 2012 |
Some dopaminergic genes polymorphisms are not associated with response to antipsychotic drugs in schizophrenic patients.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dopamine; Dopamine Antagonists; Female; Follow-Up Studies; Genotype; Humans; Male; Middle Aged; Olanzapine; Perazine; Piperazines; Polymorphism, Genetic; Schizophrenia, Paranoid; Thiazoles; Time Factors; Treatment Outcome; Young Adult | 2012 |
Comparison of metabolic effects of ziprasidone versus olanzapine treatment in patients with first-episode schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Body Weight; Female; Glucose; Humans; Insulin; Lipid Metabolism; Male; Middle Aged; Olanzapine; Piperazines; Schizophrenia; Thiazoles; Young Adult | 2013 |
One-year, randomized, open trial comparing olanzapine, quetiapine, risperidone and ziprasidone effectiveness in antipsychotic-naive patients with a first-episode psychosis.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Female; Humans; Male; Olanzapine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome | 2012 |
Characterizing relapse prevention in bipolar disorder with adjunctive ziprasidone: clinical and methodological implications.
Topics: Antipsychotic Agents; Bipolar Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Follow-Up Studies; Humans; Lithium; Piperazines; Secondary Prevention; Thiazoles; Treatment Outcome; Valproic Acid | 2013 |
Achieving and sustaining remission in bipolar I disorder with ziprasidone : a post hoc analysis of a 24-week, double-blind, placebo-controlled study.
Topics: Adult; Antimanic Agents; Bipolar Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lithium Compounds; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Remission Induction; Thiazoles; Time Factors; Treatment Outcome; Valproic Acid | 2012 |
Enhanced ziprasidone combination therapy effectiveness in obese compared to nonobese patients with bipolar disorder.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Drug Therapy, Combination; Female; Humans; Longitudinal Studies; Male; Middle Aged; Obesity; Piperazines; Thiazoles; Treatment Outcome | 2012 |
Early prediction of clinical and functional outcome in schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cognition; Cognition Disorders; Double-Blind Method; Drug Monitoring; Drug Resistance; Female; Follow-Up Studies; Humans; Male; Middle Aged; Models, Biological; Olanzapine; Patient Dropouts; Piperazines; Prognosis; Psychiatric Status Rating Scales; Schizophrenia; Thiazoles; Weight Gain | 2013 |
Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 1: results of a randomized, double-blind, placebo-controlled trial.
Topics: Administration, Oral; Adolescent; Adult; Antimanic Agents; Basal Ganglia Diseases; Bipolar Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lithium Carbonate; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Thiazoles; Treatment Outcome; Valproic Acid; Young Adult | 2012 |
Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 2: influence of protocol-specific eligibility criteria on signal detection.
Topics: Administration, Oral; Adolescent; Adult; Antimanic Agents; Bipolar Disorder; Diagnosis, Computer-Assisted; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Interview, Psychological; Lithium Carbonate; Male; Middle Aged; Patient Selection; Piperazines; Psychiatric Status Rating Scales; Psychometrics; Research Design; Signal Detection, Psychological; Thiazoles; Treatment Outcome; Valproic Acid; Young Adult | 2012 |
Lessons learned in the conduct of a global, large simple trial of treatments indicated for schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Cause of Death; Humans; International Cooperation; Longitudinal Studies; Lost to Follow-Up; Olanzapine; Patient Selection; Piperazines; Research Design; Schizophrenia; Thiazoles | 2013 |
A thorough QTc study of 3 doses of iloperidone including metabolic inhibition via CYP2D6 and/or CYP3A4 and a comparison to quetiapine and ziprasidone.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dibenzothiazepines; Drug Administration Schedule; Drug Interactions; Drug Monitoring; Electrocardiography; Enzyme Inhibitors; Female; Genotype; Heart Rate; Humans; Isoxazoles; Ketoconazole; Linear Models; Long QT Syndrome; Male; Middle Aged; Paroxetine; Pharmacogenetics; Phenotype; Piperazines; Piperidines; Quetiapine Fumarate; Thiazoles; United States; Young Adult | 2013 |
Long-term safety of ziprasidone in schizophrenic patients: an open trial.
Topics: Adolescent; Adult; Antipsychotic Agents; Electrocardiography; Female; Humans; Male; Middle Aged; Piperazines; Schizophrenia; Thiazoles | 2012 |
A 12-week, randomized, double-blind, placebo-controlled, sequential parallel comparison trial of ziprasidone as monotherapy for major depressive disorder.
Topics: Adult; Antipsychotic Agents; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Personality Inventory; Piperazines; Psychometrics; Thiazoles | 2012 |
Long-term safety and tolerability of iloperidone: results from a 25-week, open-label extension trial.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Substitution; Female; Humans; India; Isoxazoles; Longitudinal Studies; Male; Middle Aged; Piperazines; Piperidines; Psychiatric Status Rating Scales; Schizophrenia; Thiazoles; Time Factors; Treatment Outcome; United States; Young Adult | 2013 |
Dopamine D₂/₃ occupancy of ziprasidone across a day: a within-subject PET study.
Topics: Adult; Antipsychotic Agents; Brain; Case-Control Studies; Dopamine Antagonists; Female; Half-Life; Humans; Male; Middle Aged; Piperazines; Positron-Emission Tomography; Prolactin; Raclopride; Receptors, Dopamine D2; Receptors, Dopamine D3; Schizophrenia; Thiazoles; Time Factors; Young Adult | 2013 |
Aripiprazole, ziprasidone, and quetiapine in the treatment of first-episode nonaffective psychosis: results of a 6-week, randomized, flexible-dose, open-label comparison.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Dibenzothiazepines; Dose-Response Relationship, Drug; Female; Humans; Male; Piperazines; Prospective Studies; Quetiapine Fumarate; Quinolones; Schizophrenia; Thiazoles; Treatment Outcome; Young Adult | 2013 |
Intramuscular ziprasidone versus haloperidol for managing agitation in Chinese patients with schizophrenia.
Topics: Acute Disease; Adult; Antipsychotic Agents; China; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Injections, Intramuscular; Least-Squares Analysis; Male; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Schizophrenia; Thiazoles; Time Factors; Young Adult | 2013 |
Aripiprazole, Ziprasidone and Quetiapine in the treatment of first-episode nonaffective psychosis: a 12-week randomized, flexible-dose, open-label trial.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Aripiprazole; Dibenzothiazepines; Dose-Response Relationship, Drug; Female; Humans; Male; Outcome Assessment, Health Care; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Retrospective Studies; Thiazoles; Time Factors; Young Adult | 2013 |
[Effects of ziprasidone and olanzapine on glucose and lipid metabolism in first-episode schizophrenia].
Topics: Adolescent; Adult; Benzodiazepines; Blood Glucose; Female; Humans; Lipid Metabolism; Male; Middle Aged; Olanzapine; Piperazines; Schizophrenia; Thiazoles; Young Adult | 2013 |
Hyperprolactinemia and estimated dopamine D2 receptor occupancy in patients with schizophrenia: analysis of the CATIE data.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Olanzapine; Piperazines; Predictive Value of Tests; Prolactin; Receptors, Dopamine D2; Risperidone; Schizophrenia; Sensitivity and Specificity; Thiazoles | 2013 |
High-dose oral ziprasidone versus conventional dosing in schizophrenia patients with residual symptoms: the ZEBRAS study.
Topics: Adult; Antipsychotic Agents; Blood Pressure; Female; Humans; Long QT Syndrome; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Thiazoles; Time Factors; Treatment Outcome; United States | 2013 |
Effects of ziprasidone and olanzapine on body composition and metabolic parameters: an open-label comparative pilot study.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Appetite; Benzodiazepines; Body Composition; Body Weight; Cholesterol, HDL; Cholesterol, LDL; Energy Metabolism; Female; Humans; Male; Middle Aged; Olanzapine; Pilot Projects; Piperazines; Psychotic Disorders; Schizophrenia; Thiazoles; Weight Gain; Young Adult | 2013 |
A twenty-four-week, open-label study on ziprasidone's efficacy and influence on glucolipid metabolism in patients with schizophrenia and metabolic disorder.
Topics: Adult; Antipsychotic Agents; Blood Glucose; Blood Pressure; Body Mass Index; Cholesterol, HDL; Clozapine; Cognition Disorders; Female; Follow-Up Studies; Humans; Male; Metabolic Syndrome; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Schizophrenia; Thiazoles; Triglycerides | 2013 |
Estimated dopamine D₂ receptor occupancy and remission in schizophrenia: analysis of the CATIE data.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Brain; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Female; Humans; Male; Middle Aged; Nonlinear Dynamics; Olanzapine; Piperazines; Protein Binding; Psychiatric Status Rating Scales; Receptors, Dopamine D2; Remission Induction; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Time Factors; Treatment Outcome; United States | 2013 |
Treatment of first-episode non-affective psychosis: a randomized comparison of aripiprazole, quetiapine and ziprasidone over 1 year.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Dibenzothiazepines; Female; Humans; Male; Patient Dropouts; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Thiazoles; Treatment Outcome; Young Adult | 2014 |
Hallucinations in acutely admitted patients with psychosis, and effectiveness of risperidone, olanzapine, quetiapine, and ziprasidone: a pragmatic, randomized study.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Female; Hallucinations; Hospitalization; Humans; Male; Middle Aged; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome | 2013 |
Efficacy, long-term safety, and tolerability of ziprasidone in children and adolescents with bipolar disorder.
Topics: Adolescent; Antipsychotic Agents; Bipolar Disorder; Child; Double-Blind Method; Female; Humans; Male; Piperazines; Thiazoles; Treatment Outcome | 2013 |
Ziprasidone in adolescents with schizophrenia: results from a placebo-controlled efficacy and long-term open-extension study.
Topics: Adolescent; Antipsychotic Agents; Double-Blind Method; Early Termination of Clinical Trials; Female; Humans; Male; Piperazines; Placebos; Schizophrenia; Thiazoles; Treatment Outcome | 2013 |
Augmentation of clozapine with ziprasidone in refractory schizophrenia: a double-blind, placebo-controlled study.
Topics: Adult; Antipsychotic Agents; Clozapine; Cognition; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Electrocardiography; Female; Heart Rate; Humans; Italy; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Thiazoles; Time Factors; Treatment Outcome; Young Adult | 2014 |
Effectiveness of antipsychotic drugs against hostility in patients with schizophrenia in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study.
Topics: Adult; Aggression; Amisulpride; Antipsychotic Agents; Benzodiazepines; Female; Haloperidol; Hostility; Humans; Male; Middle Aged; Olanzapine; Perphenazine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Sulpiride; Thiazoles | 2014 |
A randomized, double-blind, placebo-controlled study of ziprasidone monotherapy in bipolar disorder with co-occurring lifetime panic or generalized anxiety disorder.
Topics: Adult; Antipsychotic Agents; Anxiety Disorders; Bipolar Disorder; Comorbidity; Double-Blind Method; Humans; Middle Aged; Panic Disorder; Piperazines; Placebos; Psychiatric Status Rating Scales; Severity of Illness Index; Thiazoles; Treatment Outcome; Young Adult | 2014 |
Noninferiority of perphenazine vs. three second-generation antipsychotics in chronic schizophrenia.
Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Dibenzothiazepines; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Olanzapine; Perphenazine; Piperazines; Quetiapine Fumarate; Risperidone; Sample Size; Schizophrenia; Thiazoles; Treatment Outcome | 2014 |
Association of ADRA2A and MTHFR gene polymorphisms with weight loss following antipsychotic switching to aripiprazole or ziprasidone.
Topics: Adult; Alleles; Antipsychotic Agents; Aripiprazole; Body Mass Index; Female; Follow-Up Studies; Genotype; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Piperazines; Polymorphism, Genetic; Quinolones; Receptors, Adrenergic, alpha-2; Schizophrenia; Thiazoles; Weight Gain; Weight Loss | 2014 |
Efficacy and metabolic influence of paliperidone ER, aripiprazole and ziprasidone to patients with first-episode schizophrenia through 52 weeks follow-up in China.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Body Mass Index; China; Delayed-Action Preparations; Diagnostic and Statistical Manual of Mental Disorders; Female; Follow-Up Studies; Humans; Hyperglycemia; Hyperlipidemias; Isoxazoles; Male; Metabolic Diseases; Paliperidone Palmitate; Piperazines; Psychiatric Status Rating Scales; Pyrimidines; Quinolones; Schizophrenia; Thiazoles; Weight Gain; Young Adult | 2012 |
Health-related quality of life among patients treated with lurasidone: results from a switch trial in patients with schizophrenia.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Dibenzothiazepines; Drug Substitution; Female; Humans; Isoindoles; Lurasidone Hydrochloride; Male; Middle Aged; Olanzapine; Outpatients; Piperazines; Quality of Life; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome | 2014 |
The effect of ziprasidone on metabolic syndrome risk factors in subjects with schizophrenia: a 1 year, open-label, prospective study.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Humans; Male; Metabolic Syndrome; Middle Aged; Piperazines; Prospective Studies; Risk Factors; Schizophrenia; Thiazoles; Young Adult | 2014 |
Completed and attempted suicides among 18,154 subjects with schizophrenia included in a large simple trial.
Topics: Adult; Antipsychotic Agents; Asia; Benzodiazepines; Europe; Female; Follow-Up Studies; Humans; Latin America; Male; Middle Aged; Olanzapine; Piperazines; Risk Factors; Schizophrenia; Suicide; Suicide, Attempted; Thiazoles; Time Factors; United States | 2014 |
Psychomotor symptoms and treatment outcomes of ziprasidone monotherapy in patients with major depressive disorder: a 12-week, randomized, double-blind, placebo-controlled, sequential parallel comparison trial.
Topics: Adult; Antipsychotic Agents; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Psychomotor Agitation; Thiazoles; Treatment Outcome | 2014 |
Open prospective study of ziprasidone in patients with schizophrenia with depressive symptoms: a multicenter study.
Topics: Adult; Antipsychotic Agents; Comorbidity; Depression; Female; Humans; Male; Middle Aged; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Schizophrenia; Thiazoles; Treatment Outcome | 2015 |
Pharmacogenetics of adverse events in schizophrenia treatment: comparison study of ziprasidone, olanzapine and perazine.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Catechol O-Methyltransferase; Dopamine Plasma Membrane Transport Proteins; Female; Genotype; GluK3 Kainate Receptor; Humans; Male; Middle Aged; Monoamine Oxidase; Olanzapine; Overweight; Perazine; Piperazines; Polymorphism, Genetic; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Receptors, Kainic Acid; Schizophrenia, Paranoid; Serotonin Plasma Membrane Transport Proteins; Thiazoles; Weight Gain; Young Adult | 2014 |
Evaluation of the potential for a pharmacokinetic drug-drug interaction between armodafinil and ziprasidone in healthy adults.
Topics: Adult; Antipsychotic Agents; Area Under Curve; Benzhydryl Compounds; Cytochrome P-450 CYP3A; Drug Interactions; Female; Humans; Male; Middle Aged; Modafinil; Piperazines; Thiazoles; Wakefulness-Promoting Agents; Young Adult | 2014 |
Comparison of metabolic effects of aripiprazole, quetiapine and ziprasidone after 12 weeks of treatment in first treated episode of psychosis.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Cholesterol; Dibenzothiazepines; Female; Follow-Up Studies; Humans; Male; Piperazines; Prolactin; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Sex Factors; Thiazoles; Weight Gain | 2014 |
Glucagon-like peptide 1 receptor (GLP1R) haplotypes correlate with altered response to multiple antipsychotics in the CATIE trial.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Biomarkers, Pharmacological; Dibenzothiazepines; Female; Genotyping Techniques; Glucagon-Like Peptide-1 Receptor; Haplotypes; Humans; Male; Models, Genetic; Olanzapine; Perphenazine; Piperazines; Polymorphism, Single Nucleotide; Quetiapine Fumarate; Receptors, Glucagon; Regression Analysis; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome; Weight Gain; White People | 2014 |
Schizophrenia gene expression profile reverted to normal levels by antipsychotics.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Female; Humans; Longitudinal Studies; Male; Olanzapine; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Transcriptome; Treatment Outcome | 2014 |
Comparative efficacy between clozapine and other atypical antipsychotics on depressive symptoms in patients with schizophrenia: analysis of the CATIE phase 2E data.
Topics: Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Clozapine; Depressive Disorder, Major; Double-Blind Method; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome | 2015 |
Efficacy of ziprasidone monotherapy in patients with anxious depression: a 12-week, randomized, double-blind, placebo-controlled, sequential-parallel comparison trial.
Topics: Adult; Antidepressive Agents; Anxiety Disorders; Depression; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Thiazoles; Treatment Outcome | 2015 |
A 13-week, randomized double-blind, placebo-controlled, cross-over trial of ziprasidone in bipolar spectrum disorder.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Piperazines; Psychiatric Status Rating Scales; Thiazoles | 2015 |
Randomized Trial of the Effect of Four Second-Generation Antipsychotics and One First-Generation Antipsychotic on Cigarette Smoking, Alcohol, and Drug Use in Chronic Schizophrenia.
Topics: Adolescent; Adult; Aged; Alcoholism; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Comorbidity; Cross-Sectional Studies; Dibenzothiazepines; Double-Blind Method; Female; Humans; Illicit Drugs; Male; Middle Aged; Olanzapine; Perphenazine; Piperazines; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Smoking; Smoking Prevention; Substance-Related Disorders; Thiazoles; Young Adult | 2015 |
Ziprasidone Augmentation of Escitalopram for Major Depressive Disorder: Efficacy Results From a Randomized, Double-Blind, Placebo-Controlled Study.
Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Piperazines; Thiazoles; Treatment Outcome | 2015 |
Relating Spontaneously Reported Extrapyramidal Adverse Events to Movement Disorder Rating Scales.
Topics: Adolescent; Adult; Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Double-Blind Method; Haloperidol; Humans; Middle Aged; Piperazines; Schizophrenia; Severity of Illness Index; Thiazoles; Young Adult | 2015 |
Ziprasidone augmentation for anxious depression.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Anxiety; Citalopram; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Piperazines; Thiazoles; Young Adult | 2016 |
Incidence of non-alcoholic fatty liver disease and metabolic dysfunction in first episode schizophrenia and related psychotic disorders: a 3-year prospective randomized interventional study.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Female; Humans; Incidence; Male; Metabolic Diseases; Middle Aged; Non-alcoholic Fatty Liver Disease; Piperazines; Prospective Studies; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Young Adult | 2016 |
Ziprasidone Augmentation of Escitalopram for Major Depressive Disorder: Cardiac, Endocrine, Metabolic, and Motoric Effects in a Randomized, Double-Blind, Placebo-Controlled Study.
Topics: Adolescent; Adult; Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Citalopram; Depressive Disorder, Major; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Electrocardiography; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Piperazines; Selective Serotonin Reuptake Inhibitors; Thiazoles; Weight Gain; Young Adult | 2017 |
An assessor-blinded, randomized comparison of efficacy and tolerability of switching from olanzapine to ziprasidone and the combination of both in schizophrenia spectrum disorders.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Benzodiazepines; Drug Substitution; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Male; Metabolic Syndrome; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Severity of Illness Index; Single-Blind Method; Thiazoles; Treatment Outcome; Weight Gain | 2017 |
Effects of aripiprazole, quetiapine and ziprasidone on plasma prolactin levels in individuals with first episode nonaffective psychosis: Analysis of a randomized open-label 1year study.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Brief Psychiatric Rating Scale; Cohort Studies; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Piperazines; Prolactin; Psychotic Disorders; Quetiapine Fumarate; Sex Characteristics; Thiazoles; Time Factors; Young Adult | 2017 |
Incidence and risk factors of acute akathisia in 493 individuals with first episode non-affective psychosis: a 6-week randomised study of antipsychotic treatment.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Female; Haloperidol; Humans; Incidence; Male; Olanzapine; Piperazines; Prospective Studies; Psychotic Disorders; Quetiapine Fumarate; Risk Factors; Risperidone; Schizophrenia; Thiazoles; Young Adult | 2017 |
Long-term metabolic effects of aripiprazole, ziprasidone and quetiapine: a pragmatic clinical trial in drug-naïve patients with a first-episode of non-affective psychosis.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Blood Glucose; Body Mass Index; Body Weight; Cholesterol; Dibenzothiazepines; Female; Humans; Male; Middle Aged; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Thiazoles; Triglycerides; Young Adult | 2018 |
Dose reduction of high-dose first-generation antipsychotics or switch to ziprasidone in long-stay patients with schizophrenia: A 1-year double-blind randomized clinical trial.
Topics: Antipsychotic Agents; Chronic Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Resistance; Female; Humans; Male; Middle Aged; Piperazines; Schizophrenia; Thiazoles; Treatment Outcome | 2018 |
Long-Term Antipsychotic Effectiveness in First Episode of Psychosis: A 3-Year Follow-Up Randomized Clinical Trial Comparing Aripiprazole, Quetiapine, and Ziprasidone.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Female; Follow-Up Studies; Humans; Male; Outcome Assessment, Health Care; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Schizophrenia; Thiazoles; Young Adult | 2018 |
Comparing Schizophrenia Patients With a Predicted High/Low Risk of Nonresponse Receiving Treatment with Ziprasidone and Haloperidol: A Randomized-Controlled Study.
Topics: Adult; Antipsychotic Agents; Double-Blind Method; Female; Haloperidol; Humans; Interpersonal Relations; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Risk Assessment; Schizophrenia; Severity of Illness Index; Thiazoles; Time Factors; Treatment Outcome | 2019 |
Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness.
Topics: Aged; Antipsychotic Agents; Critical Illness; Delirium; Dopamine Antagonists; Double-Blind Method; Female; Haloperidol; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Piperazines; Respiratory Insufficiency; Shock; Thiazoles; Treatment Failure | 2018 |
The role of weight gain in explaining the effects of antipsychotic drugs on positive and negative symptoms: An analysis of the CATIE schizophrenia trial.
Topics: Adult; Antipsychotic Agents; Body-Weight Trajectory; Female; Humans; Male; Middle Aged; Olanzapine; Perphenazine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome; Weight Gain | 2019 |
Antipsychotic Treatment Effectiveness in First Episode of Psychosis: PAFIP 3-Year Follow-Up Randomized Clinical Trials Comparing Haloperidol, Olanzapine, Risperidone, Aripiprazole, Quetiapine, and Ziprasidone.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Female; Follow-Up Studies; Haloperidol; Humans; Male; Olanzapine; Outcome Assessment, Health Care; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Young Adult | 2020 |
Course of Psychosis in Schizophrenia With Alcohol Use Disorder: A Post Hoc Analysis of the Clinical Antipsychotic Trials of Intervention Effectiveness in Schizophrenia Phase 1 Study.
Topics: Adult; Alcoholism; Antipsychotic Agents; Comorbidity; Female; Hospitalization; Humans; Male; Olanzapine; Outcome Assessment, Health Care; Perphenazine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Severity of Illness Index; Symptom Flare Up; Thiazoles; Time Factors | 2020 |
Metabolic Effects of 7 Antipsychotics on Patients With Schizophrenia: A Short-Term, Randomized, Open-Label, Multicenter, Pharmacologic Trial.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Female; Humans; Male; Metabolic Syndrome; Olanzapine; Piperazines; Quetiapine Fumarate; Risk Factors; Risperidone; Schizophrenia; Thiazoles; Triglycerides | 2020 |
Randomized Double-blind Trial of Intramuscular Droperidol, Ziprasidone, and Lorazepam for Acute Undifferentiated Agitation in the Emergency Department.
Topics: Antipsychotic Agents; Droperidol; Emergency Service, Hospital; Humans; Hypnotics and Sedatives; Injections, Intramuscular; Lorazepam; Piperazines; Psychomotor Agitation; Thiazoles | 2021 |
A 3-year prospective study on the metabolic effect of aripiprazole, quetiapine and ziprasidone: A pragmatic clinical trial in first episode psychosis patients.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Energy Metabolism; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Piperazines; Prospective Studies; Psychotic Disorders; Quetiapine Fumarate; Schizophrenia; Thiazoles; Time Factors; Weight Gain; Young Adult | 2020 |
Low-Dose Ziprasidone in Combination with Sertraline for First-Episode Drug-Naïve Patients with Schizophrenia: a Randomized Controlled Trial.
Topics: Antipsychotic Agents; Double-Blind Method; Humans; Piperazines; Psychiatric Status Rating Scales; Schizophrenia; Sertraline; Thiazoles; Treatment Outcome | 2022 |
528 other study(ies) available for ziprasidone and thiazoles
| Article | Year |
|---|---|
Development and validation of a high-sensitivity assay for an antipsychotic agent, CP-88,059, with solid-phase extraction and narrow-bore high-performance liquid chromatography.
Topics: Antipsychotic Agents; Chromatography, High Pressure Liquid; Humans; Piperazines; Reproducibility of Results; Spectrophotometry, Ultraviolet; Spiro Compounds; Thiazoles | 1995 |
Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.
Topics: Adenylyl Cyclases; Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Biogenic Monoamines; Brain; Catalepsy; Cattle; CHO Cells; Choroid Plexus; Cricetinae; Cyclic AMP; Dopamine Antagonists; Guinea Pigs; Humans; Male; Mice; Mice, Inbred Strains; Motor Activity; Neurotransmitter Uptake Inhibitors; Piperazines; Quipazine; Rats; Receptors, Adrenergic; Receptors, Dopamine; Receptors, Serotonin; Serotonin Antagonists; Swine; Thiazoles | 1995 |
Differential effects of repeated administration of novel antipsychotic drugs on the activity of midbrain dopamine neurons in the rat.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Dopamine; Dose-Response Relationship, Drug; Male; Mesencephalon; Neurons; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Rats; Rats, Wistar; Risperidone; Substantia Nigra; Thiazoles | 1995 |
Comparison of methods for analysis of clinical [11C]raclopride studies.
Topics: Adult; Antipsychotic Agents; Body Fluid Compartments; Brain; Carbon Radioisotopes; Cerebellum; Corpus Striatum; Dopamine Antagonists; Dose-Response Relationship, Drug; Humans; Male; Models, Biological; Nonlinear Dynamics; Piperazines; Raclopride; Receptors, Dopamine D2; Reference Values; Regression Analysis; Salicylamides; Thiazoles; Tissue Distribution; Tomography, Emission-Computed | 1996 |
Positron emission tomographic analysis of central 5-hydroxytryptamine2 receptor occupancy in healthy volunteers treated with the novel antipsychotic agent, ziprasidone.
Topics: Adult; Antipsychotic Agents; Brain Chemistry; Cerebrovascular Circulation; Humans; Male; Piperazines; Pyrimidinones; Receptors, Serotonin; Serotonin Antagonists; Thiazoles; Tomography, Emission-Computed | 1996 |
Metabolism and excretion of the novel antipsychotic drug ziprasidone in rats after oral administration of a mixture of 14C- and 3H-labeled ziprasidone.
Topics: Administration, Oral; Animals; Antipsychotic Agents; Area Under Curve; Bile; Biotransformation; Carbon Radioisotopes; Feces; Female; Half-Life; Male; Piperazines; Rats; Thiazoles; Tritium | 1997 |
Automated sample preparation using membrane microtiter extraction for bioanalytical mass spectrometry.
Topics: Autoanalysis; Chromatography, High Pressure Liquid; Humans; Indicators and Reagents; Mass Spectrometry; Membranes, Artificial; Piperazines; Serotonin Antagonists; Solvents; Thiazoles | 1997 |
Characterization of the novel benzisothiazole ring-cleaved products of the antipsychotic drug ziprasidone.
Topics: Animals; Antipsychotic Agents; Bile; Biotransformation; Chromatography, High Pressure Liquid; Chromatography, Liquid; Humans; Hydroxylation; In Vitro Techniques; Mass Spectrometry; Oxidation-Reduction; Piperazines; Rats; Subcellular Fractions; Thiazoles | 1997 |
Antipsychotic drugs induce similar effects on the release of dopamine and noradrenaline in the medial prefrontal cortex of the rat brain.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Brain; Clozapine; Dopamine; Dopamine Agonists; Extracellular Space; Haloperidol; Male; Norepinephrine; Olanzapine; Piperazines; Pirenzepine; Prefrontal Cortex; Rats; Rats, Wistar; Reference Values; Risperidone; Tetrahydronaphthalenes; Thiazoles | 1998 |
Inclusion complexation of ziprasidone mesylate with beta-cyclodextrin sulfobutyl ether.
Topics: Antipsychotic Agents; beta-Cyclodextrins; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Cyclodextrins; Drug Stability; Magnetic Resonance Spectroscopy; Models, Theoretical; Molecular Structure; Monte Carlo Method; Piperazines; Thiazoles | 1998 |
Pharmacological profile of neuroleptics at human monoamine transporters.
Topics: Antipsychotic Agents; Carrier Proteins; Cell Line; Chlorpromazine; Cocaine; Dibenzazepines; Dibenzothiepins; Dopamine Plasma Membrane Transport Proteins; Fluoxetine; Humans; Imipramine; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Norepinephrine Plasma Membrane Transport Proteins; Pimozide; Piperazines; Protein Binding; Radioligand Assay; Recombinant Fusion Proteins; Serotonin Plasma Membrane Transport Proteins; Symporters; Thiazoles; Triflupromazine; Tritium | 1999 |
The distribution of body mass index among individuals with and without schizophrenia.
Topics: Antipsychotic Agents; Body Mass Index; Clinical Trials as Topic; Comorbidity; Female; Health Surveys; Humans; Male; Obesity; Piperazines; Schizophrenia; Sex Factors; Thiazoles; United States; Weight Gain | 1999 |
Comparison of the novel antipsychotic ziprasidone with clozapine and olanzapine: inhibition of dorsal raphe cell firing and the role of 5-HT1A receptor activation.
Topics: Action Potentials; Adrenergic Uptake Inhibitors; Animals; Benzodiazepines; Clozapine; Desipramine; Dose-Response Relationship, Drug; Male; Neurons; Olanzapine; Piperazines; Pirenzepine; Pyridines; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Receptor Agonists; Thiazoles | 1999 |
[Therapy of schizophrenia with high compliance. Ziprasidon increases pharmaceutical options].
Topics: Antipsychotic Agents; Hospitalization; Humans; Piperazines; Schizophrenia; Thiazoles | 1999 |
Quality of life and new antipsychotics in schizophrenia. Are patients better off?
Topics: Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Humans; Olanzapine; Patient Compliance; Patient Satisfaction; Piperazines; Pirenzepine; Quality of Life; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles | 1999 |
Introduction. Ziprasidone appears to offer important therapeutic and tolerability advantages over conventional, and some novel, antipsychotics.
Topics: Antipsychotic Agents; Drug Interactions; Humans; Piperazines; Thiazoles | 2000 |
Identification of the major human liver cytochrome P450 isoform(s) responsible for the formation of the primary metabolites of ziprasidone and prediction of possible drug interactions.
Topics: Antipsychotic Agents; Biotransformation; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Humans; In Vitro Techniques; Isoenzymes; Isoxazoles; Liver; Microsomes, Liver; Paliperidone Palmitate; Piperazines; Pyrimidines; Risperidone; Sulfones; Sulfoxides; Thiazoles | 2000 |
Ziprasidone overdose.
Topics: Antipsychotic Agents; Charcoal; Drug Overdose; Electrocardiography; Humans; Male; Middle Aged; Piperazines; Schizophrenia, Paranoid; Sorbitol; Thiazoles | 2000 |
Novel antipsychotic use in schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Dibenzothiepins; Drug Administration Schedule; Humans; Olanzapine; Piperazines; Pirenzepine; Practice Patterns, Physicians'; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome | 2000 |
5-HT(1A) receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Chromatography, High Pressure Liquid; Clozapine; Corpus Striatum; Dopamine; Haloperidol; Male; Microdialysis; Olanzapine; Piperazines; Pirenzepine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Sensitivity and Specificity; Synaptic Transmission; Thiazoles; Time Factors | 2000 |
Sustaining short-term gains for future progress.
Topics: Acute Disease; Administration, Oral; Antipsychotic Agents; Humans; Injections, Intramuscular; Piperazines; Psychotic Disorders; Thiazoles | 2001 |
Ziprasidone hydrochloride approved for treatment of schizophrenia, but with major warning.
Topics: Antipsychotic Agents; Drug Labeling; Humans; Piperazines; Randomized Controlled Trials as Topic; Schizophrenia; Thiazoles | 2001 |
Generalization of serotonin (5-HT)1A agonists and the antipsychotics, clozapine, ziprasidone and S16924, but not haloperidol, to the discriminative stimuli elicited by PD128,907 and 7-OH-DPAT.
Topics: Animals; Antipsychotic Agents; Benzopyrans; Clozapine; Discrimination Learning; Dopamine; Dopamine Agonists; Haloperidol; Humans; Male; Oxazines; Piperazines; Pyrrolidines; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin; Serotonin Receptor Agonists; Tetrahydronaphthalenes; Thiazoles | 2001 |
Ziprasidone (Geodon) for schizophrenia.
Topics: Antipsychotic Agents; Clinical Trials as Topic; Dopamine Antagonists; Humans; Intestinal Absorption; Piperazines; Schizophrenia; Serotonin Antagonists; Thiazoles | 2001 |
Psychopharmacology news.
Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Drug Approval; Fluoxetine; Humans; Piperazines; Psychotropic Drugs; Thiazoles | 2001 |
Ziprasidone approved.
Topics: Antipsychotic Agents; Drug Approval; Humans; Piperazines; Schizophrenia; Thiazoles | 2001 |
Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Binding Sites; Binding, Competitive; Cell Line; Clozapine; Dibenzothiazepines; Dopamine Antagonists; Haloperidol; Humans; Neurons; Norepinephrine; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Rats; Receptors, Adrenergic, alpha; Receptors, Dopamine; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Risperidone; Serotonin; Serotonin Antagonists; Thiazoles | 2001 |
Efficacy of antipsychotic agents at human 5-HT(1A) receptors determined by [3H]WAY100,635 binding affinity ratios: relationship to efficacy for G-protein activation.
Topics: Animals; Antipsychotic Agents; Binding, Competitive; Chlorpromazine; CHO Cells; Clozapine; Cricetinae; Dose-Response Relationship, Drug; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Haloperidol; Humans; Membranes; Piperazines; Piperidines; Pyridines; Pyrimidinones; Pyrrolidines; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Thiazoles; Thioridazine; Tritium | 2001 |
Ziprasidone hydrochloride.
Topics: Antipsychotic Agents; Drug Interactions; Female; Humans; Male; Piperazines; Pregnancy; Schizophrenia; Thiazoles | 2002 |
Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum.
Topics: Acetylcholine; Acetylcholinesterase; Animals; Antipsychotic Agents; Benzodiazepines; Cerebral Cortex; Cholinesterase Inhibitors; Clozapine; Corpus Striatum; Haloperidol; Male; Nucleus Accumbens; Olanzapine; Oxotremorine; Piperazines; Pirenzepine; Rats; Rats, Sprague-Dawley; Risperidone; Scopolamine; Sulpiride; Thiazoles; Thioridazine | 2002 |
Psychotropic drugs and adverse events in the treatment of bipolar disorders revisited.
Topics: Anticonvulsants; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Female; Fructose; Humans; Lamotrigine; Male; Obesity; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Risperidone; Thiazoles; Topiramate; Triazines | 2002 |
Ziprasidone induction of hypomania in depression?
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Piperazines; Recurrence; Thiazoles | 2002 |
Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat.
Topics: Acetylcholine; Adrenergic alpha-Antagonists; Animals; Antipsychotic Agents; Benzodiazepines; Chlorpromazine; Clozapine; Dialysis Solutions; Dopamine Antagonists; Extracellular Space; Haloperidol; Hippocampus; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Microdialysis; Olanzapine; Piperazines; Pirenzepine; Rats; Rats, Wistar; Risperidone; Serotonin Antagonists; Thiazoles; Thioridazine | 2002 |
Experience with ziprasidone.
Topics: Adolescent; Antipsychotic Agents; Contraindications; Depressive Disorder, Major; Drug Evaluation; Electrocardiography; Female; Humans; Long QT Syndrome; Male; Piperazines; Psychotic Disorders; Thiazoles | 2002 |
Overdose of ziprasidone.
Topics: Adult; Antipsychotic Agents; Arrhythmias, Cardiac; Blood Pressure; Delirium; Drug Overdose; Electrocardiography; Female; Humans; Hypotension; Piperazines; Severity of Illness Index; Thiazoles | 2002 |
Prolongation of QTc interval and antipsychotics.
Topics: Antipsychotic Agents; Death, Sudden, Cardiac; Drug Administration Schedule; Drug Labeling; Drug Monitoring; Haloperidol; Humans; Long QT Syndrome; Piperazines; Risperidone; Thiazoles | 2002 |
[Exercising caution in choice of psychotropic drugs. Avoid drug-induced weight gain].
Topics: Antipsychotic Agents; Clinical Trials as Topic; Humans; Piperazines; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome; Weight Gain | 2002 |
Stimulation by antipsychotic agents of mitogen-activated protein kinase (MAPK) coupled to cloned, human (h)serotonin (5-HT)(1A) receptors.
Topics: Animals; Antipsychotic Agents; CHO Cells; Clozapine; Cricetinae; Enzyme Activation; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Immunoblotting; Mitogen-Activated Protein Kinases; Phosphorylation; Piperazines; Pyrrolidines; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Antagonists; Serotonin Receptor Agonists; Thiazoles | 2002 |
Ziprasidone and migraine headache.
Topics: Adult; Antipsychotic Agents; Drug Interactions; Female; Humans; Migraine Disorders; Photophobia; Piperazines; Psychotic Disorders; Pyrantel Pamoate; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Thiazoles; Trismus | 2002 |
Rhabdomyolysis, pancreatitis, and hyperglycemia with ziprasidone.
Topics: Antipsychotic Agents; Diabetes Mellitus, Type 2; Diagnosis, Differential; Female; Fever; Humans; Hyperglycemia; Middle Aged; Muscle Rigidity; Neuroleptic Malignant Syndrome; Pancreatitis; Piperazines; Psychotic Disorders; Rhabdomyolysis; Thiazoles | 2002 |
Tardive dyskinesia and ziprasidone.
Topics: Antipsychotic Agents; Bipolar Disorder; Dyskinesia, Drug-Induced; Humans; Male; Middle Aged; Piperazines; Recurrence; Risk Factors; Thiazoles | 2002 |
Case series: use of ziprasidone for maladaptive symptoms in youths with autism.
Topics: Adolescent; Adult; Aggression; Autistic Disorder; Child; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Irritable Mood; Male; Piperazines; Psychomotor Agitation; Serotonin Antagonists; Thiazoles | 2002 |
Priapism associated with two atypical antipsychotic agents.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Humans; Male; Piperazines; Priapism; Risperidone; Schizophrenia; Thiazoles | 2002 |
The value of atypical antipsychotics in the treatment of schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Dopamine Antagonists; Drug Labeling; Humans; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Risperidone; Safety; Schizophrenia; Thiazoles; United States | 2002 |
Ziprasidone alternative for olanzapine-induced hyperglycemia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Diabetes Mellitus, Type 2; Humans; Hyperglycemia; Male; Olanzapine; Piperazines; Pirenzepine; Schizophrenia, Paranoid; Thiazoles; Treatment Outcome | 2002 |
New drugs 2002, part 1.
Topics: Amides; Aminosalicylic Acids; Anti-Ulcer Agents; Antipsychotic Agents; Bimatoprost; Cloprostenol; Cyclohexanes; Drug Approval; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Galantamine; Glaucoma; Gonadotropin-Releasing Hormone; Humans; Hypoglycemic Agents; Insulin; Insulin Glargine; Insulin, Long-Acting; Lipids; Mesalamine; Nateglinide; Nootropic Agents; Phenylalanine; Phenylhydrazines; Piperazines; Thiazoles; Travoprost | 2002 |
Neuroleptic Malignant Syndrome with ziprasidone.
Topics: Affective Disorders, Psychotic; Antipsychotic Agents; Dopamine Antagonists; Female; Humans; Middle Aged; Neuroleptic Malignant Syndrome; Piperazines; Serotonin Antagonists; Thiazoles | 2002 |
Ziprasidone-associated galactorrhea in a female teenager.
Topics: Adolescent; Antipsychotic Agents; Female; Galactorrhea; Humans; Piperazines; Thiazoles | 2003 |
A case of ziprasidone-induced mania and the role of 5-HT2A in mood changes induced by atypical antipsychotics.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Humans; Male; Piperazines; Psychotic Disorders; Serotonin; Thiazoles | 2002 |
Prolonged erections associated with ziprasidone treatment: a case report.
Topics: Adult; Antipsychotic Agents; Humans; Male; Penile Erection; Piperazines; Priapism; Schizophrenia; Thiazoles | 2003 |
alpha2C-Adrenoceptor blockade by clozapine and other antipsychotic drugs.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Brimonidine Tartrate; Chlorpromazine; CHO Cells; Clozapine; Cricetinae; Cyclic AMP; Dibenzothiazepines; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Gene Expression; Haloperidol; Humans; Isoxazoles; Norepinephrine; Olanzapine; Piperazines; Piperidines; Pirenzepine; Quetiapine Fumarate; Quinolones; Quinoxalines; Receptors, Adrenergic, alpha-2; Receptors, Dopamine D2; Risperidone; Thiazoles; Transfection; Yohimbine | 2003 |
Psychic akathisia.
Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Humans; Piperazines; Psychotic Disorders; Thiazoles | 2003 |
Cardiotoxicity associated with intentional ziprasidone and bupropion overdose.
Topics: Adult; Anti-Arrhythmia Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Bupropion; Drug Overdose; Electrocardiography; Heart Diseases; Humans; Hydrogen-Ion Concentration; Long QT Syndrome; Male; Piperazines; Suicide, Attempted; Thiazoles | 2003 |
Ziprasidone-associated mania: a case series and review of the mechanism.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Female; Humans; Male; Middle Aged; Piperazines; Thiazoles | 2003 |
A comparison of the effects of loxapine with ziprasidone and thioridazine on the release of dopamine and acetylcholine in the prefrontal cortex and nucleus accumbens.
Topics: Acetylcholine; Animals; Antipsychotic Agents; Binding Sites; Chromatography, High Pressure Liquid; Dopamine; Dose-Response Relationship, Drug; Drug Combinations; Loxapine; Male; Nucleus Accumbens; Piperazines; Prefrontal Cortex; Pyridines; Rats; Rats, Sprague-Dawley; Serotonin Antagonists; Thiazoles; Thioridazine; Time Factors | 2003 |
A case series of ziprasidone overdoses.
Topics: Adolescent; Adult; Antipsychotic Agents; Diagnosis, Differential; Drug Overdose; Female; Humans; Middle Aged; Piperazines; Thiazoles | 2003 |
The atypical antipsychotic ziprasidone, but not haloperidol, improves phencyclidine-induced cognitive deficits in a reversal learning task in the rat.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Cognition Disorders; Excitatory Amino Acid Antagonists; Female; Haloperidol; Injections, Intraperitoneal; Phencyclidine; Piperazines; Rats; Reversal Learning; Social Isolation; Thiazoles | 2003 |
Comparison of the effects of antipsychotics on a delayed radial maze task in the rat.
Topics: Administration, Oral; Animals; Antipsychotic Agents; Benzodiazepines; Clozapine; Cognition; Dose-Response Relationship, Drug; Food Deprivation; Haloperidol; Male; Maze Learning; Memory; Olanzapine; Piperazines; Pirenzepine; Rats; Rats, Sprague-Dawley; Risperidone; Thiazoles | 2003 |
Mania associated with initiation of ziprasidone.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Drug Administration Schedule; Humans; Male; Piperazines; Schizophrenia; Thiazoles | 2003 |
Cardiotoxicity associated with intentional ziprasidone and bupropion overdose.
Topics: Adolescent; Anti-Arrhythmia Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Bupropion; Consciousness; Depressive Disorder, Major; Drug Overdose; Electrocardiography; Heart Diseases; Humans; Hydrogen-Ion Concentration; Lidocaine; Long QT Syndrome; Male; Piperazines; Suicide, Attempted; Thiazoles | 2003 |
Side effects of ziprasidone.
Topics: Antipsychotic Agents; Female; Humans; Hypokalemia; Long QT Syndrome; Magnesium; Middle Aged; Mood Disorders; Piperazines; Thiazoles; Water-Electrolyte Imbalance | 2003 |
[Treatment of young people with atypical antipsychotic agents].
Topics: Adolescent; Antipsychotic Agents; Humans; Piperazines; Schizophrenia; Thiazoles | 2003 |
Ziprasidone in autism.
Topics: Adolescent; Antipsychotic Agents; Autistic Disorder; Bipolar Disorder; Comorbidity; Dose-Response Relationship, Drug; Female; Humans; Male; Piperazines; Thiazoles | 2003 |
Possible ziprasidone-induced mania.
Topics: Adolescent; Antipsychotic Agents; Bipolar Disorder; Female; Humans; Piperazines; Schizophrenia; Thiazoles | 2003 |
Ziprasidone-induced oculogyric crisis.
Topics: Antipsychotic Agents; Child; Dystonia; Humans; Male; Mental Disorders; Ocular Motility Disorders; Piperazines; Thiazoles | 2003 |
Schizophrenia, VI: Treatments.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Perphenazine; Piperazines; Pirenzepine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome | 2003 |
Extrapyramidal symptoms in children on atypical antipsychotic drugs.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Child; Dibenzothiazepines; Female; Humans; Male; Piperazines; Quetiapine Fumarate; Thiazoles | 2003 |
Ziprasidone-induced Pisa syndrome after clozapine treatment.
Topics: Clozapine; Diagnostic and Statistical Manual of Mental Disorders; Dose-Response Relationship, Drug; Drug Interactions; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Piperazines; Schizophrenia; Serotonin Antagonists; Thiazoles | 2003 |
Ziprasidone--not an option for serotonin syndrome.
Topics: Antipsychotic Agents; Humans; Piperazines; Receptors, Serotonin; Serotonin Syndrome; Thiazoles | 2003 |
Mania from dose-related ziprasidone augmentation of an SSRI.
Topics: Antipsychotic Agents; Anxiety Disorders; Bipolar Disorder; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Middle Aged; Piperazines; Selective Serotonin Reuptake Inhibitors; Thiazoles | 2003 |
Determination of plasma ziprasidone using liquid chromatography with fluorescence detection.
Topics: Antipsychotic Agents; Calibration; Chromatography, Liquid; Humans; Piperazines; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence; Thiazoles | 2004 |
Similarities and differences among antipsychotics.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Haloperidol; Humans; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Thiazoles | 2003 |
Ziprasidone-related tardive dyskinesia.
Topics: Aged; Antipsychotic Agents; Depressive Disorder, Major; Dyskinesia, Drug-Induced; Female; Humans; Piperazines; Thiazoles | 2004 |
Introduction. Ziprasidone in schizophrenia: from acute treatment to long-term management.
Topics: Acute Disease; Antipsychotic Agents; Chronic Disease; Clinical Trials as Topic; Humans; Long-Term Care; Piperazines; Schizophrenia; Schizophrenic Psychology; Serotonin Antagonists; Thiazoles | 2003 |
Ziprasidone and cognition: the evolving story.
Topics: Antipsychotic Agents; Clinical Trials as Topic; Cognition Disorders; Dose-Response Relationship, Drug; Humans; Neuropsychological Tests; Piperazines; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Serotonin Antagonists; Thiazoles; Treatment Outcome | 2003 |
Hypomanic episodes after receiving ziprasidone: an unintended "on-off-on" course of treatment.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Drug Administration Schedule; Humans; Male; Piperazines; Psychotic Disorders; Thiazoles | 2004 |
Ziprasidone in Parkinson's disease psychosis.
Topics: Aged; Antipsychotic Agents; Dopamine Agonists; Humans; Levodopa; Male; Parkinson Disease; Piperazines; Psychoses, Substance-Induced; Thiazoles | 2004 |
Ziprasidone in Huntington's disease: the first case reports.
Topics: Adult; Dopamine Antagonists; Female; Humans; Huntington Disease; Male; Middle Aged; Piperazines; Thiazoles | 2003 |
Clinical case presentation: therapeutic challenges in adolescent-onset bipolar disorder.
Topics: Adolescent; Aggression; Anti-Anxiety Agents; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Clonazepam; Diagnosis, Differential; Education; Family; GABA Modulators; Haloperidol; Hospitalization; Humans; Irritable Mood; Lithium; Lorazepam; Male; Piperazines; Psychiatric Status Rating Scales; Sexual Behavior; Thiazoles; Valproic Acid | 2003 |
Occupancy of agonist drugs at the 5-HT1A receptor.
Topics: Adult; Animals; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Piperazines; Pyridines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Serotonin Antagonists; Serotonin Receptor Agonists; Thiazoles; Tomography, Emission-Computed | 2004 |
Use of ziprasidone to treat bipolar-associated catatonia.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Catatonia; Female; Humans; Piperazines; Thiazoles | 2004 |
[Hypomania induced by Ziprasidone].
Topics: Aged; Antipsychotic Agents; Bipolar Disorder; Female; Humans; Piperazines; Thiazoles | 2004 |
Ziprasidone-related neuroleptic malignant syndrome in a patient with Parkinson's disease: a diagnostic challenge.
Topics: Antipsychotic Agents; Female; Humans; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease; Piperazines; Thiazoles | 2004 |
Stability indicating reversed-phase high-performance liquid chromatographic and thin layer densitometric methods for the determination of ziprasidone in bulk powder and in pharmaceutical formulations.
Topics: Antipsychotic Agents; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Densitometry; Pharmaceutical Preparations; Piperazines; Powders; Thiazoles | 2004 |
Improvement in prosocial functioning after a switch to ziprasidone treatment.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Female; Humans; Male; Middle Aged; Olanzapine; Piperazines; Schizophrenia; Thiazoles | 2004 |
QTc prolongation in multiple drug overdose.
Topics: Adult; Bupropion; Drug Overdose; Fluoxetine; Humans; Long QT Syndrome; Male; Piperazines; Psychotic Disorders; Thiazoles; Valproic Acid | 2004 |
Ziprasidone for sedation of the agitated ED patient.
Topics: Antipsychotic Agents; Droperidol; Drug Labeling; Emergency Treatment; Humans; Long QT Syndrome; Piperazines; Practice Guidelines as Topic; Psychomotor Agitation; Thiazoles; Torsades de Pointes; United States; United States Food and Drug Administration | 2004 |
Ziprasidone treatment of two adolescents with psychosis.
Topics: Adolescent; Female; Humans; Male; Piperazines; Psychotic Disorders; Thiazoles | 2004 |
Combination of ziprasidone and clozapine in treatment-resistant schizophrenia.
Topics: Adult; Antipsychotic Agents; Clozapine; Drug Resistance; Drug Therapy, Combination; Female; Humans; Piperazines; Schizophrenia; Thiazoles; Treatment Outcome | 2004 |
Ziprasidone and mania.
Topics: Adolescent; Antipsychotic Agents; Bipolar Disorder; Child; Humans; Piperazines; Thiazoles | 2004 |
[Non-information from a drug industry].
Topics: Antipsychotic Agents; Drug Industry; Drug Information Services; Humans; Piperazines; Serotonin Antagonists; Thiazoles | 2004 |
[Ziprasidone-augmentation of clozapine].
Topics: Adult; Antipsychotic Agents; Clozapine; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance; Drug Therapy, Combination; Follicle Stimulating Hormone; Humans; Hyperprolactinemia; Male; Piperazines; Prolactin; Psychiatric Status Rating Scales; Schizophrenia, Paranoid; Thiazoles | 2004 |
Evaluating the reconstitution of intramuscular ziprasidone (Geodon) into solution.
Topics: Antipsychotic Agents; Drug Compounding; Piperazines; Solutions; Thiazoles; Time Factors | 2004 |
Antipsychotic treatment of psychosis associated with multiple sclerosis.
Topics: Antipsychotic Agents; Female; Humans; Middle Aged; Multiple Sclerosis; Piperazines; Psychotic Disorders; Schizophrenic Psychology; Thiazoles | 2004 |
Ziprasidone-induced lupus erythematosus.
Topics: Depressive Disorder, Major; Female; Humans; Lupus Erythematosus, Systemic; Middle Aged; Piperazines; Psychotic Disorders; Serotonin Antagonists; Thiazoles | 2004 |
Ziprasidone and mania.
Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Comorbidity; Drug Interactions; Drug Therapy, Combination; Humans; Piperazines; Randomized Controlled Trials as Topic; Research Design; Sleep Initiation and Maintenance Disorders; Thiazoles; Treatment Outcome | 2004 |
The effectiveness of olanzapine, risperidone, quetiapine, and ziprasidone as augmentation agents in treatment-resistant major depressive disorder.
Topics: Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Depressive Disorder; Dibenzothiazepines; Drug Therapy, Combination; Female; Humans; Male; Medical Records; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Quetiapine Fumarate; Research Design; Retrospective Studies; Risperidone; Thiazoles; Treatment Outcome | 2004 |
Tourette syndrome: efficient treatment with ziprasidone and normalization of body weight in a patient with excessive weight gain under tiapride.
Topics: Adult; Antipsychotic Agents; Body Weight; Female; Humans; Obesity; Piperazines; Thiazoles; Tiapamil Hydrochloride; Tourette Syndrome; Weight Gain | 2004 |
Intravenous ziprasidone for treatment of delirium in the intensive care unit.
Topics: Antipsychotic Agents; Bone Transplantation; Critical Care; Delirium; Haloperidol; Humans; Male; Middle Aged; Piperazines; Postoperative Complications; Thiazoles | 2004 |
[Ziprasidone and dementia].
Topics: Aged; Antipsychotic Agents; Contraindications; Dementia; Humans; Piperazines; Risk Factors; Serotonin Antagonists; Stroke; Thiazoles | 2004 |
Neuroleptic malignant syndrome associated with ziprasidone in an adolescent.
Topics: Adolescent; Antipsychotic Agents; Humans; Male; Neuroleptic Malignant Syndrome; Piperazines; Psychotic Disorders; Thiazoles | 2004 |
Effects of acute treatment with antidepressant drugs on sensorimotor gating deficits in rats.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Antipsychotic Agents; Bupropion; Citalopram; Desipramine; Dextroamphetamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Male; Norepinephrine; Piperazines; Rats; Rats, Wistar; Reflex, Startle; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Thiazoles | 2005 |
Acute dystonic reaction with moderate-dose ziprasidone.
Topics: Acute Disease; Adult; Alcoholism; Antipsychotic Agents; Cocaine-Related Disorders; Dystonic Disorders; Female; Hallucinations; Humans; Piperazines; Risk Factors; Thiazoles; Tongue Diseases; Torticollis; Violence | 2004 |
Successful switch to aripiprazole after induction of hyperprolactinemia by ziprasidone: a case report.
Topics: Adult; Ambulatory Care; Antipsychotic Agents; Aripiprazole; Female; Humans; Hyperprolactinemia; Piperazines; Prolactin; Quinolones; Schizophrenia, Paranoid; Sexual Dysfunctions, Psychological; Thiazoles | 2004 |
Atypical antipsychotic drugs and diabetes mellitus in a large outpatient population: a retrospective cohort study.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Clozapine; Cohort Studies; Databases, Factual; Diabetes Mellitus; Dibenzothiazepines; Drug Prescriptions; Female; Humans; Incidence; Insurance Claim Reporting; Male; Middle Aged; Multivariate Analysis; Olanzapine; Outpatients; Piperazines; Quetiapine Fumarate; Retrospective Studies; Risperidone; Sex Factors; Thiazoles; Thioridazine; Time Factors; United States | 2005 |
The risk of harm in mania and the very early time course of improvement: important but neglected variables in treatment research.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Humans; Olanzapine; Piperazines; Quality of Life; Quinolones; Risk Factors; Self-Injurious Behavior; Thiazoles | 2004 |
Prolactin elevation with ziprasidone.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Bipolar Disorder; Comorbidity; Depression, Postpartum; Dibenzothiazepines; Female; Humans; Hyperprolactinemia; Piperazines; Quetiapine Fumarate; Risperidone; Thiazoles; Treatment Outcome | 2004 |
Atypical antipsychotics: matching receptor profile to individual patient's clinical profile.
Topics: Adult; Affect; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Cognition; Dibenzothiazepines; Dose-Response Relationship, Drug; Histamine; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Receptors, Muscarinic; Receptors, Serotonin; Risperidone; Schizophrenia; Thiazoles | 2004 |
No significant QTc interval changes with high-dose ziprasidone: a case series.
Topics: Adult; Dose-Response Relationship, Drug; Electrocardiography; Female; Humans; Long QT Syndrome; Male; Middle Aged; Piperazines; Retrospective Studies; Serotonin Antagonists; Thiazoles | 2004 |
Ziprasidone suppresses olanzapine-induced increases in ingestive behaviour in the rat.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Benzodiazepines; Eating; Injections, Intraperitoneal; Male; Motor Activity; Olanzapine; Piperazines; Rats; Thiazoles | 2004 |
[Risk of QTc prolongation due to combination of ziprasidone and quetiapine].
Topics: Acute Disease; Aged; Antipsychotic Agents; Dibenzothiazepines; Drug Interactions; Drug Therapy, Combination; Electrocardiography; Hallucinations; Humans; Long QT Syndrome; Male; Piperazines; Quetiapine Fumarate; Schizophrenia, Paranoid; Thiazoles | 2004 |
Ziprasidone: first year experience in a hospital setting.
Topics: Adult; Antipsychotic Agents; Depressive Disorder; Electrocardiography; Female; Hospitalization; Humans; Inpatients; Length of Stay; Long QT Syndrome; Male; Middle Aged; Mood Disorders; Piperazines; Retrospective Studies; Schizophrenia; Thiazoles; Treatment Outcome | 2004 |
Tardive dyskinesia in 2 patients treated with ziprasidone.
Topics: Adult; Antipsychotic Agents; Delusions; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyskinesia, Drug-Induced; Follow-Up Studies; Hallucinations; Humans; Long-Term Care; Male; Neurologic Examination; Piperazines; Psychiatric Status Rating Scales; Recurrence; Schizophrenia; Thiazoles | 2004 |
Intramuscular ziprasidone for acute agitation in adolescents.
Topics: Acute Disease; Adolescent; Aggression; Child; Humans; Injections, Intramuscular; Male; Piperazines; Psychomotor Agitation; Thiazoles | 2004 |
Ziprasidone monotherapy in pediatric bipolar disorder.
Topics: Adolescent; Bipolar Disorder; Child; Female; Humans; Male; Piperazines; Thiazoles | 2004 |
The use of two neuroleptics to treat bipolar illness in two children.
Topics: Adolescent; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Benzodiazepines; Bipolar Disorder; Child; Drug Therapy, Combination; Humans; Male; Olanzapine; Piperazines; Thiazoles | 2004 |
Intramuscular ziprasidone in youth: a retrospective chart review.
Topics: Adolescent; Aggression; Antipsychotic Agents; Child; Dose-Response Relationship, Drug; Female; Humans; Injections, Intramuscular; Male; Piperazines; Psychomotor Agitation; Psychotic Disorders; Retrospective Studies; Thiazoles; Treatment Outcome | 2004 |
New onset of diabetes mellitus with ziprasidone: a case report.
Topics: Adult; Antipsychotic Agents; Diabetes Mellitus; Humans; Male; Piperazines; Schizophrenia, Paranoid; Thiazoles | 2005 |
Ziprasidone-induced galactorrhea: a case report.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Clonazepam; Depressive Disorder, Major; Female; Galactorrhea; Humans; Lithium; Piperazines; Prolactin; Recurrence; Thiazoles | 2005 |
Sudden death in a patient with Tourette syndrome during a clinical trial of ziprasidone.
Topics: Adult; Antipsychotic Agents; Cholesterol; Death, Sudden; Fatal Outcome; Humans; Male; Piperazines; Psychiatric Status Rating Scales; Thiazoles; Tourette Syndrome | 2005 |
Comparison of the metabolic effects observed in patients treated with ziprasidone versus olanzapine.
Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Body Weight; Cholesterol, HDL; Cholesterol, LDL; Electrocardiography; Female; Glycated Hemoglobin; Heart Rate; Humans; Hyperlipidemias; Lipids; Male; Middle Aged; Olanzapine; Piperazines; Retrospective Studies; Schizophrenia; Thiazoles; Triglycerides | 2005 |
D2-blockade and possible ziprasidone-induced galactorrhea.
Topics: Adult; Antipsychotic Agents; Depressive Disorder, Major; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Galactorrhea; Humans; Male; Piperazines; Psychiatric Status Rating Scales; Thiazoles | 2005 |
Ziprasidone-induced acute dystonia.
Topics: Acute Disease; Antipsychotic Agents; Basal Ganglia Diseases; Dose-Response Relationship, Drug; Drug Administration Schedule; Dystonia; Humans; Male; Middle Aged; Piperazines; Schizophrenia, Paranoid; Thiazoles | 2005 |
Ziprasidone as an augmenting agent in the treatment of anxiety-spectrum disorders.
Topics: Adult; Antipsychotic Agents; Anxiety Disorders; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Panic Disorder; Piperazines; Selective Serotonin Reuptake Inhibitors; Thiazoles; Treatment Outcome | 2005 |
Automated determination of ziprasidone by HPLC with column switching and spectrophotometric detection.
Topics: Adult; Automation; Benzodiazepines; Chromatography, High Pressure Liquid; Clozapine; Drug Administration Schedule; Drug Monitoring; Female; Humans; Male; Middle Aged; Olanzapine; Piperazines; Reproducibility of Results; Schizophrenia; Sensitivity and Specificity; Spectrophotometry; Thiazoles; Time Factors | 2005 |
Antipsychotic drug-induced weight gain: development of an animal model.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Body Constitution; Body Weight; Dibenzothiazepines; Eating; Male; Mice; Mice, Inbred C57BL; Models, Animal; Obesity; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Thiazoles | 2005 |
Characterization of a novel metabolite intermediate of ziprasidone in hepatic cytosolic fractions of rat, dog, and human by ESI-MS/MS, hydrogen/deuterium exchange, and chemical derivatization.
Topics: Animals; Antipsychotic Agents; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Cytosol; Deuterium; Dogs; Humans; Hydrogen; Liver; Piperazines; Rats; Spectrometry, Mass, Electrospray Ionization; Thiazoles | 2005 |
[Misdiagnosed PTSD and zeldox pharmacotherapy in case of a political prisoner].
Topics: Antipsychotic Agents; Communism; Diagnostic Errors; Humans; Hungary; Male; Middle Aged; Piperazines; Prisoners; Schizophrenia, Paranoid; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Antagonists; Stress Disorders, Post-Traumatic; Thiazoles | 2004 |
Ziprasidone pretreatment attenuates the lethal effects of cocaine in a mouse model.
Topics: Acute Disease; Animals; Antipsychotic Agents; Cocaine; Cocaine-Related Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Overdose; Injections, Intraperitoneal; Mice; Piperazines; Premedication; Random Allocation; Seizures; Single-Blind Method; Survival Analysis; Thiazoles; Treatment Outcome | 2005 |
Clozapine, ziprasidone and aripiprazole but not haloperidol protect against kainic acid-induced lesion of the striatum in mice, in vivo: role of 5-HT1A receptor activation.
Topics: Aminopyridines; Animals; Antipsychotic Agents; Aripiprazole; Clozapine; Corpus Striatum; Disease Models, Animal; Excitatory Amino Acid Agonists; Haloperidol; Kainic Acid; Male; Mice; Mice, Inbred C57BL; Piperazines; Piperidines; Pyridines; Quinolones; Receptor, Serotonin, 5-HT1A; Schizophrenia; Serotonin 5-HT1 Receptor Agonists; Serotonin Antagonists; Thiazoles | 2005 |
Investigation into the effects of the novel antipsychotic ziprasidone on weight gain and reproductive function in female rats.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Behavior, Animal; Body Weight; Dose-Response Relationship, Drug; Drinking; Female; Piperazines; Rats; Thiazoles; Time Factors | 2005 |
FDA warns antipsychotic drugs may be risky for elderly.
Topics: Aged; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dementia; Dibenzothiazepines; Drug Approval; Drug Labeling; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles; United States; United States Food and Drug Administration | 2005 |
The highest intentional ziprasidone overdose was not fatal.
Topics: Antipsychotic Agents; Bipolar Disorder; Drug Overdose; Female; Humans; Intention; Middle Aged; Piperazines; Suicide, Attempted; Thiazoles | 2005 |
An African patient with ziprasidone intolerance.
Topics: Africa; Antipsychotic Agents; Aripiprazole; Dystonia; Ethnicity; Germany; Humans; Male; Middle Aged; Pharmacogenetics; Piperazines; Quinolones; Schizophrenia; Thiazoles; Treatment Outcome | 2005 |
Ziprasidone for agitation or psychosis in dementia: four cases.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Dementia; Diagnostic and Statistical Manual of Mental Disorders; Electrocardiography; Female; Humans; Male; Middle Aged; Piperazines; Psychomotor Agitation; Psychotic Disorders; Retrospective Studies; Thiazoles | 2005 |
Pharmacokinetic-pharmacodynamic analysis of antipsychotics-induced extrapyramidal symptoms based on receptor occupancy theory incorporating endogenous dopamine release.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Clozapine; Controlled Clinical Trials as Topic; Dibenzothiazepines; Haloperidol; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Risperidone; Schizophrenia; Thiazoles | 2005 |
The atypical antipsychotics quetiapine, risperidone and ziprasidone do not increase insulin release in vitro.
Topics: Animals; Antipsychotic Agents; Dibenzothiazepines; Glucose; Insulin; Islets of Langerhans; Male; Organ Culture Techniques; Piperazines; Quetiapine Fumarate; Rats; Rats, Wistar; Risperidone; Thiazoles | 2005 |
Methodological concerns in a trial of ziprasidone and olanzapine.
Topics: Antipsychotic Agents; Benzodiazepines; Bias; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Industry; Humans; Olanzapine; Piperazines; Product Labeling; Randomized Controlled Trials as Topic; Research Design; Research Support as Topic; Schizophrenia; Thiazoles | 2005 |
Methodological concerns in a trial of ziprasidone and olanzapine.
Topics: Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Bias; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Humans; Lorazepam; Olanzapine; Piperazines; Randomized Controlled Trials as Topic; Research Design; Schizophrenia; Schizophrenic Psychology; Thiazoles | 2005 |
The atypical antipsychotic agents ziprasidone [correction of zisprasidone], risperdone and olanzapine as treatment for and prophylaxis against progressive multifocal leukoencephalopathy.
Topics: Antipsychotic Agents; Benzodiazepines; Humans; Leukoencephalopathy, Progressive Multifocal; Olanzapine; Piperazines; Risperidone; Thiazoles | 2005 |
Effects of novel antipsychotics with mixed D(2) antagonist/5-HT(1A) agonist properties on PCP-induced social interaction deficits in the rat.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Aripiprazole; Clozapine; Dioxanes; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Excitatory Amino Acid Antagonists; Haloperidol; Interpersonal Relations; Male; Phencyclidine; Piperazines; Pyridines; Quinolones; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Remoxipride; Serotonin Antagonists; Serotonin Receptor Agonists; Thiazoles; Tropanes | 2005 |
A retrospective study of the safety of intramuscular ziprasidone in agitated elderly patients.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Arrhythmias, Cardiac; Dementia; Electrocardiography; Female; Haloperidol; Humans; Injections, Intramuscular; Long QT Syndrome; Male; Middle Aged; Piperazines; Psychomotor Agitation; Retrospective Studies; Risk Factors; Thiazoles; Torsades de Pointes | 2005 |
Three-year experience with ziprasidone exposures.
Topics: Adolescent; Adult; Antipsychotic Agents; Child; Child, Preschool; Drug Overdose; Emergency Medicine; Humans; Infant; Piperazines; Retrospective Studies; Thiazoles; Treatment Outcome | 2005 |
Ziprasidone-induced hypersensitivity syndrome in an aged schizophrenia patient.
Topics: Aged; Antipsychotic Agents; Drug Hypersensitivity; Female; Humans; Piperazines; Schizophrenia; Thiazoles; Treatment Outcome | 2005 |
Rhabdomyolysis after correction of hyponatremia in psychogenic polydipsia possibly complicated by ziprasidone.
Topics: Antipsychotic Agents; Humans; Hyponatremia; Male; Middle Aged; Piperazines; Rhabdomyolysis; Schizophrenia, Paranoid; Sodium Chloride; Thiazoles; Water Intoxication | 2005 |
Ziprasidone in the treatment of Parkinson's disease psychosis.
Topics: Antipsychotic Agents; Dose-Response Relationship, Drug; Humans; Male; Middle Aged; Motor Activity; Parkinson Disease; Piperazines; Psychotic Disorders; Taiwan; Thiazoles; Treatment Outcome | 2006 |
Treatment of refractory chronic daily headache with the atypical antipsychotic ziprasidone--a case series.
Topics: Adult; Antipsychotic Agents; Female; Headache Disorders; Humans; Middle Aged; Piperazines; Severity of Illness Index; Thiazoles; Treatment Failure; Treatment Outcome | 2005 |
Rapid liquid chromatography-tandem mass spectrometry method for quantification of ziprasidone in human plasma.
Topics: Chromatography, Liquid; Piperazines; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Thiazoles | 2006 |
An in vitro approach to detect metabolite toxicity due to CYP3A4-dependent bioactivation of xenobiotics.
Topics: Adenosine Triphosphate; Albendazole; Amitriptyline; Animals; Buthionine Sulfoximine; Carbamazepine; Cell Culture Techniques; Cell Line, Tumor; Cell Survival; Chromans; Coculture Techniques; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dapsone; Enzyme Activation; Flutamide; Glutathione; Humans; Isoniazid; Microsomes; Ochratoxins; Piperazines; Quinidine; Substrate Specificity; Tamoxifen; Tetrazolium Salts; Thiazoles; Thiazolidinediones; Toxicity Tests; Triazolam; Troglitazone; Xenobiotics | 2005 |
Ziprasidone and hypomania.
Topics: Bipolar Disorder; Humans; Piperazines; Serotonin Antagonists; Thiazoles | 2005 |
Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events versus other antipsychotics.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Cerebrovascular Disorders; Cohort Studies; Dementia; Dibenzothiazepines; Dose-Response Relationship, Drug; Female; Haloperidol; Hospitalization; Humans; Male; Middle Aged; Olanzapine; Patient Admission; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Retrospective Studies; Risk Factors; Risperidone; Thiazoles | 2005 |
Uniformity of ionization response of structurally diverse analytes using a chip-based nanoelectrospray ionization source.
Topics: Animals; Antipsychotic Agents; Glutathione; Humans; Microchip Analytical Procedures; Nanotechnology; Pharmaceutical Preparations; Piperazines; Spectrometry, Mass, Electrospray Ionization; Thiazoles | 2005 |
Ziprasidone-induced tardive dyskinesia.
Topics: Adult; Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; Humans; Piperazines; Psychotic Disorders; Thiazoles | 2005 |
Tardive dystonia associated with ziprasidone.
Topics: Antipsychotic Agents; Dyskinesia, Drug-Induced; Dystonic Disorders; Female; Humans; Middle Aged; Migraine Disorders; Piperazines; Thiazoles | 2005 |
Drugs that inhibit oxidation reactions catalyzed by aldehyde oxidase do not inhibit the reductive metabolism of ziprasidone to its major metabolite, S-methyldihydroziprasidone: an in vitro study.
Topics: Aldehyde Oxidase; Antipsychotic Agents; Catalysis; Drug Interactions; Humans; Liver; Oxidation-Reduction; Phthalazines; Piperazines; Thiazoles; Tissue Culture Techniques | 2005 |
Effects of atypical antipsychotic drugs on intralipid intake and cocaine-induced hyperactivity in rats.
Topics: Animals; Antipsychotic Agents; Cocaine; Dibenzothiazepines; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Eating; Fat Emulsions, Intravenous; Female; Hyperkinesis; Male; Motor Activity; Piperazines; Quetiapine Fumarate; Rats; Risperidone; Thiazoles | 2006 |
Atypical antipsychotics: special formulations for acute agitation.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Humans; Olanzapine; Piperazines; Psychomotor Agitation; Psychotic Disorders; Quinolones; Risperidone; Thiazoles | 2005 |
Involvement of 5-HT1A receptors in prefrontal cortex in the modulation of dopaminergic activity: role in atypical antipsychotic action.
Topics: Animals; Antipsychotic Agents; Benzopyrans; Dopamine; Electrophysiology; Extracellular Fluid; Haloperidol; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neural Pathways; Neurons; Osmolar Concentration; Piperazines; Prefrontal Cortex; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Serotonin 5-HT1 Receptor Agonists; Serotonin Receptor Agonists; Thiazoles; Ventral Tegmental Area | 2005 |
Atypical antipsychotic drugs and organization of long-term semantic memory: multidimensional scaling and cluster analyses of category fluency performance in schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cluster Analysis; Female; Humans; Male; Memory; Olanzapine; Piperazines; Quality of Life; Reading; Schizophrenia; Schizophrenic Psychology; Semantics; Thiazoles | 2006 |
Urinary hesitancy and retention caused by ziprasidone.
Topics: Adult; Antipsychotic Agents; Humans; Male; Piperazines; Schizophrenia; Thiazoles; Urinary Retention | 2006 |
Block of hERG channel by ziprasidone: biophysical properties and molecular determinants.
Topics: Animals; Antipsychotic Agents; Cell Line; Cloning, Molecular; Dose-Response Relationship, Drug; Ether-A-Go-Go Potassium Channels; Humans; Mutation; Oocytes; Piperazines; Potassium Channel Blockers; Thiazoles; Xenopus | 2006 |
Ziprasidone therapy for post-traumatic stress disorder.
Topics: Antipsychotic Agents; Combat Disorders; Humans; Male; Middle Aged; Piperazines; Stress Disorders, Post-Traumatic; Thiazoles | 2005 |
The effects of ziprasidone on regional c-Fos expression in the rat forebrain.
Topics: Animals; Antipsychotic Agents; Dose-Response Relationship, Drug; Immunohistochemistry; Male; Piperazines; Prosencephalon; Proto-Oncogene Proteins c-fos; Rats; Thiazoles; Time Factors | 2006 |
Parkinsonism with intramuscular ziprasidone.
Topics: Antipsychotic Agents; Dose-Response Relationship, Drug; Humans; Injections, Intramuscular; Male; Middle Aged; Parkinson Disease, Secondary; Piperazines; Schizophrenia, Paranoid; Thiazoles; Violence | 2005 |
Ziprasidone- and lithium-induced neuroleptic malignant syndrome.
Topics: Antipsychotic Agents; Humans; Hypotension; Lithium; Male; Middle Aged; Neuroleptic Malignant Syndrome; Piperazines; Psychotic Disorders; Thiazoles | 2006 |
Ziprasidone-induced priapism requiring surgical treatment.
Topics: Adult; Bipolar Disorder; Erectile Dysfunction; Humans; Male; Piperazines; Priapism; Psychotic Disorders; Thiazoles | 2006 |
From clinical research to clinical practice: a 4-year review of ziprasidone.
Topics: Antipsychotic Agents; Controlled Clinical Trials as Topic; Dopamine Antagonists; Humans; Mood Disorders; Piperazines; Psychotic Disorders; Schizophrenia; Serotonin Antagonists; Thiazoles; Treatment Outcome | 2005 |
Patient- and facility-level factors associated with diffusion of a new antipsychotic in the VA health system.
Topics: Aged; Algorithms; Antipsychotic Agents; Drug Approval; Drug Therapy; Drug Utilization Review; Female; Humans; International Classification of Diseases; Male; Mental Health Services; Middle Aged; Piperazines; Registries; Schizophrenia; Thiazoles; United States; United States Department of Veterans Affairs; Veterans | 2006 |
Interpreting the results of the CATIE study.
Topics: Antipsychotic Agents; Dibenzothiazepines; Humans; National Institute of Mental Health (U.S.); Perphenazine; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome; United States | 2006 |
Interpreting the results of the CATIE study.
Topics: Antipsychotic Agents; Dibenzothiazepines; Humans; Perphenazine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome | 2006 |
Interpreting the results of the CATIE study.
Topics: Antipsychotic Agents; Dibenzothiazepines; Humans; Perphenazine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome | 2006 |
Applying parsimony to "An African patient with ziprasidone intolerance".
Topics: Antipsychotic Agents; Anxiety Disorders; Black or African American; Culture; Depressive Disorder; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Pharmacogenetics; Piperazines; Polymorphism, Genetic; Thiazoles | 2005 |
Antipsychotic drugs and schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Humans; Olanzapine; Patient Compliance; Perphenazine; Piperazines; Quetiapine Fumarate; Schizophrenia; Thiazoles | 2006 |
Real-life switching strategies with second-generation antipsychotics.
Topics: Antipsychotic Agents; Benzodiazepines; Cohort Studies; Dibenzothiazepines; Drug Administration Schedule; Drug Resistance; Humans; Mental Disorders; Olanzapine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Selection Bias; Thiazoles; Treatment Outcome | 2006 |
Methodological issues in a comparative study of ziprasidone and risperidone.
Topics: Antipsychotic Agents; Drug Administration Schedule; Humans; Piperazines; Randomized Controlled Trials as Topic; Research Design; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome | 2006 |
Intramuscular ziprasidone: an effective agent for sedation of the agitated ED patient.
Topics: Adult; Antipsychotic Agents; Emergency Service, Hospital; Female; Humans; Hypnotics and Sedatives; Injections, Intramuscular; Male; Pain Measurement; Piperazines; Prospective Studies; Psychomotor Agitation; Thiazoles | 2006 |
Naturalistic study of intramuscular ziprasidone versus conventional agents in agitated elderly patients: retrospective findings from a psychiatric emergency service.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Databases, Factual; Emergency Medical Services; Emergency Service, Hospital; Female; Haloperidol; Humans; Hypnotics and Sedatives; Injections, Intramuscular; Lorazepam; Male; Piperazines; Psychomotor Agitation; Retrospective Studies; Thiazoles; Treatment Outcome | 2005 |
Sudden akathisia after a ziprasidone dose reduction.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Bipolar Disorder; Dose-Response Relationship, Drug; Female; Humans; Middle Aged; Piperazines; Substance Withdrawal Syndrome; Thiazoles | 2006 |
Prescribing behavior and marketing practices.
Topics: Aged; Antipsychotic Agents; Drug Industry; Drug Therapy; Female; Humans; Male; Marketing; Mental Health Services; Middle Aged; Piperazines; Practice Patterns, Physicians'; Registries; Schizophrenia; Thiazoles; United States; United States Department of Veterans Affairs; Veterans | 2006 |
Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE study.
Topics: Antipsychotic Agents; Comorbidity; Conduct Disorder; Cross-Sectional Studies; Diagnosis, Dual (Psychiatry); Double-Blind Method; Female; Humans; Male; Multicenter Studies as Topic; Piperazines; Prevalence; Randomized Controlled Trials as Topic; Risk Factors; Schizophrenia; Schizophrenic Psychology; Sex Factors; Substance-Related Disorders; Thiazoles; Treatment Outcome; United States | 2006 |
Cost analysis of the treatment of schizophrenia in Thailand: a simulation model comparing olanzapine, risperidone, quetiapine, ziprasidone and haloperidol.
Topics: Antipsychotic Agents; Benzodiazepines; Computer Simulation; Cost of Illness; Cost-Benefit Analysis; Dibenzothiazepines; Drug Costs; Haloperidol; Health Care Costs; Humans; Models, Econometric; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Thailand; Thiazoles; Treatment Outcome | 2005 |
Treatment adherence among patients with bipolar or manic disorder taking atypical and typical antipsychotics.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Drug Costs; Drug Prescriptions; Drug Utilization Review; Episode of Care; Follow-Up Studies; Humans; Insurance Claim Review; International Classification of Diseases; Middle Aged; Olanzapine; Patient Compliance; Piperazines; Quetiapine Fumarate; Regression Analysis; Retrospective Studies; Risperidone; Thiazoles; Treatment Outcome | 2006 |
Ziprasidone-induced acute dystonic reactions in patients with bipolar disorder.
Topics: Acute Disease; Adult; Antipsychotic Agents; Bipolar Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Male; Piperazines; Thiazoles | 2006 |
Body weights and plasma prolactin levels in female rats treated subchronically with ziprasidone versus olanzapine.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Body Weight; Female; Olanzapine; Piperazines; Prolactin; Rats; Rats, Sprague-Dawley; Thiazoles; Weight Gain | 2006 |
Acute dystonia after initial doses of ziprasidone: a case report.
Topics: Adolescent; Antipsychotic Agents; Dystonia; Humans; Male; Obsessive-Compulsive Disorder; Piperazines; Thiazoles | 2006 |
Ziprasidone in the treatment of delayed carbon monoxide encephalopathy.
Topics: Antipsychotic Agents; Brain Diseases; Carbon Monoxide Poisoning; Female; Humans; Middle Aged; Piperazines; Thiazoles | 2006 |
Ziprasidone-associated pedal edema in the treatment of schizophrenia.
Topics: Antipsychotic Agents; Diuretics; Drug Hypersensitivity; Edema; Female; Foot Diseases; Humans; Immunoglobulin E; Middle Aged; Piperazines; Schizophrenia; Thiazoles | 2006 |
Early bicarbonate loading and dantroline for ziprasidone/haloperidol-induced neuroleptic malignant syndrome.
Topics: Adolescent; Antipsychotic Agents; Autistic Disorder; Combined Modality Therapy; Dantrolene; Disruptive, Impulse Control, and Conduct Disorders; Drug Administration Schedule; Fluid Therapy; Haloperidol; Humans; Male; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Piperazines; Self-Injurious Behavior; Sodium Bicarbonate; Thiazoles | 2006 |
Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Brain; Clozapine; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Male; Mice; Mice, Inbred C57BL; Olanzapine; Phosphorylation; Piperazines; Quetiapine Fumarate; Risperidone; Selective Serotonin Reuptake Inhibitors; Serine; Thiazoles; Time Factors | 2007 |
Time-dependent effects of haloperidol and ziprasidone on nerve growth factor, cholinergic neurons, and spatial learning in rats.
Topics: Animals; Antipsychotic Agents; Autoradiography; Brain Chemistry; Choline O-Acetyltransferase; Darkness; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Haloperidol; Image Processing, Computer-Assisted; Immunohistochemistry; Light; Male; Maze Learning; Motor Activity; Nerve Growth Factors; Nerve Tissue Proteins; Neurons; Parasympathetic Nervous System; Piperazines; Rats; Rats, Wistar; Receptors, Muscarinic; Receptors, Nicotinic; Thiazoles; Time Factors | 2006 |
Atypical antipsychotics and pituitary tumors: a pharmacovigilance study.
Topics: Adolescent; Adverse Drug Reaction Reporting Systems; Amenorrhea; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Clozapine; Dibenzothiazepines; Female; Galactorrhea; Gynecomastia; Haloperidol; Humans; Hyperprolactinemia; Male; Olanzapine; Piperazines; Pituitary Neoplasms; Quetiapine Fumarate; Quinolones; Retrospective Studies; Risperidone; Sex Factors; Thiazoles; United States; United States Food and Drug Administration | 2006 |
Clozapine and ziprasidone: a useful combination in patients with treatment-resistant schizophrenia.
Topics: Adult; Antipsychotic Agents; Clozapine; Dose-Response Relationship, Drug; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Female; Humans; Middle Aged; Piperazines; Schizophrenia, Paranoid; Thiazoles | 2006 |
Electrocardiographic changes with ziprasidone.
Topics: Adolescent; Antipsychotic Agents; Child; Data Interpretation, Statistical; Electrocardiography; Female; Humans; Long QT Syndrome; Male; Piperazines; Psychotic Disorders; Research Design; Selection Bias; Thiazoles; Tourette Syndrome | 2006 |
Injectable atypical antipsychotics for agitation in borderline personality disorder.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Borderline Personality Disorder; Comorbidity; Emergency Services, Psychiatric; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Psychotic Disorders; Schizophrenia; Thiazoles; Treatment Outcome | 2006 |
Ziprasidone in bipolar disorder.
Topics: Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Drug Administration Schedule; Drug Therapy, Combination; Humans; Lithium Compounds; Piperazines; Practice Guidelines as Topic; Thiazoles | 2006 |
A model for antipsychotic-induced obesity in the male rat.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Body Composition; Body Weight; Circadian Rhythm; Diet; Disease Models, Animal; Dose-Response Relationship, Drug; Eating; Feeding Behavior; Haloperidol; Male; Obesity; Olanzapine; Piperazines; Rats; Rats, Sprague-Dawley; Thiazoles; Time Factors; Weight Gain | 2006 |
The dimensions of clinical and cognitive change in schizophrenia: evidence for independence of improvements.
Topics: Adolescent; Adult; Antipsychotic Agents; Basal Ganglia Diseases; Cognition Disorders; Female; Humans; Male; Middle Aged; Piperazines; Schizophrenia; Schizophrenic Psychology; Thiazoles | 2006 |
A patient using ziprasidone with polydipsia, seizure, hyponatremia and rhabdomyolysis.
Topics: Adult; Antipsychotic Agents; Drinking Behavior; Humans; Hyponatremia; Male; Piperazines; Rhabdomyolysis; Schizophrenia; Seizures; Thiazoles | 2006 |
Pharmacological profile of antipsychotics at monoamine receptors: atypicality beyond 5-HT2A receptor blockade.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Binding, Competitive; Biogenic Monoamines; CHO Cells; Clozapine; Cricetinae; Dibenzothiazepines; Dopamine; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Dopamine; Receptors, Serotonin; Schizophrenia; Serotonin; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists; Synaptic Transmission; Thiazoles | 2006 |
A model of anticholinergic activity of atypical antipsychotic medications.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Binding Sites; Clozapine; Cognition Disorders; Dibenzothiazepines; Dose-Response Relationship, Drug; Female; Humans; Male; Neuropsychological Tests; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Receptors, Cholinergic; Risperidone; Schizophrenia; Thiazoles | 2006 |
Probable association between ziprasidone and worsening hypertension.
Topics: Antipsychotic Agents; Female; Humans; Hypertension; Middle Aged; Piperazines; Schizophrenia; Thiazoles | 2006 |
Treatment of drug-induced psychosis in Parkinson's disease with ziprasidone can induce severe dose-dependent off-periods and pathological laughing.
Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Clozapine; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Laughter; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Parkinson Disease, Secondary; Piperazines; Psychoses, Substance-Induced; Quetiapine Fumarate; Thiazoles | 2007 |
Advanced pediatric psychopharmacology.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Cannabinoids; Combined Modality Therapy; Comorbidity; Drug Therapy, Combination; Humans; Male; Marijuana Abuse; Mental Status Schedule; Neuroleptic Malignant Syndrome; Patient Readmission; Piperazines; Prognosis; Psychoses, Substance-Induced; Quinolones; Recurrence; Social Environment; Thiazoles; Treatment Refusal | 2006 |
Treatment adherence among patients with schizophrenia treated with atypical and typical antipsychotics.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Drug Administration Schedule; Drug Prescriptions; Female; Humans; International Classification of Diseases; Male; Olanzapine; Patient Compliance; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Time Factors | 2006 |
Does antipsychotic polypharmacy increase the risk for metabolic syndrome?
Topics: Adult; Age Factors; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Body Mass Index; Cholesterol, HDL; Clozapine; Cross-Sectional Studies; Dibenzothiazepines; Drug Therapy, Combination; Female; Humans; Insulin Resistance; Male; Metabolic Syndrome; Middle Aged; Piperazines; Quetiapine Fumarate; Quinolones; Risk Factors; Schizophrenia; Thiazoles; Triglycerides | 2007 |
Determination of ziprasidone in human plasma by liquid chromatography-electrospray tandem mass spectrometry and its application to plasma level determination in schizophrenia patients.
Topics: Adult; Aged; Chromatography, Liquid; Female; Humans; Male; Middle Aged; Molecular Structure; Piperazines; Reproducibility of Results; Schizophrenia; Tandem Mass Spectrometry; Thiazoles | 2007 |
High-dose ziprasidone-induced acute dystonia.
Topics: Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Dystonia; Female; Humans; Piperazines; Schizophrenia; Thiazoles | 2007 |
Improvement in antipsychotic-related metabolic disturbances in patients with schizophrenia switched to ziprasidone.
Topics: Adult; Antipsychotic Agents; Blood Glucose; Body Weight; Cholesterol; Female; Humans; Male; Metabolic Diseases; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Retrospective Studies; Schizophrenia; Severity of Illness Index; Statistics, Nonparametric; Thiazoles; Time Factors | 2007 |
Effectiveness, tolerability, and safety of ziprasidone in patients with schizophrenia or schizoaffective disorder: results of a multi-centre observational trial.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Austria; Blood Glucose; Body Weight; Brief Psychiatric Rating Scale; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Germany; Humans; Lipids; Male; Middle Aged; Patient Dropouts; Piperazines; Product Surveillance, Postmarketing; Prospective Studies; Psychotic Disorders; Quality of Life; Schizophrenia; Thiazoles; Treatment Outcome | 2007 |
Cost-effectiveness analysis of schizophrenia relapse prevention : an economic evaluation of the ZEUS (Ziprasidone-Extended-Use-In-Schizophrenia) study in Spain.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Models, Econometric; Piperazines; Program Evaluation; Recurrence; Reproducibility of Results; Schizophrenia; Spain; Thiazoles; Time Factors | 2006 |
A naturalistic evaluation of intramuscular ziprasidone versus intramuscular olanzapine for the management of acute agitation and aggression in children and adolescents.
Topics: Acute Disease; Adolescent; Aggression; Antipsychotic Agents; Benzodiazepines; Child; Ethnicity; Female; Humans; Injections, Intramuscular; Inpatients; Male; Olanzapine; Piperazines; Psychomotor Agitation; Retrospective Studies; Sex Characteristics; Thiazoles; Treatment Outcome | 2006 |
Alterations of lipid metabolism and gene expression in rat adipocytes during chronic olanzapine treatment.
Topics: Adipocytes; Animals; Antipsychotic Agents; Benzodiazepines; Cell Size; Drug Administration Schedule; Fatty Acid Synthases; Gene Expression Regulation; Glucose Transport Proteins, Facilitative; Haloperidol; Lipid Metabolism; Male; Obesity; Olanzapine; Piperazines; Rats; Rats, Sprague-Dawley; RNA; Statistics, Nonparametric; Sterol Esterase; Thiazoles; Weight Gain | 2007 |
Datapoints: The ups and downs of dosing second-generation antipsychotics.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Dibenzothiazepines; Dose-Response Relationship, Drug; Humans; Olanzapine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Thiazoles | 2007 |
The bane of a silent illness: when Wilson's disease takes its course.
Topics: Adult; Chelating Agents; Cognitive Behavioral Therapy; Female; Hepatolenticular Degeneration; Humans; Patient Compliance; Patient Education as Topic; Piperazines; Quality of Life; Thiazoles; Trientine; Zinc Oxide | 2006 |
Treatment refractory psychosis remitted upon treatment with continuous positive airway pressure: a case report.
Topics: Antipsychotic Agents; Combined Modality Therapy; Comorbidity; Continuous Positive Airway Pressure; Diagnosis, Differential; Drug Resistance; Female; Humans; Middle Aged; Obesity Hypoventilation Syndrome; Piperazines; Recurrence; Schizophrenia, Disorganized; Sleep Apnea Syndromes; Thiazoles | 2007 |
Ziprasidone-induced acute laryngeal dystonia.
Topics: Adolescent; Antipsychotic Agents; Dystonia; Humans; Laryngeal Diseases; Male; Piperazines; Schizophrenia, Paranoid; Thiazoles | 2007 |
Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment.
Topics: Adult; Antipsychotic Agents; Biperiden; Diagnosis, Differential; Diazepam; Drug Therapy, Combination; Humans; Infusions, Intravenous; Male; Neuroleptic Malignant Syndrome; Neurologic Examination; Parkinsonian Disorders; Piperazines; Schizophrenia; Thiazoles | 2007 |
Possible case of allopurinol causing relapse of psychosis.
Topics: Adult; Allopurinol; Antipsychotic Agents; Chronic Disease; Clozapine; Drug Therapy, Combination; Female; Gout; Gout Suppressants; Hallucinations; Humans; Piperazines; Psychoses, Substance-Induced; Recurrence; Schizophrenia, Paranoid; Thiazoles | 2007 |
Atypical antipsychotic drug-induced acute laryngeal dystonia: 2 case reports.
Topics: Acute Disease; Adult; Antipsychotic Agents; Bipolar Disorder; Dystonia; Humans; Laryngeal Diseases; Male; Middle Aged; Piperazines; Thiazoles | 2007 |
Hospitalization risks in the treatment of bipolar disorder: comparison of antipsychotic medications.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Drug Therapy; Female; Hospitalization; Humans; Male; Olanzapine; Piperazines; Quetiapine Fumarate; Risk Factors; Risperidone; Thiazoles | 2007 |
Urticaria and angio-oedema due to ziprasidone.
Topics: Adult; Angioedema; Antipsychotic Agents; Female; Humans; Piperazines; Schizophrenia, Paranoid; Thiazoles; Urticaria | 2007 |
Treatment schedules for 5-HT2A blocking in progressive multifocal leukoencephalopathy using risperidone or ziprasidone.
Topics: Adult; Female; Humans; Leukoencephalopathy, Progressive Multifocal; Piperazines; Risperidone; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Thiazoles | 2007 |
Comments on the report of neuroleptic malignant syndrome induced by ziprasidone.
Topics: Antipsychotic Agents; Benzodiazepines; Diagnosis, Differential; Humans; Male; Neuroleptic Malignant Syndrome; Olanzapine; Patient Compliance; Patient Discharge; Piperazines; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome | 2007 |
Ziprasidone-associated galactorrhea in an adolescent female.
Topics: Adolescent; Antipsychotic Agents; Female; Galactorrhea; Humans; Hyperprolactinemia; Mental Disorders; Piperazines; Thiazoles | 2007 |
Ziprasidone for maladaptive behavior and attention-deficit/hyperactivity disorder symptoms in autistic disorder.
Topics: Adolescent; Aggression; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Child Behavior Disorders; Humans; Male; Piperazines; Thiazoles | 2007 |
The relationship between symptomatic remission and neuropsychological improvement in schizophrenia patients switched to treatment with ziprasidone.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Cognition Disorders; Humans; Middle Aged; Neuropsychological Tests; Olanzapine; Piperazines; Remission Induction; Risperidone; Schizophrenia; Thiazoles | 2007 |
Impairment in error monitoring predicts poor executive function in schizophrenia patients.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Clozapine; Cognition Disorders; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Male; Memory, Short-Term; Neuropsychological Tests; Olanzapine; Piperazines; Reaction Time; Risperidone; Schizophrenia; Self Efficacy; Severity of Illness Index; Thiazoles | 2007 |
Multi-drug overdose risperidone, ziprasidone, valproate, trihexyphenidyl, and clonazepam.
Topics: Adult; Antipsychotic Agents; Clonazepam; Drug Overdose; Drug Prescriptions; Female; Humans; Piperazines; Polypharmacy; Risperidone; Schizophrenia, Paranoid; Thiazoles; Trihexyphenidyl; Valproic Acid | 2007 |
Ziprasidone, diazepam, or the combination for prevention of cocaine toxicity in a mouse model.
Topics: Animals; Cocaine; Cocaine-Related Disorders; Confidence Intervals; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Male; Mice; Mice, Inbred Strains; Piperazines; Random Allocation; Reference Values; Sensitivity and Specificity; Statistics, Nonparametric; Survival Rate; Thiazoles | 2007 |
The distinct effects of subchronic antipsychotic drug treatment on macronutrient selection, body weight, adiposity, and metabolism in female rats.
Topics: Adiposity; Animals; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Body Composition; Body Weight; Cholesterol; Drinking; Eating; Energy Metabolism; Fatty Acids, Nonesterified; Female; Food Preferences; Glycerol; Insulin; Leptin; Motor Activity; Olanzapine; Piperazines; Prolactin; Rats; Risperidone; Thiazoles; Triglycerides | 2007 |
A different mechanism to understand activation/sedation side effects of ziprasidone.
Topics: Antipsychotic Agents; Humans; Piperazines; Psychomotor Agitation; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT2C; Thiazoles | 2007 |
Risk of discontinuation of atypical antipsychotic agents in the treatment of schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Dibenzothiazepines; Female; Follow-Up Studies; Humans; Male; Middle Aged; Patient Readmission; Piperazines; Proportional Hazards Models; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risk Factors; Risperidone; Schizophrenia; Schizophrenia, Paranoid; Schizophrenic Psychology; Sensitivity and Specificity; Substance Withdrawal Syndrome; Survival Rate; Thiazoles | 2008 |
The impact of ziprasidone in combination with sertraline on visually-evoked event-related potentials in depressed patients with psychotic features.
Topics: Adult; Affective Disorders, Psychotic; Aged; Antipsychotic Agents; Data Interpretation, Statistical; Drug Therapy, Combination; Evoked Potentials, Visual; Female; Humans; Male; Middle Aged; Piperazines; Prolactin; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Thiazoles | 2007 |
The effectiveness of ziprasidone in treating impaired quality of life in schizophrenia: a 12-month, open-label, flexible-dose, naturalistic observational study of patients undergoing usual care.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Chronic Disease; Female; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Quality of Life; Schizophrenia; Schizophrenic Psychology; Surveys and Questionnaires; Thiazoles | 2007 |
Characterization of atypical antipsychotic drugs by a late decrease of striatal alpha1 spectral power in the electropharmacogram of freely moving rats.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Clozapine; Corpus Striatum; Dibenzothiazepines; Dose-Response Relationship, Drug; Electroencephalography; Female; Hippocampus; Injections, Intraperitoneal; Male; Motor Activity; Movement; Olanzapine; Piperazines; Prefrontal Cortex; Quetiapine Fumarate; Rats; Rats, Inbred F344; Reticular Formation; Risperidone; Thiazoles; Time Factors | 2007 |
The effect of atypical antipsychotics, perospirone, ziprasidone and quetiapine on microglial activation induced by interferon-gamma.
Topics: Animals; Antipsychotic Agents; Cell Survival; Cells, Cultured; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Interactions; Interferon-gamma; Isoindoles; Mice; Mice, Inbred C57BL; Microglia; Nitrites; Piperazines; Quetiapine Fumarate; Rats; Tetrazolium Salts; Thiazoles | 2008 |
Sensitive liquid chromatography/tandem mass spectrometry method for the simultaneous determination of olanzapine, risperidone, 9-hydroxyrisperidone, clozapine, haloperidol and ziprasidone in rat brain tissue.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Brain; Chromatography, Liquid; Clozapine; Haloperidol; Isoxazoles; Male; Olanzapine; Paliperidone Palmitate; Piperazines; Pyrimidines; Rats; Reproducibility of Results; Risperidone; Tandem Mass Spectrometry; Thiazoles | 2007 |
A retrospective chart review of intramuscular ziprasidone for agitation in children and adolescents on psychiatric units: prospective studies are needed.
Topics: Adolescent; Adult; Age Factors; Antipsychotic Agents; Child; Child, Preschool; Electrocardiography; Female; Hospitals, Pediatric; Humans; Injections, Intramuscular; Male; Mental Disorders; Piperazines; Psychiatric Department, Hospital; Psychiatric Status Rating Scales; Psychomotor Agitation; Regression Analysis; Retrospective Studies; Sex Factors; Sleep Stages; Thiazoles; Treatment Outcome | 2007 |
Acute urinary retention associated with selective serotonin reuptake inhibitors and ziprasidone.
Topics: Acute Disease; Antipsychotic Agents; Depressive Disorder, Major; Drug Monitoring; Electroconvulsive Therapy; Humans; Male; Middle Aged; Piperazines; Receptors, Serotonin, 5-HT2; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Thiazoles; Urinary Catheterization; Urinary Retention | 2007 |
Show me the evidence: using number needed to treat.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Confidence Intervals; Data Interpretation, Statistical; Decision Making; Evidence-Based Medicine; Humans; Likelihood Functions; Olanzapine; Piperazines; Randomized Controlled Trials as Topic; Research Design; Risk Assessment; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome | 2007 |
Ziprasidone-associated mania in a case of obssessive-compulsive disorder.
Topics: Anticonvulsants; Bipolar Disorder; Citalopram; Clonazepam; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Piperazines; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Thiazoles | 2007 |
Practical strategies for assessing and stabilizing bipolar patients in urgent situations.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Emergency Services, Psychiatric; Humans; Impulsive Behavior; Injections, Intramuscular; Olanzapine; Piperazines; Practice Guidelines as Topic; Quinolones; Risperidone; Suicide, Attempted; Thiazoles; Time Factors | 2007 |
Ventricular arrhythmias and cerebrovascular events in the elderly using conventional and atypical antipsychotic medications.
Topics: Administration, Oral; Aged; Antipsychotic Agents; Aripiprazole; Arrhythmias, Cardiac; Benzodiazepines; Clozapine; Databases, Factual; Dementia; Dibenzothiazepines; Drug Utilization Review; Health Services for the Aged; Humans; Olanzapine; Pharmaceutical Services; Piperazines; Quetiapine Fumarate; Quinolones; Risk Assessment; Risperidone; Stroke; Thiazoles; Treatment Outcome | 2007 |
Ziprasidone for drug-induced psychotic symptoms in Parkinson's Disease.
Topics: Acute Disease; Antipsychotic Agents; Brief Psychiatric Rating Scale; Carbidopa; Drug Combinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Piperazines; Psychoses, Substance-Induced; Thiazoles | 2008 |
Efficacy of antipsychotics to reverse phencyclidine-induced social interaction deficits in female rats--a preliminary investigation.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Behavior, Animal; Clozapine; Disease Models, Animal; Drug Interactions; Excitatory Amino Acid Antagonists; Female; Haloperidol; Matched-Pair Analysis; Phencyclidine; Piperazines; Rats; Rats, Inbred Strains; Schizophrenia; Schizophrenic Psychology; Social Behavior; Social Behavior Disorders; Thiazoles | 2008 |
A case report with ziprasidone-induced catatonic symptoms.
Topics: Adult; Antipsychotic Agents; Catatonia; Humans; Male; Piperazines; Psychiatric Status Rating Scales; Schizophrenia; Thiazoles | 2007 |
QT prolongation and Torsades de Pointes following overdose of ziprasidone and amantadine.
Topics: Adult; Amantadine; Analgesics, Non-Narcotic; Antipsychotic Agents; Drug Overdose; Drug Therapy, Combination; Electrocardiography; Fatal Outcome; Female; Humans; Ibuprofen; Long QT Syndrome; Piperazines; Suicide, Attempted; Thiazoles; Torsades de Pointes | 2007 |
Determination of Ziprasidone in pharmaceutical formulations by capillary zone electrophoresis.
Topics: Calibration; Capsules; Drug Stability; Electrophoresis, Capillary; Hydrogen-Ion Concentration; Piperazines; Thiazoles | 2008 |
Ziprasidone and aripiprazole attenuate olanzapine-induced hyperphagia in rats.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Eating; Female; Hyperphagia; Motor Activity; Olanzapine; Piperazines; Quinolones; Rats; Thiazoles; Weight Gain | 2008 |
Use of antipsychotics to treat cocaine toxicity?
Topics: Animals; Antipsychotic Agents; Cocaine; Cocaine-Related Disorders; Diazepam; Disease Models, Animal; Mice; Piperazines; Thiazoles; Treatment Outcome | 2008 |
Ziprasidone-induced hyperprolactinemia: a case report.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Female; Humans; Hyperprolactinemia; Piperazines; Thiazoles | 2008 |
Acute pisa syndrome and pharnygolaryngeal dystonia due to ziprasidone.
Topics: Adult; Antipsychotic Agents; Dyskinesia, Drug-Induced; Dystonia; Humans; Male; Pharyngeal Diseases; Piperazines; Psychotic Disorders; Thiazoles | 2008 |
Investigation into the influence of a high fat diet on antipsychotic-induced weight gain in female rats.
Topics: Abdominal Fat; Animals; Antipsychotic Agents; Benzodiazepines; Dietary Fats; Drinking Behavior; Feeding Behavior; Female; Injections, Intraperitoneal; Olanzapine; Piperazines; Rats; Risperidone; Thiazoles; Weight Gain | 2008 |
Ziprasidone in adolescents with autism: an open-label pilot study.
Topics: Adolescent; Antipsychotic Agents; Autistic Disorder; Child; Cholesterol; Dose-Response Relationship, Drug; Dystonia; Electrocardiography; Female; Humans; Male; Pilot Projects; Piperazines; Prolactin; Psychiatric Status Rating Scales; Psychometrics; Thiazoles; Treatment Outcome; Weight Gain | 2007 |
Determination of the lipophilic antipsychotic drug ziprasidone in rat plasma and brain tissue using liquid chromatography-tandem mass spectrometry.
Topics: Animals; Antipsychotic Agents; Brain Chemistry; Chromatography, Liquid; Linear Models; Piperazines; Rats; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Thiazoles | 2008 |
Comparative effects of olanzapine and ziprasidone on hypophagia induced by enhanced histamine neurotransmission in the rat.
Topics: Animals; Antipsychotic Agents; Appetite; Benzodiazepines; Brain; Dose-Response Relationship, Drug; Eating; Fat Emulsions, Intravenous; Histamine; Histamine H1 Antagonists; Histamine H3 Antagonists; Hypothalamus; Male; Neurons; Olanzapine; Piperazines; Piperidines; Rats; Synaptic Transmission; Taste; Thiazoles | 2008 |
High-dose ziprasidone monotherapy in bipolar I disorder patients with depressed or mixed episodes.
Topics: Adult; Bipolar Disorder; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Male; Piperazines; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Agonists; Thiazoles; Treatment Outcome | 2008 |
Urinary retention associated with ziprasidone: a case report.
Topics: Antipsychotic Agents; Diagnostic and Statistical Manual of Mental Disorders; Efferent Pathways; Female; Humans; Middle Aged; Muscle Contraction; Muscle, Smooth; Piperazines; Psychotic Disorders; Raphe Nuclei; Thiazoles; Urinary Bladder; Urinary Retention | 2008 |
Critical thinking about adverse drug effects: lessons from the psychology of risk and medical decision-making for clinical psychopharmacology.
Topics: Advertising; Benzodiazepines; Conflict of Interest; Decision Support Techniques; Drug Industry; Ethics, Medical; Evidence-Based Medicine; Humans; Marketing; Mental Disorders; Olanzapine; Piperazines; Propaganda; Psychiatry; Psychotropic Drugs; Randomized Controlled Trials as Topic; Research Design; Risk Assessment; Thiazoles; United States | 2008 |
Did CATIE influence antipsychotic use?
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Drug Therapy; Haloperidol; Humans; Olanzapine; Perphenazine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles | 2008 |
Inadvertent administration of intravenous ziprasidone leading to bradycardia and QT interval prolongation.
Topics: Adult; Antipsychotic Agents; Bradycardia; Electrocardiography; Female; Humans; Injections, Intramuscular; Injections, Intravenous; Long QT Syndrome; Medication Errors; Piperazines; Thiazoles | 2008 |
Quetiapine and ziprasidone as adjuncts in treatment-resistant obsessive-compulsive disorder: a retrospective comparative study.
Topics: Adult; Antipsychotic Agents; Dibenzothiazepines; Female; Follow-Up Studies; Humans; Male; Obsessive-Compulsive Disorder; Piperazines; Psychometrics; Quetiapine Fumarate; Retrospective Studies; Severity of Illness Index; Thiazoles; Treatment Outcome | 2008 |
Assessment of clinical and metabolic status, and subjective well-being, in schizophrenic patients switched from typical and atypical antipsychotics to ziprasidone.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Female; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Patient Compliance; Piperazines; Quality of Life; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles | 2008 |
Clinical experiences and clinical trials.
Topics: Antipsychotic Agents; Benzodiazepines; Chronic Disease; Dyskinesia, Drug-Induced; Humans; Olanzapine; Perphenazine; Piperazines; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome | 2008 |
Repeated acute dystonia following administration of amisulpride and ziprasidone in a patient with iron deficiency.
Topics: Adolescent; Amisulpride; Anemia, Iron-Deficiency; Antipsychotic Agents; Dibenzothiazepines; Dystonia; Female; Hemoglobins; Humans; Piperazines; Quetiapine Fumarate; Schizophrenia; Sulpiride; Thiazoles | 2008 |
Profound hypothermia secondary to normal ziprasidone use.
Topics: Aged; Antipsychotic Agents; Diagnosis, Differential; Humans; Hypothermia; Male; Piperazines; Thiazoles | 2008 |
The potential relationship between QTc interval prolongation and ziprasidone treatment: three cases.
Topics: Adult; Antipsychotic Agents; Electrocardiography; Female; Humans; Male; Middle Aged; Piperazines; Thiazoles | 2009 |
The antipsychotics clozapine and olanzapine increase plasma glucose and corticosterone levels in rats: comparison with aripiprazole, ziprasidone, bifeprunox and F15063.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Benzofurans; Benzoxazoles; Benzylamines; Blood Glucose; Clozapine; Corticosterone; Cyclopentanes; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Haloperidol; Male; Olanzapine; Piperazines; Quinolones; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D2; Thiazoles | 2008 |
Differential effects of ziprasidone and haloperidol on immobilization stress-induced mRNA BDNF expression in the hippocampus and neocortex of rats.
Topics: Animals; Antipsychotic Agents; Brain-Derived Neurotrophic Factor; Gene Expression; Haloperidol; Hippocampus; In Situ Hybridization; Injections, Intraperitoneal; Male; Neocortex; Piperazines; Rats; Rats, Sprague-Dawley; Restraint, Physical; RNA, Messenger; Stress, Psychological; Thiazoles | 2009 |
Pattern of ziprasidone exposures reported to Texas poison centers, 2001-2005.
Topics: Adolescent; Adult; Antipsychotic Agents; Child; Female; Humans; Male; Piperazines; Poison Control Centers; Poisoning; Texas; Thiazoles | 2008 |
Haloperidol (but not ziprasidone) withdrawal potentiates sensitization to the hyperlocomotor effect of cocaine in mice.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Cocaine; Cocaine-Related Disorders; Haloperidol; Humans; Male; Mice; Motor Activity; Piperazines; Schizophrenia; Substance Withdrawal Syndrome; Thiazoles | 2008 |
Effects of quetiapine, risperidone, 9-hydroxyrisperidone and ziprasidone on the survival of human neuronal and immune cells in vitro.
Topics: Adenosine Triphosphate; Antipsychotic Agents; Cell Line; Cell Survival; Dibenzothiazepines; Dose-Response Relationship, Drug; Energy Metabolism; Humans; Isoxazoles; Monocytes; Neurons; Paliperidone Palmitate; Piperazines; Pyrimidines; Quetiapine Fumarate; Risperidone; Thiazoles | 2010 |
Administration of ziprasidone for 10 days increases cocaine toxicity in mice.
Topics: Animals; Antipsychotic Agents; Cocaine; Cocaine-Related Disorders; Disease Models, Animal; Dopamine Uptake Inhibitors; Drug Synergism; Longevity; Male; Mice; Mice, Inbred Strains; Piperazines; Seizures; Thiazoles; Time Factors; Withholding Treatment | 2008 |
Aripiprazole resolves amisulpride and ziprasidone-induced hyperprolactinemia.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Female; Humans; Hyperprolactinemia; Long-Term Care; Piperazines; Quinolones; Schizophrenia, Paranoid; Sulpiride; Thiazoles; Young Adult | 2008 |
The use of ziprasidone in clinical practice: analysis of pharmacokinetic and pharmacodynamic aspects from data of a drug monitoring survey.
Topics: Antipsychotic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Male; Mood Disorders; Piperazines; Psychotic Disorders; Retrospective Studies; Severity of Illness Index; Thiazoles; Treatment Outcome | 2009 |
Ziprasidone-associated mania in Korean schizophrenic patient.
Topics: Adult; Antipsychotic Agents; Asian People; Bipolar Disorder; Humans; Korea; Male; Piperazines; Schizophrenia; Schizophrenic Psychology; Thiazoles | 2008 |
Chronic Pisa syndrome associated with switching antipsychotics from olanzapine to ziprasidone.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dystonia; Humans; Male; Olanzapine; Piperazines; Schizophrenia, Paranoid; Thiazoles | 2009 |
Ziprasidone-induced spontaneous orgasm.
Topics: Antipsychotic Agents; Bipolar Disorder; Female; Humans; Middle Aged; Orgasm; Piperazines; Sexual Dysfunctions, Psychological; Thiazoles; Torticollis | 2010 |
A possible case of Capgras syndrome after a right anterior cerebral artery cerebrovascular accident treated successfully with mirtazapine.
Topics: Adrenergic alpha-Antagonists; Antipsychotic Agents; Capgras Syndrome; Electroencephalography; Female; Humans; Infarction, Anterior Cerebral Artery; Mianserin; Middle Aged; Mirtazapine; Piperazines; Thiazoles; Tomography, X-Ray Computed | 2008 |
Low concentration of ziprasidone in human milk: a case report.
Topics: Antipsychotic Agents; Chromatography, High Pressure Liquid; Female; Humans; Mental Disorders; Milk, Human; Piperazines; Thiazoles; Time Factors; Young Adult | 2009 |
Extrapyramidal side effects: could you identify them in the emergency department?
Topics: Acute Disease; Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Dopamine Antagonists; Dyskinesia, Drug-Induced; Dystonia; Emergency Nursing; Emergency Treatment; Female; Humans; Infant; Male; Muscle Rigidity; Nursing Assessment; Parkinson Disease, Secondary; Piperazines; Risk Factors; Risperidone; Syndrome; Thiazoles | 2009 |
Weight effects associated with antipsychotics: a comprehensive database analysis.
Topics: Antipsychotic Agents; Databases, Bibliographic; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Piperazines; Randomized Controlled Trials as Topic; Schizophrenia; Thiazoles; Time Factors; Weight Gain | 2009 |
Maintenance of response with atypical antipsychotics in the treatment of schizophrenia: a post-hoc analysis of 5 double-blind, randomized clinical trials.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Dibenzothiazepines; Female; Humans; Male; Middle Aged; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Thiazoles; Time Factors; Treatment Outcome | 2009 |
Pediatric ziprasidone overdose.
Topics: Adrenergic alpha-1 Receptor Antagonists; Antidotes; Antipsychotic Agents; Charcoal; Child, Preschool; Coma; Drug Resistance; Emergencies; Female; Humans; Hypotension, Orthostatic; Intubation, Intratracheal; Miosis; Naloxone; Piperazines; Tachycardia; Thiazoles | 2009 |
Switch to ziprazidone treatment is associated with changes in MMN amplitude: a case report.
Topics: Acoustic Stimulation; Adolescent; Antipsychotic Agents; Contingent Negative Variation; Electroencephalography; Humans; Male; Neuropsychological Tests; Piperazines; Psychiatric Status Rating Scales; Schizophrenia, Paranoid; Thiazoles | 2009 |
Atypical antipsychotic drugs and the risk of sudden cardiac death.
Topics: Antipsychotic Agents; Aripiprazole; Death, Sudden, Cardiac; Dose-Response Relationship, Drug; Humans; Mental Disorders; Piperazines; Quinolones; Risk; Thiazoles | 2009 |
Differences among conventional, atypical and novel putative D(2)/5-HT(1A) antipsychotics on catalepsy-associated behaviour in cynomolgus monkeys.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Aripiprazole; Benzamides; Benzodiazepines; Benzoxazoles; Catalepsy; Clozapine; Dibenzothiazepines; Dioxanes; Dopamine Antagonists; Female; Haloperidol; Macaca fascicularis; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Remoxipride; Risperidone; Serotonin Receptor Agonists; Thiazoles; Tropanes; Video Recording | 2009 |
Agitation and/or aggression after traumatic brain injury in the pediatric population treated with ziprasidone. Clinical article.
Topics: Adolescent; Aggression; Antipsychotic Agents; Brain Injuries; Child; Child, Preschool; Humans; Infant; Piperazines; Psychomotor Agitation; Thiazoles | 2009 |
Targeting cognition in schizophrenia research: from etiology to treatment.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Cognition; Cognition Disorders; Dibenzothiazepines; Drug Administration Schedule; Haloperidol; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Reaction Time; Schizophrenia; Sulpiride; Thiazoles | 2009 |
The incidence of diabetes in atypical antipsychotic users differs according to agent--results from a multisite epidemiologic study.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Cohort Studies; Diabetes Mellitus; Female; Humans; Male; Mental Disorders; Middle Aged; Olanzapine; Piperazines; Quinolones; Retrospective Studies; Thiazoles; United States | 2009 |
Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Costs and Cost Analysis; Dibenzothiazepines; Drug Therapy, Combination; Female; Health Care Costs; Humans; Male; Middle Aged; Mood Disorders; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Retrospective Studies; Risperidone; Thiazoles; Treatment Outcome; Young Adult | 2009 |
Electrocardiographic monitoring for QT prolongation in patients treated with ziprasidone--a claims database approach.
Topics: Adult; Antipsychotic Agents; Databases, Factual; Electrocardiography; Female; Humans; Long QT Syndrome; Male; Middle Aged; Piperazines; Retrospective Studies; Taiwan; Thiazoles; Young Adult | 2009 |
Unintentional ingestion of ziprasidone in a 22-month-old.
Topics: Antipsychotic Agents; Diagnosis, Differential; Drug Overdose; Electrocardiography; Female; Humans; Infant; Piperazines; Thiazoles | 2009 |
Efficacy of ziprasidone in dysphoric mania: pooled analysis of two double-blind studies.
Topics: Acute Disease; Adult; Affect; Aged; Bipolar Disorder; Depression; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Thiazoles | 2010 |
P wave and QT changes among inpatients with schizophrenia after parenteral ziprasidone administration.
Topics: Adult; Antipsychotic Agents; Atrial Fibrillation; Electrocardiography; Female; Humans; Male; Middle Aged; Piperazines; Schizophrenia; Thiazoles | 2009 |
How dosing of ziprasidone in a state hospital system differs from product labeling.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Utilization; Female; Hospitalization; Hospitals, Psychiatric; Hospitals, State; Humans; Male; Piperazines; Prescription Drugs; Product Labeling; Psychotic Disorders; Quetiapine Fumarate; Schizophrenia; Thiazoles; Treatment Outcome | 2009 |
Ziprasidone-induced angioedema: a case report.
Topics: Adult; Angioedema; Antipsychotic Agents; Bipolar Disorder; Humans; Male; Piperazines; Thiazoles | 2009 |
Tardive dyskinesia in a patient treated with quetiapine.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Dibenzothiazepines; Dyskinesia, Drug-Induced; Female; Humans; Middle Aged; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Sulpiride; Thiazoles | 2009 |
FDA panel OKs 3 antipsychotic drugs for pediatric use, cautions against overuse.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Child; Dibenzothiazepines; Drug Approval; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Schizophrenia; Thiazoles; United States; United States Food and Drug Administration | 2009 |
Ziprasidone-related oculogyric crisis in an adult.
Topics: Adult; Antipsychotic Agents; Clonazepam; Dyskinesia, Drug-Induced; Electroencephalography; Female; GABA Modulators; Humans; Ocular Motility Disorders; Oculomotor Muscles; Piperazines; Schizophrenia; Thiazoles | 2009 |
Switching to duloxetine remits ziprasidone - associated urinary incontinence and improves neuropsychiatric behavior in dementia: possible relationship of incontinence to 5HT2 receptor blockade.
Topics: Aged, 80 and over; Alzheimer Disease; Dementia, Vascular; Duloxetine Hydrochloride; Humans; Male; Parkinsonian Disorders; Piperazines; Receptors, Serotonin, 5-HT2; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Thiazoles; Thiophenes; Urinary Incontinence | 2009 |
Pregnancy and atypical antipsychotics.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Drug Therapy, Combination; Female; Fluphenazine; Humans; Infant, Newborn; Piperazines; Pregnancy; Pregnancy Complications; Recurrence; Schizophrenia; Thiazoles | 2009 |
Activation induced by high-dose ziprasidone: a case report.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Male; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Psychotic Disorders; Thiazoles | 2009 |
Impact of real-world ziprasidone dosing on treatment discontinuation rates in patients with schizophrenia or bipolar disorder.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Bipolar Disorder; Clinical Trials as Topic; Databases, Factual; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; International Classification of Diseases; Male; Middle Aged; Piperazines; Probability; Propensity Score; Proportional Hazards Models; Psychiatric Status Rating Scales; Retrospective Studies; Schizophrenia; Thiazoles; Time Factors; Treatment Outcome | 2009 |
Ziprasidone and citalopram use in pregnancy and lactation in a woman with psychotic depression.
Topics: Adult; Affective Disorders, Psychotic; Antipsychotic Agents; Citalopram; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Lactation; Male; Milk, Human; Piperazines; Pregnancy; Pregnancy Complications; Selective Serotonin Reuptake Inhibitors; Thiazoles | 2009 |
Vocal tics associated with ziprasidone.
Topics: Adult; Humans; Male; Piperazines; Thiazoles; Tics; Tourette Syndrome | 2009 |
New-onset vascular mania in a patient with chronic depression.
Topics: Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Dementia, Vascular; Depressive Disorder; Humans; Male; Middle Aged; Piperazines; Thiazoles; Treatment Outcome | 2009 |
Brugada syndrome unmasked by lithium.
Topics: Adult; Antimanic Agents; Bipolar Disorder; Brugada Syndrome; Cardiopulmonary Resuscitation; Drug Therapy, Combination; Electrocardiography; Heart Arrest; Heart Conduction System; Humans; Lamotrigine; Lithium Compounds; Male; Piperazines; Sodium Channel Blockers; Thiazoles; Triazines | 2009 |
Torsade de pointes after ziprasidone overdose with coingestants.
Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Anxiety Disorders; Bipolar Disorder; Drug Overdose; Female; Humans; Long QT Syndrome; Middle Aged; Piperazines; Thiazoles; Torsades de Pointes | 2010 |
Free your MIND and the rest will follow: decoding delirium in the intensive care unit.
Topics: Antipsychotic Agents; Delirium; Haloperidol; Humans; Intensive Care Units; Piperazines; Postoperative Complications; Respiration, Artificial; Thiazoles; Treatment Outcome | 2010 |
Functional SNPs in genes encoding the 5-HT2A receptor modify the affinity and potency of several atypical antipsychotic drugs.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Drug Resistance; HEK293 Cells; Humans; Mutagenesis, Site-Directed; Neuroleptic Malignant Syndrome; Nursing Research; Olanzapine; Pharmacogenetics; Piperazines; Polymorphism, Single Nucleotide; Quetiapine Fumarate; Quinolones; Receptor, Serotonin, 5-HT2A; Risperidone; Thiazoles | 2011 |
Effects of atypical antipsychotic drugs on body weight and food intake in dopamine D2 receptor knockout mice.
Topics: Adipose Tissue; Animals; Antipsychotic Agents; Benzodiazepines; Body Weight; Eating; Male; Mice; Mice, Knockout; Motor Activity; Olanzapine; Piperazines; Receptors, Dopamine D2; Risperidone; Thiazoles; Weight Gain | 2010 |
Evidence-based use of second-generation antipsychotics in a state Medicaid pediatric population, 2001-2005.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Child, Preschool; Clozapine; Dibenzothiazepines; Drug Utilization; Evidence-Based Medicine; Female; Humans; Infant; Insurance Claim Review; Male; Medicaid; Mental Disorders; Off-Label Use; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles; United States; United States Food and Drug Administration | 2010 |
Pediatric uptake of a newly available antipsychotic medication.
Topics: Adolescent; Antipsychotic Agents; Child; Child, Preschool; Female; Humans; Infant; Male; Michigan; Off-Label Use; Piperazines; Retrospective Studies; Thiazoles; Young Adult | 2010 |
Pattern of acute induction of Homer1a gene is preserved after chronic treatment with first- and second-generation antipsychotics: effect of short-term drug discontinuation and comparison with Homer1a-interacting genes.
Topics: Animals; Antipsychotic Agents; Basal Ganglia; Carrier Proteins; Cerebral Cortex; Disks Large Homolog 4 Protein; Dose-Response Relationship, Drug; Drug Administration Schedule; Haloperidol; Homer Scaffolding Proteins; Inositol 1,4,5-Trisphosphate Receptors; Intracellular Signaling Peptides and Proteins; Male; Membrane Proteins; Piperazines; Rats; Rats, Sprague-Dawley; RNA, Messenger; Thiazoles; Time Factors; Up-Regulation | 2011 |
The successful treatment of mania due to acquired immunodeficiency syndrome using ziprasidone: a case series.
Topics: Acquired Immunodeficiency Syndrome; Antipsychotic Agents; Bipolar Disorder; Drug Administration Schedule; Female; Humans; Middle Aged; Piperazines; Thiazoles; Treatment Outcome | 2010 |
Characteristics and mortality among hospitalized patients treated with intramuscular antipsychotics: analysis of a United States hospital database.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Cohort Studies; Databases, Factual; Female; Haloperidol; Hospital Mortality; Humans; Injections, Intramuscular; Male; Olanzapine; Piperazines; Thiazoles; United States; Young Adult | 2010 |
Respiratory failure following isolated ziprasidone ingestion in a toddler.
Topics: Accidents; Antipsychotic Agents; Chromatography, Liquid; Humans; Hypnotics and Sedatives; Infant; Intubation, Intratracheal; Male; Mass Spectrometry; Midazolam; Piperazines; Respiration, Artificial; Respiratory Insufficiency; Thiazoles; Treatment Outcome | 2010 |
Symptomatic bradycardia with oral aripiprazole and oral ziprasidone.
Topics: Adolescent; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Bradycardia; Delusions; Electrocardiography; Female; Humans; Lithium Carbonate; Piperazines; Psychotic Disorders; Quinolones; Thiazoles | 2010 |
Ziprasidone as a possible cause of cleft palate in a newborn.
Topics: Adult; Antipsychotic Agents; Cleft Palate; Dose-Response Relationship, Drug; Female; Humans; Infant, Newborn; Piperazines; Pregnancy; Pregnancy Complications; Risk Factors; Schizophrenia; Thiazoles; Ultrasonography, Prenatal | 2010 |
Comparison of short-acting intramuscular antipsychotic medication: impact on length of stay and cost.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Cohort Studies; Drug Costs; Female; Haloperidol; Humans; Injections, Intramuscular; Length of Stay; Male; Middle Aged; Olanzapine; Piperazines; Psychomotor Agitation; Quinolones; Retrospective Studies; Schizophrenia; Thiazoles | 2011 |
Safety of the electroconvulsive therapy-ziprasidone combination.
Topics: Adult; Antipsychotic Agents; Combined Modality Therapy; Depressive Disorder, Major; Electroconvulsive Therapy; Female; Humans; Middle Aged; Piperazines; Thiazoles | 2010 |
Increased striatal dopamine transporter levels, as indicated by a DAT scan, induced by ziprasidone in association to improvement of tardive dyskinesia--a case report.
Topics: Antipsychotic Agents; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Dyskinesia, Drug-Induced; Humans; Male; Middle Aged; Piperazines; Schizophrenia; Thiazoles; Treatment Outcome | 2010 |
Atypical antipsychotics rapidly and inappropriately switch peripheral fuel utilization to lipids, impairing metabolic flexibility in rodents.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Carnitine; Clozapine; Energy Metabolism; Fatty Acids, Nonesterified; Female; Haloperidol; Insulin Resistance; Lipolysis; Male; Malonyl Coenzyme A; Mice; Olanzapine; Piperazines; Rats; Rats, Sprague-Dawley; Risperidone; Thiazoles; Vitamin B Complex | 2012 |
How sequential studies inform drug development: evaluating the effect of food intake on optimal bioavailability of ziprasidone.
Topics: Administration, Oral; Adolescent; Adult; Antipsychotic Agents; Biological Availability; Biomedical Research; Bipolar Disorder; Dietary Fats; Dose-Response Relationship, Drug; Drug Evaluation; Drug Monitoring; Drugs, Investigational; Energy Intake; Fasting; Female; Food-Drug Interactions; Humans; Intestinal Absorption; Male; Middle Aged; Piperazines; Postprandial Period; Psychotic Disorders; Schizophrenia; Thiazoles; Treatment Outcome; Young Adult | 2010 |
A nearly overlooked mild case of ziprasidone-induced lingual dystonia.
Topics: Adult; Dystonia; Female; Humans; Piperazines; Thiazoles; Tongue Diseases | 2010 |
Prescription persistence and safety of antipsychotic medication: a national registry-based 3-year follow-up.
Topics: Adult; Aged; Antiparkinson Agents; Antipsychotic Agents; Chlorprothixene; Cholinergic Antagonists; Clopenthixol; Clozapine; Drug Prescriptions; Female; Follow-Up Studies; Haloperidol; Humans; Logistic Models; Male; Methotrimeprazine; Middle Aged; Mortality; Norway; Odds Ratio; Piperazines; Registries; Thiazoles | 2010 |
Ziprasidone induced tardive cervical dystonia.
Topics: Antipsychotic Agents; Botulinum Toxins, Type A; Clonazepam; Depressive Disorder; Dyskinesia, Drug-Induced; Female; Humans; Middle Aged; Neuromuscular Agents; Piperazines; Thiazoles | 2009 |
Protracted, dose-dependent weight loss after addition of ziprasidone to a stable regimen of clozapine.
Topics: Adult; Antipsychotic Agents; Clozapine; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Female; Humans; Piperazines; Schizophrenia; Thiazoles; Time Factors; Weight Loss | 2010 |
Serotonin syndrome caused by ziprasidone alone.
Topics: Antipsychotic Agents; Female; Humans; Middle Aged; Piperazines; Serotonin Syndrome; Thiazoles | 2010 |
A thermodynamic-based approach to analyzing a highly solvating polymorphic system: the desolvation window method.
Topics: Antineoplastic Agents; Axitinib; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Imidazoles; Indazoles; Isomerism; Kinetics; Phase Transition; Piperazines; Powder Diffraction; Solubility; Solvents; Technology, Pharmaceutical; Temperature; Thermodynamics; Thiazoles; Transition Temperature; Water | 2011 |
Ziprasidone, monoamine oxidase inhibitors, and the serotonin syndrome.
Topics: Adult; Depressive Disorder, Major; Drug Interactions; Female; Humans; Monoamine Oxidase Inhibitors; Piperazines; Serotonin Antagonists; Serotonin Syndrome; Thiazoles; Tranylcypromine | 2010 |
Primary add-on of ziprasidone in sertraline treatment of posttraumatic stress disorder: lessons from a stopped trial?
Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Patient Dropouts; Piperazines; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sertraline; Stress Disorders, Post-Traumatic; Thiazoles | 2010 |
[Descriptive analysis of the use of atypical antipsychotics under compassionate-use in a health area in Ferrol (La Coruña, Spain)].
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Compassionate Use Trials; Dementia; Dibenzothiazepines; Female; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Retrospective Studies; Spain; Thiazoles; Treatment Outcome | 2010 |
Pediatric ziprasidone ingestions.
Topics: Accidents; Antipsychotic Agents; Child; Child, Preschool; Humans; Infant; Piperazines; Poison Control Centers; Poisoning; Thiazoles | 2010 |
Electroanalytical characteristics of antipsychotic drug ziprasidone and its determination in pharmaceuticals and serum samples on solid electrodes.
Topics: Antipsychotic Agents; Boron; Centrifugation; Chemical Precipitation; Chromatography, Liquid; Diamond; Electrochemistry; Electrodes; Glass; Humans; Oxidation-Reduction; Pharmaceutical Preparations; Piperazines; Reproducibility of Results; Thiazoles; Time Factors | 2010 |
Third degree heart block following intramuscular ziprasidone.
Topics: Aged; Alzheimer Disease; Antipsychotic Agents; Bradycardia; Cardiopulmonary Resuscitation; Dementia, Vascular; Dose-Response Relationship, Drug; Female; Heart Block; Hospitalization; Humans; Injections, Intramuscular; Long QT Syndrome; Piperazines; Schizophrenia, Paranoid; Thiazoles | 2011 |
Two models for weight gain and hyperphagia as side effects of atypical antipsychotics in male rats: validation with olanzapine and ziprasidone.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Disease Models, Animal; Dose-Response Relationship, Drug; Feeding Behavior; Hyperphagia; Male; Olanzapine; Piperazines; Rats; Rats, Sprague-Dawley; Thiazoles; Weight Gain | 2011 |
A simple liquid chromatography-tandem mass spectrometry method to determine relative plasma exposures of drug metabolites across species for metabolite safety assessments.
Topics: Animals; Chromatography, Liquid; Humans; Pharmaceutical Preparations; Piperazines; Rats; Risk Assessment; Species Specificity; Tandem Mass Spectrometry; Thiazoles | 2010 |
Bitter pills for drug companies.
Topics: Acetamides; Drug Approval; Drug Industry; Fraud; gamma-Aminobutyric Acid; Isoxazoles; Linezolid; Motivation; Off-Label Use; Oxazolidinones; Piperazines; Pregabalin; Sulfonamides; Thiazoles; United States | 2010 |
The impact of antipsychotic drugs on food intake and body weight and on leptin levels in blood and hypothalamic ob-r leptin receptor expression in wistar rats.
Topics: Animals; Antipsychotic Agents; Blotting, Western; Clozapine; Eating; Exploratory Behavior; Haloperidol; Hypothalamus; Leptin; Male; Motor Activity; Piperazines; Rats; Rats, Wistar; Receptors, Leptin; Thiazoles; Time Factors; Weight Gain | 2010 |
A case of catatonia successfully treated with ziprasidone, in a patient with DSM-IV delusional disorder.
Topics: Antipsychotic Agents; Brief Psychiatric Rating Scale; Catatonia; Diagnostic and Statistical Manual of Mental Disorders; Humans; Male; Middle Aged; Piperazines; Schizophrenia, Paranoid; Thiazoles; Treatment Outcome | 2010 |
Differential effects of ziprasidone and haloperidol on immobilization-stress-induced CRF mRNA expression in the hypothalamic paraventricular nucleus of rats.
Topics: Animals; Corticotropin-Releasing Hormone; Drug Evaluation, Preclinical; Haloperidol; Immobilization; Male; Paraventricular Hypothalamic Nucleus; Piperazines; Rats; Rats, Sprague-Dawley; Stress, Psychological; Thiazoles | 2011 |
Measurement of the serotonin 1A receptor availability in patients with schizophrenia during treatment with the antipsychotic medication ziprasidone.
Topics: Adult; Antipsychotic Agents; Brain; Carbon Radioisotopes; Female; Humans; Magnetic Resonance Imaging; Male; Piperazines; Positron-Emission Tomography; Psychiatric Status Rating Scales; Pyridines; Radioligand Assay; Receptor, Serotonin, 5-HT1A; Schizophrenia; Serotonin Antagonists; Thiazoles | 2011 |
Quantification of antidepressants and antipsychotics in human serum by precipitation and ultra high pressure liquid chromatography-tandem mass spectrometry.
Topics: Antidepressive Agents; Antipsychotic Agents; Chemical Precipitation; Chromatography, High Pressure Liquid; Cyclohexanols; Desvenlafaxine Succinate; Dibenzothiazepines; Humans; Methanol; Mianserin; Mirtazapine; Piperazines; Quetiapine Fumarate; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Thiazoles; Venlafaxine Hydrochloride; Zinc Sulfate | 2011 |
Effects of risperidone, quetiapine and ziprasidone on ethanol withdrawal syndrome in rats.
Topics: Alcoholism; Animals; Antipsychotic Agents; Behavior, Animal; Body Weight; Central Nervous System Depressants; Comorbidity; Dibenzothiazepines; Ethanol; Humans; Hyperkinesis; Male; Motor Activity; Piperazines; Psychomotor Agitation; Quetiapine Fumarate; Rats; Rats, Wistar; Risperidone; Schizophrenia; Substance Withdrawal Syndrome; Thiazoles; Time Factors | 2011 |
Clinical Global Impression of Improvement (CGI-I) as a valid proxy measure for remission in schizophrenia: analyses of ziprasidone clinical study data.
Topics: Antipsychotic Agents; Follow-Up Studies; Humans; Outcome Assessment, Health Care; Piperazines; Predictive Value of Tests; Proxy; Psychiatric Status Rating Scales; ROC Curve; Schizophrenia; Schizophrenic Psychology; Secondary Prevention; Thiazoles | 2011 |
Protective effects of atypical antipsychotic drugs against MPP(+)-induced oxidative stress in PC12 cells.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Antipsychotic Agents; Aripiprazole; bcl-2-Associated X Protein; Benzodiazepines; Blotting, Western; Cell Survival; Haloperidol; Herbicides; Olanzapine; Oxidative Stress; PC12 Cells; Piperazines; Quinolones; Rats; Reactive Oxygen Species; Superoxide Dismutase; Thiazoles | 2011 |
Molecular dynamics of the cryomilled base and hydrochloride ziprasidones by means of dielectric spectroscopy.
Topics: Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Crystallization; Crystallography, X-Ray; Dielectric Spectroscopy; Hydrogen-Ion Concentration; Kinetics; Molecular Dynamics Simulation; Molecular Structure; Motion; Piperazines; Technology, Pharmaceutical; Thiazoles; Transition Temperature; Water | 2011 |
Ziprasidone and the relative risk of diabetes.
Topics: Antipsychotic Agents; Diabetes Mellitus; Humans; Piperazines; Thiazoles | 2011 |
Effect of cyclodextrin derivation and amorphous state of complex on accelerated degradation of ziprasidone.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Antipsychotic Agents; beta-Cyclodextrins; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Crystallization; Crystallography, X-Ray; Drug Compounding; Drug Stability; Excipients; Gamma Rays; Hot Temperature; Hydrogen-Ion Concentration; Kinetics; Magnetic Resonance Spectroscopy; Oxidation-Reduction; Piperazines; Powder Diffraction; Solubility; Technology, Pharmaceutical; Thiazoles | 2011 |
Switching among antipsychotics in everyday clinical practice: focus on ziprasidone.
Topics: Antipsychotic Agents; Drug Substitution; Humans; Patient Education as Topic; Piperazines; Schizophrenia; Thiazoles | 2011 |
What can large simple trials do for psychiatry?
Topics: Adverse Drug Reaction Reporting Systems; Antipsychotic Agents; Death, Sudden, Cardiac; Humans; Long QT Syndrome; Multicenter Studies as Topic; Piperazines; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic; Risk Factors; Schizophrenia; Thiazoles | 2011 |
Comparative effectiveness of second-generation antipsychotic medications in early-onset schizophrenia.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Dibenzothiazepines; Female; Hospitalization; Hospitals, Psychiatric; Humans; Male; Medication Adherence; Olanzapine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome | 2012 |
Stability-indicating spectrofluorimetric method for the assay of ziprasidone in capsules.
Topics: Capsules; Drug Stability; Fluorescence; Molecular Structure; Piperazines; Spectrometry, Fluorescence; Thiazoles | 2011 |
Open adjunctive ziprasidone associated with weight loss in obese and overweight bipolar disorder patients.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Bipolar Disorder; Blood Glucose; Body Mass Index; Dose-Response Relationship, Drug; Fasting; Female; Humans; Male; Middle Aged; Obesity; Overweight; Piperazines; Prospective Studies; Thiazoles; Waist Circumference; Weight Loss | 2011 |
Ziprasidone for maintenance treatment of bipolar I disorder in adults.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Double-Blind Method; Humans; Piperazines; Placebos; Randomized Controlled Trials as Topic; Thiazoles | 2011 |
Quantification of lurasidone, an atypical antipsychotic drug, in rat plasma with high-performance liquid chromatography with tandem mass spectrometry.
Topics: Acetonitriles; Animals; Antipsychotic Agents; Chromatography, High Pressure Liquid; Isoindoles; Linear Models; Lurasidone Hydrochloride; Male; Piperazines; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Thiazoles | 2011 |
Impact of geographical and cultural factors on clinical trials in acute mania: lessons from a ziprasidone and haloperidol placebo-controlled study.
Topics: Adolescent; Adult; Antipsychotic Agents; Bipolar Disorder; Cultural Characteristics; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Haloperidol; Health Status Disparities; Healthcare Disparities; Humans; India; Internationality; Male; Piperazines; Placebos; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Research Design; Russia; Thiazoles; Treatment Outcome; United States; Young Adult | 2011 |
Use of ziprasidone in patients with schizophrenia in four European countries.
Topics: Adult; Antipsychotic Agents; Cross-Sectional Studies; Europe; Female; Health Care Surveys; Humans; Male; Piperazines; Retrospective Studies; Schizophrenia; Thiazoles | 2011 |
Switching among antipsychotics--focus on side effects.
Topics: Affective Disorders, Psychotic; Antipsychotic Agents; Benzodiazepines; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Eruptions; Drug Substitution; Drug Therapy, Combination; Female; Humans; Middle Aged; Olanzapine; Piperazines; Pruritus; Sulpiride; Thiazoles; Weight Gain | 2011 |
Antipsychotic treatment--side-effect and/or metabolic syndrome.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Combined Modality Therapy; Drug Substitution; Female; Humans; Metabolic Syndrome; Olanzapine; Piperazines; Psychotherapy; Schizophrenia; Schizophrenic Psychology; Social Adjustment; Thiazoles; Weight Gain | 2011 |
Weight gain--as possible predictor of metabolic syndrome.
Topics: Adult; Antipsychotic Agents; Body Mass Index; Dibenzothiazepines; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Metabolic Syndrome; Patient Admission; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Thiazoles; Weight Gain | 2011 |
Assessments of suicidality in double-blind, placebo-controlled trials of ziprasidone.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Child; Confidence Intervals; Humans; Odds Ratio; Piperazines; Randomized Controlled Trials as Topic; Risk; Schizophrenia; Suicidal Ideation; Suicide; Suicide, Attempted; Thiazoles | 2011 |
QT interval duration and dispersion in children and adolescents treated with ziprasidone.
Topics: Adolescent; Antipsychotic Agents; Child; Dose-Response Relationship, Drug; Electrocardiography; Female; Heart Rate; Humans; Long QT Syndrome; Male; Piperazines; Potassium; Thiazoles; Torsades de Pointes | 2011 |
The safety of atypical antipsychotics: does QTc provide all the answers?
Topics: Antipsychotic Agents; Humans; Long QT Syndrome; Piperazines; Thiazoles; Torsades de Pointes | 2011 |
Single-dose ziprasidone associated with QT interval prolongation.
Topics: Antipsychotic Agents; Electrocardiography; Emergency Service, Hospital; Humans; Long QT Syndrome; Male; Middle Aged; Piperazines; Psychomotor Agitation; Thiazoles | 2012 |
Question regarding ziprasidone and QTc interval prolongation in the ZODIAC study.
Topics: Adult; Antipsychotic Agents; Female; Humans; Long QT Syndrome; Male; Piperazines; Schizophrenia; Thiazoles; Treatment Outcome | 2011 |
Ziprasidone induced symptomatic bradycardia: a case report.
Topics: Adult; Antipsychotic Agents; Bradycardia; Humans; Male; Piperazines; Psychotic Disorders; Thiazoles | 2011 |
Improved ziprasidone formulations with enhanced bioavailability in the fasted state and a reduced food effect.
Topics: Area Under Curve; Biological Availability; Dopamine Antagonists; Excipients; Fasting; Food-Drug Interactions; Humans; Piperazines; Solubility; Thiazoles | 2011 |
Outcome assessment of an antipsychotic drug algorithm: effects of the Mississippi State Hospital algorithm project.
Topics: Adult; Algorithms; Antipsychotic Agents; Female; Hospitals, State; Humans; Male; Medication Adherence; Mississippi; Piperazines; Psychiatric Status Rating Scales; Quality of Health Care; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome | 2011 |
Digital Holter measurement of QT prolongation in ziprasidone overdose.
Topics: Action Potentials; Antipsychotic Agents; Bradycardia; Drug Overdose; Electrocardiography, Ambulatory; Female; Heart Conduction System; Humans; Kinetics; Middle Aged; Piperazines; Predictive Value of Tests; Telemetry; Thiazoles | 2011 |
Pharmacokinetics of lurasidone, a novel atypical anti-psychotic drug, in rats.
Topics: Administration, Oral; Animals; Antipsychotic Agents; Injections, Intravenous; Isoindoles; Lurasidone Hydrochloride; Male; Piperazines; Rats; Rats, Sprague-Dawley; Reference Standards; Thiazoles | 2011 |
Effects of antipsychotics with different weight gain liabilities on human in vitro models of adipose tissue differentiation and metabolism.
Topics: Adipocytes; Adipogenesis; Adipose Tissue; Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Female; Haloperidol; Humans; Olanzapine; Piperazines; Thiazoles; Weight Gain | 2011 |
Hyperosmolar hyperglycemic state associated with ziprasidone treatment: a case report.
Topics: Adult; Antipsychotic Agents; Humans; Hyperglycemia; Male; Osmolar Concentration; Piperazines; Risperidone; Schizophrenia, Paranoid; Thiazoles | 2011 |
Cytogenetic effects of valproic acid and ziprasidone in human lymphocyte cultures.
Topics: Adult; Antipsychotic Agents; Cell Proliferation; Cytogenetic Analysis; Drug Synergism; Female; Humans; Lymphocytes; Male; Piperazines; Primary Cell Culture; Sister Chromatid Exchange; Thiazoles; Valproic Acid | 2011 |
Pisa syndrome and laryngeal dystonia induced by novel antipsychotics.
Topics: Adult; Antipsychotic Agents; Dystonia; Humans; Imidazoles; Indoles; Laryngeal Diseases; Male; Middle Aged; Piperazines; Risperidone; Schizophrenia; Syndrome; Thiazoles | 2011 |
Use of a new ziprasidone-selective electrode in mixed solvents and its application in the analysis of pharmaceuticals and biological fluids.
Topics: Body Fluids; Calibration; Electrodes; Humans; Membranes, Artificial; Pharmaceutical Preparations; Piperazines; Solvents; Thiazoles | 2011 |
Onset of action of atypical and typical antipsychotics in the treatment of adolescent schizophrenic psychoses.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Female; Haloperidol; Humans; Male; Medical Records; Olanzapine; Perphenazine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Sulpiride; Thiazoles; Time Factors; Treatment Outcome | 2011 |
Ziprasidone's effect on metabolic markers in patients with diabetes and chronic schizophrenia.
Topics: Analysis of Variance; Antipsychotic Agents; Biomarkers; Blood Glucose; Body Mass Index; Body Weight; Chronic Disease; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Humans; Insulin; Lipids; Male; Metabolic Syndrome; Middle Aged; Piperazines; Polypharmacy; Prospective Studies; Psychiatric Status Rating Scales; Schizophrenia; Thiazoles; Treatment Outcome | 2012 |
The effect of ziprasidone on body weight and energy expenditure in female rats.
Topics: Abdominal Fat; Adiposity; Animals; Antipsychotic Agents; Body Temperature; Body Weight; Eating; Energy Metabolism; Female; Motor Activity; Piperazines; Rats; Rats, Sprague-Dawley; Thiazoles | 2012 |
The impact of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) on prescribing practices: an analysis of data from a large midwestern state.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chi-Square Distribution; Clozapine; Dibenzothiazepines; Humans; Missouri; Olanzapine; Piperazines; Practice Patterns, Physicians'; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome | 2012 |
Adolescent female with withdrawal psychosis following abrupt termination of ziprasidone.
Topics: Depressive Disorder; Female; Hallucinations; Humans; Piperazines; Psychoses, Substance-Induced; Substance Withdrawal Syndrome; Thiazoles | 2012 |
Updating and confirming an industry-sponsored pharmacoeconomic model: comparing two antipsychotics in the treatment of schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Cost-Benefit Analysis; Decision Support Techniques; Economics, Pharmaceutical; Health Services; Humans; Models, Economic; Olanzapine; Piperazines; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Recurrence; Schizophrenia; Thiazoles | 2012 |
Antipsychotic-induced psychotic-like syndrome and pathological smiling in an adolescent.
Topics: Adolescent; Antipsychotic Agents; Female; Humans; Piperazines; Psychoses, Substance-Induced; Smiling; Suicide, Attempted; Thiazoles | 2012 |
In vitro and in vivo characterization of amorphous, nanocrystalline, and crystalline ziprasidone formulations.
Topics: Absorption; Acetates; Animals; Antipsychotic Agents; Chemistry, Pharmaceutical; Cyclodextrins; Dogs; Drug Stability; Fasting; Hypromellose Derivatives; Male; Methylcellulose; Nanoparticles; Particle Size; Piperazines; Solubility; Succinic Acid; Suspensions; Thiazoles | 2012 |
Serum prolactin levels and the acute-phase efficacy in drug-naïve schizophrenia treated with ziprasidone and olanzapine (translated version).
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Drug Monitoring; Female; Humans; Interview, Psychological; Male; Olanzapine; Pharmacovigilance; Piperazines; Prolactin; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome | 2012 |
Reduction and methylation of ziprasidone by glutathione, aldehyde oxidase, and thiol S-methyltransferase in humans: an in vitro study.
Topics: Aldehyde Oxidase; Antipsychotic Agents; Cytosol; Glutathione; Humans; Liver; Methylation; Methyltransferases; Microsomes, Liver; Oxidation-Reduction; Piperazines; Thiazoles | 2012 |
Network-assisted investigation of antipsychotic drugs and their targets.
Topics: Antipsychotic Agents; Clopenthixol; Databases, Factual; Drug Interactions; Gene Regulatory Networks; Humans; Piperazines; Schizophrenia; Thiazoles; Thiothixene | 2012 |
Ziprasidone--not haloperidol--induces more de-novo neurogenesis of adult neural stem cells derived from murine hippocampus.
Topics: Animals; Antipsychotic Agents; Cell Differentiation; Cell Movement; Cells, Cultured; Epidermal Growth Factor; Fibroblast Growth Factor 2; Haloperidol; Hippocampus; Immunohistochemistry; Mice; Mice, Inbred C57BL; Neural Stem Cells; Neurogenesis; Piperazines; Receptor, Serotonin, 5-HT1A; Serotonin Antagonists; Thiazoles; Tubulin | 2013 |
Drug rash with eosinophilia and systemic symptoms (DRESS syndrome).
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Drug Eruptions; Drug Hypersensitivity; Eosinophilia; Female; Humans; Piperazines; Prednisone; Risk Factors; Syndrome; Thiazoles; Treatment Outcome | 2012 |
Ziprasidone attenuates brain injury after focal cerebral ischemia induced by middle cerebral artery occlusion in rats.
Topics: Animals; Antigens, Nuclear; Antipsychotic Agents; Biomarkers; Brain Injuries; Brain Ischemia; Calcium-Binding Proteins; Cerebral Infarction; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Microfilament Proteins; Microglia; Nerve Tissue Proteins; Neurons; Neuroprotective Agents; Piperazines; Rats; Rats, Sprague-Dawley; Recovery of Function; Severity of Illness Index; Thiazoles | 2012 |
Buffered nanoemulsion for nose to brain delivery of ziprasidone hydrochloride: preformulation and pharmacodynamic evaluation.
Topics: Acrylates; Administration, Intranasal; Animals; Antipsychotic Agents; Behavior, Animal; Brain; Chitosan; Drug Compounding; Drug Delivery Systems; Emulsions; Mice; Motor Activity; Nanoparticles; Nasal Mucosa; Piperazines; Rats; Sheep; Thiazoles | 2012 |
Inhibition of mouse brown adipocyte differentiation by second-generation antipsychotics.
Topics: Adipocytes, Brown; Adipogenesis; Adipokines; Animals; Antipsychotic Agents; Cell Differentiation; Cell Line; Cell Survival; Clozapine; Dibenzothiazepines; Gene Expression Regulation; Humans; Mice; Piperazines; Quetiapine Fumarate; Schizophrenia; Thiazoles; Weight Gain | 2012 |
Medication adherence and utilization in patients with schizophrenia or bipolar disorder receiving aripiprazole, quetiapine, or ziprasidone at hospital discharge: a retrospective cohort study.
Topics: Adult; Aged; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Databases, Factual; Dibenzothiazepines; Female; Humans; Male; Medication Adherence; Patient Discharge; Piperazines; Quetiapine Fumarate; Quinolones; Retrospective Studies; Schizophrenia; Thiazoles | 2012 |
The chemometric study and quantitative structure retention relationship modeling of liquid chromatography separation of ziprasidone components.
Topics: Chromatography, High Pressure Liquid; Cluster Analysis; Models, Molecular; Molecular Structure; Piperazines; Principal Component Analysis; Thiazoles | 2012 |
Solid nanocrystalline dispersions of ziprasidone with enhanced bioavailability in the fasted state.
Topics: Absorption; Administration, Oral; Animals; Antipsychotic Agents; Biological Availability; Calorimetry, Differential Scanning; Capsules; Crystallization; Dogs; Fasting; Methylcellulose; Piperazines; Solubility; Thiazoles; Tissue Distribution; X-Ray Diffraction | 2012 |
A case of severe hyponatremia induced by duloxetine and ziprasidone.
Topics: Antidepressive Agents; Antipsychotic Agents; Creatine Kinase; Depressive Disorder, Major; Duloxetine Hydrochloride; Female; Humans; Hyponatremia; Middle Aged; Piperazines; Thiazoles; Thiophenes | 2012 |
Effect of atypical antipsychotics on antioxidant enzyme activities in human erythrocytes (in vitro study).
Topics: Adult; Amisulpride; Antioxidants; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Catalase; Clozapine; Dibenzothiazepines; Enzyme Activation; Erythrocytes; Glutathione Peroxidase; Glutathione Reductase; Humans; Imidazoles; Indoles; Male; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Sulpiride; Superoxide Dismutase; Superoxide Dismutase-1; Thiazoles; Treatment Outcome; Young Adult | 2013 |
Methodologies to avoid the enrollment of ineligible patients in clinical trials.
Topics: Antimanic Agents; Bipolar Disorder; Female; Humans; Lithium Carbonate; Male; Patient Selection; Piperazines; Signal Detection, Psychological; Thiazoles; Valproic Acid | 2012 |
Assessment of propofol, midazolam and ziprasidone, or the combinations for the prevention of acute cocaine toxicity in a mouse model.
Topics: Animals; Anticonvulsants; Antipsychotic Agents; Cocaine-Related Disorders; Disease Models, Animal; Dopamine Antagonists; Drug Therapy, Combination; GABA Modulators; Male; Mice; Midazolam; Piperazines; Propofol; Seizures; Serotonin Antagonists; Thiazoles | 2013 |
A case of catatonia in a 14-year-old girl with schizophrenia treated with electroconvulsive therapy.
Topics: Adolescent; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Catatonia; Combined Modality Therapy; Creatine Kinase; Dibenzothiazepines; Diseases in Twins; Drug Substitution; Drug Therapy, Combination; Electroconvulsive Therapy; Female; Humans; Neurologic Examination; Olanzapine; Piperazines; Quetiapine Fumarate; Recurrence; Schizophrenia; Thiazoles | 2013 |
Gingival pain: an unusual side effect of ziprasidone.
Topics: Antipsychotic Agents; Gingiva; Humans; Male; Middle Aged; Pain; Piperazines; Thiazoles | 2013 |
A case of recurrent psychosis during sickle cell disease crisis treated successfully with ziprasidone.
Topics: Adult; Analgesics, Opioid; Anemia, Sickle Cell; Antipsychotic Agents; Blood Transfusion; Diagnosis, Differential; Fluid Therapy; Hospitalization; Humans; Male; Pain; Pain Management; Piperazines; Psychotic Disorders; Recurrence; Thiazoles | 2013 |
Ziprasidone ameliorates anxiety-like behaviors in a rat model of PTSD and up-regulates neurogenesis in the hippocampus and hippocampus-derived neural stem cells.
Topics: Animals; Anti-Anxiety Agents; Butadienes; Cell Proliferation; Cell Survival; Cells, Cultured; Hippocampus; Male; MAP Kinase Signaling System; Neural Stem Cells; Neurogenesis; Nitriles; Piperazines; Protein Kinase Inhibitors; Rats; Stress Disorders, Post-Traumatic; Thiazoles; Up-Regulation | 2013 |
Association between second-generation antipsychotics and changes in body mass index in adolescents.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Confidence Intervals; Dibenzothiazepines; Female; Humans; Male; Medical Audit; Olanzapine; Piperazines; Quetiapine Fumarate; Regression Analysis; Retrospective Studies; Risperidone; Thiazoles; United States; Weight Gain | 2013 |
Significance of reductive metabolism in human intestine and quantitative prediction of intestinal first-pass metabolism by cytosolic reductive enzymes.
Topics: Cytosol; Haloperidol; Humans; Intestinal Mucosa; Intestines; Liver; Mebendazole; NADP; Oxidation-Reduction; Piperazines; Thiazoles | 2013 |
Comparison of outcomes for African Americans, Hispanics, and Non-Hispanic Whites in the CATIE study.
Topics: Adult; Antipsychotic Agents; Black or African American; Clinical Trials as Topic; Female; Hispanic or Latino; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Patient Dropouts; Perphenazine; Piperazines; Schizophrenia; Thiazoles; United States; White People; Young Adult | 2013 |
Violent behavior and hallucination in a 32-year-old patient.
Topics: Adult; Hallucinations; Humans; Hypnotics and Sedatives; Lorazepam; Male; Piperazines; Thiazoles; Violence | 2013 |
Immediate intervention: life-long success.
Topics: Adult; Antipsychotic Agents; Cognitive Behavioral Therapy; Female; Humans; Piperazines; Schizophrenia; Thiazoles; Treatment Outcome; Trifluoperazine | 2014 |
The effects of ziprasidone, clozapine and haloperidol on lipid peroxidation in human plasma (in vitro): comparison.
Topics: Adult; Antipsychotic Agents; Clozapine; Female; Haloperidol; Humans; In Vitro Techniques; Lipid Peroxidation; Male; Piperazines; Thiazoles; Thiobarbituric Acid Reactive Substances | 2013 |
Metoprolol and diltiazem ameliorate ziprasidone-induced prolonged corrected QT interval in rats.
Topics: Adrenergic beta-1 Receptor Antagonists; Anesthesia; Animals; Anti-Arrhythmia Agents; Antipsychotic Agents; Calcium Channel Blockers; Diltiazem; Electrocardiography; Heart; Injections, Intraperitoneal; Long QT Syndrome; Male; Metoprolol; Piperazines; Random Allocation; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Thiazoles | 2015 |
Weight Gain While Switching from Polypharmacy to Ziprasidone: A Case Report.
Topics: Adult; Antipsychotic Agents; Female; Humans; Metabolic Syndrome; Piperazines; Polypharmacy; Schizophrenia, Paranoid; Thiazoles; Weight Gain | 2015 |
Short-term remission in schizophrenia as a combination of several outcome measures.
Topics: Adolescent; Adult; Antipsychotic Agents; Body Mass Index; Cognition Disorders; Female; Humans; Logistic Models; Male; Middle Aged; Outcome Assessment, Health Care; Piperazines; Psychiatric Status Rating Scales; Recurrence; Schizophrenia; Thiazoles; Treatment Outcome; Young Adult | 2013 |
Serotonin syndrome with ziprasidone and sertraline.
Topics: Adult; Female; Humans; Piperazines; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Syndrome; Sertraline; Thiazoles | 2013 |
Pharmacodynamic effects of aripiprazole and ziprasidone with respect to p-glycoprotein substrate properties.
Topics: Animals; Antipsychotic Agents; Aripiprazole; ATP Binding Cassette Transporter, Subfamily B, Member 1; Buspirone; Haloperidol; Ketanserin; Male; Mice; Mice, Knockout; Motor Activity; Piperazines; Quinolones; Rotarod Performance Test; Serotonin Antagonists; Serotonin Receptor Agonists; Thiazoles | 2013 |
Folie à deux: a case report.
Topics: Adult; Antipsychotic Agents; Diagnosis, Differential; Female; Flurazepam; Humans; Middle Aged; Mother-Child Relations; Patient Compliance; Piperazines; Shared Paranoid Disorder; Social Isolation; Thiazoles; Treatment Refusal | 2013 |
Transient, asymptomatic, fluctuating bradycardia with oral ziprasidone in an older woman.
Topics: Administration, Oral; Aged, 80 and over; Aging; Antipsychotic Agents; Asymptomatic Diseases; Bradycardia; Female; Humans; Piperazines; Thiazoles | 2014 |
Switching to ziprasidone in the clinical practice setting: an open-label study.
Topics: Adult; Antipsychotic Agents; Body Weight; Brief Psychiatric Rating Scale; Drug Substitution; Female; Follow-Up Studies; Humans; Male; Middle Aged; Piperazines; Psychometrics; Psychotic Disorders; Quality of Life; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome | 2013 |
Behavioral and metabolic effects of the atypical antipsychotic ziprasidone on the nematode Caenorhabditis elegans.
Topics: Adipose Tissue; Adiposity; Animals; Antipsychotic Agents; Behavior, Animal; Caenorhabditis elegans; Gene Expression Profiling; Lipid Metabolism; Piperazines; Thiazoles | 2013 |
Intramuscular ziprasidone: influence of alcohol and benzodiazepines on vital signs in the emergency setting.
Topics: Administration, Oral; Adult; Alcoholic Intoxication; Antipsychotic Agents; Benzodiazepines; Drug Therapy, Combination; Emergency Service, Hospital; Female; Humans; Injections, Intramuscular; Length of Stay; Male; Middle Aged; Oxygen; Piperazines; Practice Patterns, Physicians'; Psychomotor Agitation; Retrospective Studies; Thiazoles; Vital Signs | 2013 |
Ziprasidone-induced hypersensitivity syndrome confirmed by reintroduction.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Drug Hypersensitivity Syndrome; Female; Humans; Piperazines; Recurrence; Retreatment; Thiazoles | 2014 |
From the editor-in-chief's desk.
Topics: Antipsychotic Agents; Humans; Piperazines; Schizophrenia; Thiazoles | 2013 |
A fast and feasible microextraction by packed sorbent (MEPS) procedure for HPLC analysis of the atypical antipsychotic ziprasidone in human plasma.
Topics: Antipsychotic Agents; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Monitoring; Humans; Limit of Detection; Piperazines; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Microextraction; Thiazoles | 2014 |
Administration of mesenchymal stem cells and ziprasidone enhanced amelioration of ischemic brain damage in rats.
Topics: Animals; Brain Ischemia; Brain-Derived Neurotrophic Factor; Cell Survival; Combined Modality Therapy; Disease Models, Animal; Gene Expression Regulation; Glial Cell Line-Derived Neurotrophic Factor; Humans; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Microglia; Nerve Growth Factor; Neural Stem Cells; Neuroprotective Agents; Piperazines; Rats; Rats, Sprague-Dawley; Thiazoles | 2013 |
Selective action of an atypical neuroleptic on the mechanisms related to the development of cocaine addiction: a pre-clinical behavioural study.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Behavior, Animal; Central Nervous System Sensitization; Cocaine; Cocaine-Related Disorders; Disease Models, Animal; Dopamine Antagonists; Dopamine Uptake Inhibitors; Haloperidol; Male; Mice; Motor Activity; Piperazines; Quinolones; Thiazoles | 2014 |
Effects of acute and long-term typical or atypical neuroleptics on morphine-induced behavioural effects in mice.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Female; Haloperidol; Mice; Morphine; Motor Activity; Piperazines; Substance Withdrawal Syndrome; Thiazoles | 2014 |
Clinical lycanthropy: delusional misidentification of the "self".
Topics: Delusions; Dopamine Antagonists; Humans; Male; Mental Disorders; Piperazines; Self Concept; Thiazoles; Young Adult | 2014 |
Despite expert recommendations, second-generation antipsychotics are not often prescribed in the emergency department.
Topics: Administration, Oral; Adult; Alcoholic Intoxication; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Dibenzothiazepines; Droperidol; Drug Prescriptions; Drug Therapy, Combination; Emergency Service, Hospital; Female; Haloperidol; Hospitals, University; Humans; Male; Middle Aged; Olanzapine; Piperazines; Practice Guidelines as Topic; Practice Patterns, Physicians'; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles | 2014 |
Effects of antipsychotic drugs on insight in schizophrenia.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Awareness; Benzodiazepines; Female; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Piperazines; Psychotic Disorders; Quinolones; Schizophrenia; Schizophrenic Psychology; Thiazoles | 2014 |
Comparison of health services use associated with ziprasidone and olanzapine among schizophrenia and bipolar disorder patients in the USA.
Topics: Adult; Ambulatory Care; Benzodiazepines; Bipolar Disorder; Emergency Service, Hospital; Female; Health Care Costs; Health Services; Humans; Male; Middle Aged; Olanzapine; Piperazines; Schizophrenia; Thiazoles; United States | 2014 |
Cost-effectiveness of second-generation antipsychotics for the treatment of schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Cost-Benefit Analysis; Dibenzothiazepines; Drug Therapy, Combination; Female; Humans; Male; Markov Chains; Olanzapine; Piperazines; Quality-Adjusted Life Years; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles | 2014 |
Dried blood spot testing: a novel approach for the therapeutic drug monitoring of ziprasidone-treated patients.
Topics: Blood Specimen Collection; Chromatography, Liquid; Dried Blood Spot Testing; Drug Monitoring; Humans; Piperazines; Schizophrenia; Tandem Mass Spectrometry; Thiazoles | 2014 |
Treatment with Ziprasidone for schizophrenia patients with OCD.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Schizophrenia; Thiazoles; Treatment Outcome; Young Adult | 2014 |
Update on putative novel antipsychotics.
Topics: Antipsychotic Agents; Brain Injuries; Clozapine; Cognition Disorders; Drug Therapy, Combination; Employment, Supported; Humans; Piperazines; Schizophrenia; Thiazoles | 2014 |
Controlled release of ziprasidone solid dispersion systems from osmotic pump tablets with enhanced bioavailability in the fasted state.
Topics: Animals; Antipsychotic Agents; Biological Availability; Delayed-Action Preparations; Dogs; Fasting; Osmotic Pressure; Piperazines; Tablets; Thiazoles | 2015 |
Characterization and evaluation of self-nanoemulsifying sustained-release pellet formulation of ziprasidone with enhanced bioavailability and no food effect.
Topics: Administration, Oral; Animals; Biological Availability; Chemistry, Pharmaceutical; Delayed-Action Preparations; Dogs; Drug Delivery Systems; Drug Liberation; Emulsions; Excipients; Glycerides; Nanoparticles; Particle Size; Piperazines; Polyethylene Glycols; Solubility; Surface-Active Agents; Thiazoles | 2016 |
Involvement of cholinergic system in hyperactivity in dopamine-deficient mice.
Topics: Acetylcholine; Akathisia, Drug-Induced; Animals; Anti-Dyskinesia Agents; Antipsychotic Agents; Central Nervous System Stimulants; Choline O-Acetyltransferase; Clozapine; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Agents; Extracellular Space; Haloperidol; Levodopa; Locomotion; Mice, Inbred C57BL; Piperazines; Psychomotor Agitation; Thiazoles | 2015 |
The improvement of the dissolution rate of ziprasidone free base from solid oral formulations.
Topics: Administration, Oral; Chemistry, Pharmaceutical; Piperazines; Powder Diffraction; Solubility; Thiazoles | 2015 |
Antipsychotics-associated serious adverse events in children: an analysis of the FAERS database.
Topics: Algorithms; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Data Mining; Databases, Factual; Dibenzothiazepines; Haloperidol; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Thiazoles | 2015 |
Understanding responder neurobiology in schizophrenia using a quantitative systems pharmacology model: application to iloperidone.
Topics: Antipsychotic Agents; Computer Simulation; Genotype; Humans; Isoxazoles; Models, Biological; Molecular Targeted Therapy; Neurobiology; Pharmacogenetics; Piperazines; Piperidines; Schizophrenia; Thiazoles | 2015 |
Metabolic monitoring for youths initiating use of second-generation antipsychotics, 2003-2011.
Topics: Adolescent; Affective Disorders, Psychotic; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Benzodiazepines; Blood Glucose; Child; Child, Preschool; Cohort Studies; Conduct Disorder; Databases, Factual; Depressive Disorder; Diabetes Mellitus; Female; Glycated Hemoglobin; Guideline Adherence; Humans; Hyperkinesis; Male; Mass Screening; Mental Disorders; Olanzapine; Piperazines; Practice Guidelines as Topic; Practice Patterns, Physicians'; Psychotic Disorders; Quetiapine Fumarate; Retrospective Studies; Risperidone; Thiazoles | 2015 |
Transient agranulocytosis associated with ziprasidone in a 45-year-old man on hemodialysis.
Topics: Agranulocytosis; Antipsychotic Agents; Humans; Kidney Failure, Chronic; Male; Middle Aged; Piperazines; Renal Dialysis; Schizophrenia; Thiazoles | 2015 |
Implications of atypical antipsychotic prescribing in the intensive care unit.
Topics: Adult; Aged; Antipsychotic Agents; Aripiprazole; Arrhythmias, Cardiac; Basal Ganglia Diseases; Benzodiazepines; Cohort Studies; Delirium; Disorders of Excessive Somnolence; Female; Humans; Inappropriate Prescribing; Intensive Care Units; Male; Middle Aged; Olanzapine; Patient Discharge; Piperazines; Quetiapine Fumarate; Retrospective Studies; Risperidone; Survivors; Thiazoles | 2015 |
A Retrospective Naturalistic Study of Ziprasidone for Irritability in Youth with Autism Spectrum Disorder.
Topics: Adolescent; Antipsychotic Agents; Autism Spectrum Disorder; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Irritable Mood; Male; Piperazines; Psychotropic Drugs; Retrospective Studies; Thiazoles; Treatment Outcome | 2015 |
Drug-Induced Systemic Hypersensitivity Reaction Associated With Ziprasidone: An Atypical Occurrence.
Topics: Antipsychotic Agents; Drug Hypersensitivity Syndrome; Humans; Male; Middle Aged; Piperazines; Thiazoles | 2015 |
Pharmacoscintigraphy studies to assess the feasibility of a controlled release formulation of ziprasidone.
Topics: Administration, Oral; Antipsychotic Agents; Biological Availability; Capsules; Colon; Delayed-Action Preparations; Humans; Intestinal Absorption; Piperazines; Radionuclide Imaging; Solubility; Thiazoles | 2015 |
Formulation development and systematic optimization of stabilized ziprasidone hydrochloride capsules devoid of any food effect.
Topics: Administration, Oral; Area Under Curve; Biological Availability; Capsules; Chemistry, Pharmaceutical; Cross-Over Studies; Eating; Food; Food-Drug Interactions; Humans; Piperazines; Thiazoles | 2016 |
Mucoadhesive-floating zinc-pectinate-sterculia gum interpenetrating polymer network beads encapsulating ziprasidone HCl.
Topics: Adhesives; Animals; Calorimetry, Differential Scanning; Drug Liberation; Goats; Microspheres; Mucins; Particle Size; Pectins; Piperazines; Plant Gums; Polymers; Spectroscopy, Fourier Transform Infrared; Sterculia; Surface Properties; Thiazoles; X-Ray Diffraction | 2015 |
Neuromotor Adverse Effects in 342 Youth During 12 Weeks of Naturalistic Treatment With 5 Second-Generation Antipsychotics.
Topics: Adolescent; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Male; Mental Disorders; Multivariate Analysis; New York; Olanzapine; Parkinson Disease, Secondary; Piperazines; Prospective Studies; Quetiapine Fumarate; Regression Analysis; Risperidone; Thiazoles | 2015 |
A paired case-control comparison of ziprasidone on visual sustained attention and visual selective attention in patients with paranoid schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Attention; Attention Deficit Disorder with Hyperactivity; Case-Control Studies; Cognition Disorders; Female; Healthy Volunteers; Humans; Male; Middle Aged; Piperazines; Schizophrenia, Paranoid; Thiazoles; Young Adult | 2015 |
Effects of ziprasidone, SCH23390 and SB277011 on spatial memory in the Morris water maze test in naive and MK-801 treated mice.
Topics: Animals; Antipsychotic Agents; Benzazepines; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Male; Maze Learning; Mice; Mice, Inbred BALB C; Motor Activity; Nitriles; Piperazines; Psychomotor Performance; Spatial Memory; Tetrahydroisoquinolines; Thiazoles | 2015 |
US Food and Drug Administration warning about the risk of drug reaction with eosinophilia and systemic symptoms with ziprasidone.
Topics: Adverse Drug Reaction Reporting Systems; Antipsychotic Agents; Drug Hypersensitivity Syndrome; Humans; Piperazines; Thiazoles; United States; United States Food and Drug Administration | 2015 |
Adjunctive Ziprasidone in Major Depression and the Current Status of Adjunctive Atypical Antipsychotics.
Topics: Antidepressive Agents; Citalopram; Depressive Disorder, Major; Female; Humans; Male; Piperazines; Thiazoles | 2015 |
ADDENDUM.
Topics: Antidepressive Agents; Citalopram; Depressive Disorder, Major; Female; Humans; Male; Piperazines; Thiazoles | 2015 |
Preparation and evaluation of ziprasidone-phospholipid complex from sustained-release pellet formulation with enhanced bioavailability and no food effect.
Topics: Adjuvants, Pharmaceutic; Animals; Antipsychotic Agents; Biological Availability; Delayed-Action Preparations; Dogs; Food-Drug Interactions; Microscopy, Electron, Scanning; Phospholipids; Piperazines; Solubility; Spectroscopy, Fourier Transform Infrared; Technology, Pharmaceutical; Thiazoles; X-Ray Diffraction | 2016 |
Silica encapsulated lipid-based drug delivery systems for reducing the fed/fasted variations of ziprasidone in vitro.
Topics: Administration, Oral; Biological Availability; Chemistry, Pharmaceutical; Drug Carriers; Drug Delivery Systems; Drug Stability; Emulsions; Fasting; Humans; Lipids; Nanoparticles; Piperazines; Polysorbates; Silicon Dioxide; Solubility; Thiazoles; Water | 2016 |
Effectiveness of switching from oral ziprasidone to risperidone in a patient with comorbid autistic disorder, profound intellectual disability, Gilbert syndrome, and exacerbation of psychosis.
Topics: Adult; Antipsychotic Agents; Autistic Disorder; Comorbidity; Gilbert Disease; Humans; Intellectual Disability; Male; Piperazines; Psychotic Disorders; Risperidone; Thiazoles | 2016 |
Did FDA Decisionmaking Affect Anti-Psychotic Drug Prescribing in Children?: A Time-Trend Analysis.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Child; Decision Making; Drug Approval; Drug Prescriptions; Female; Humans; Male; Middle Aged; Olanzapine; Pediatrics; Piperazines; Quetiapine Fumarate; Schizophrenia; Thiazoles; United States; United States Food and Drug Administration | 2016 |
Clozapine and olanzapine are better antioxidants than haloperidol, quetiapine, risperidone and ziprasidone in in vitro models.
Topics: Antioxidants; Antipsychotic Agents; Benzodiazepines; Biphenyl Compounds; Clozapine; Free Radical Scavengers; Haloperidol; Humans; Models, Biological; Neutrophil Activation; Neutrophils; Olanzapine; Picrates; Piperazines; Quetiapine Fumarate; Reactive Oxygen Species; Risperidone; Tetradecanoylphorbol Acetate; Thiazoles | 2016 |
A Case of Sleepwalking With Sleep-Related Eating Associated With Ziprasidone Therapy in a Patient With Schizoaffective Disorder.
Topics: Adult; Antipsychotic Agents; Feeding and Eating Disorders; Humans; Male; Parasomnias; Piperazines; Psychotic Disorders; Somnambulism; Thiazoles | 2016 |
Effects of antipsychotic drug administration on antioxidative defense enzymes in male rat kidney.
Topics: Animals; Antioxidants; Antipsychotic Agents; Clozapine; Imidazoles; Indoles; Kidney; Male; Oxidative Stress; Piperazines; Random Allocation; Rats; Rats, Wistar; Thiazoles | 2016 |
A pharmacological mouse model suggests a novel risk pathway for postpartum psychosis.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Coumarins; Disease Models, Animal; Female; Gene Expression; Mice; Mice, Inbred C57BL; Piperazines; Psychotic Disorders; Puerperal Disorders; Steryl-Sulfatase; Sulfonamides; Thiazoles | 2016 |
Development of a Web-Based Clinical Decision Support System for Drug Prescription: Non-Interventional Naturalistic Description of the Antipsychotic Prescription Patterns in 4345 Outpatients and Future Applications.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Community Mental Health Centers; Decision Support Systems, Clinical; Drug Prescriptions; Female; Humans; Inappropriate Prescribing; Internet; Male; Middle Aged; Outpatients; Paliperidone Palmitate; Piperazines; Schizophrenia; Thiazoles; Young Adult | 2016 |
Context-dependent efficacy of a counter-conditioning strategy with atypical neuroleptic drugs in mice previously sensitized to cocaine.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Cocaine; Conditioning, Operant; Dopamine Uptake Inhibitors; Exploratory Behavior; Hyperkinesis; Locomotion; Male; Mice; Piperazines; Statistics, Nonparametric; Thiazoles | 2017 |
Ziprasidone-induced sub acute cutaneous lupus erythematosus.
Topics: Aged, 80 and over; Autoantibodies; Female; Humans; Lupus Erythematosus, Cutaneous; Piperazines; Skin; Thiazoles | 2017 |
Ziprasidone induces cytotoxicity and genotoxicity in human peripheral lymphocytes.
Topics: Activation, Metabolic; Adult; Antipsychotic Agents; Cell Nucleus Division; Cell Proliferation; Cells, Cultured; Chromosome Aberrations; Dopamine Antagonists; Female; Humans; Lymphocytes; Male; Micronucleus Tests; Microsomes, Liver; Mitotic Index; Mutagenicity Tests; Mutagens; Piperazines; Serotonin Antagonists; Sister Chromatid Exchange; Thiazoles | 2017 |
Kounis syndrome and ziprasidone.
Topics: Acute Coronary Syndrome; Adult; Antipsychotic Agents; Bipolar Disorder; Drug Hypersensitivity; Emergency Service, Hospital; Humans; Male; Piperazines; Suicidal Ideation; Syndrome; Thiazoles | 2017 |
Serotonergic Synergy in the Pharmacotherapy of Acute Posttraumatic Stress Disorder Exacerbation: A Case Report.
Topics: Adult; Antipsychotic Agents; Drug Synergism; Fear; Histamine H1 Antagonists; Humans; Hydroxyzine; Male; Piperazines; Propranolol; Serotonin Agents; Stress Disorders, Post-Traumatic; Suicidal Ideation; Thiazoles; Vasodilator Agents | 2017 |
Development of a UPLC-MS/MS method for routine therapeutic drug monitoring of aripiprazole, amisulpride, olanzapine, paliperidone and ziprasidone with a discussion of their therapeutic reference ranges for Chinese patients.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; China; Chromatography, High Pressure Liquid; Drug Monitoring; Female; Humans; Limit of Detection; Male; Middle Aged; Olanzapine; Paliperidone Palmitate; Piperazines; Reference Values; Tandem Mass Spectrometry; Thiazoles; Young Adult | 2017 |
Real-world adherence assessment of lurasidone and other oral atypical antipsychotics among patients with schizophrenia: an administrative claims analysis.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Female; Humans; Insurance Claim Review; Lurasidone Hydrochloride; Male; Medicaid; Medication Adherence; Middle Aged; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; United States | 2017 |
Intramuscular Ziprasidone Dosing for Acute Agitation in the Pediatric Emergency Department: An Observational Study.
Topics: Adolescent; Antipsychotic Agents; Child; Dose-Response Relationship, Drug; Emergency Service, Hospital; Female; Humans; Injections, Intramuscular; Male; Piperazines; Psychomotor Agitation; Retrospective Studies; Thiazoles | 2018 |
A neuroimaging study of emotion-cognition interaction in schizophrenia: the effect of ziprasidone treatment.
Topics: Adolescent; Adult; Antipsychotic Agents; Brain Mapping; Cognition; Emotions; Female; Gray Matter; Humans; Magnetic Resonance Imaging; Male; Neuroimaging; Piperazines; Prefrontal Cortex; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Thiazoles; White Matter; Young Adult | 2017 |
The impact of gastric pH, volume, and emptying on the food effect of ziprasidone oral absorption.
Topics: Administration, Oral; Antipsychotic Agents; Dietary Fats; Energy Intake; Food-Drug Interactions; Gastric Emptying; Gastric Mucosa; Humans; Hydrogen-Ion Concentration; Piperazines; Thiazoles | 2017 |
[Psychosis, Intoxication or Serotonin Syndrome? - A 20-Year Old Male with Ziprasidone und Sertraline].
Topics: Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Lorazepam; Male; Piperazines; Psychotropic Drugs; Schizophrenia, Paranoid; Schizophrenic Psychology; Serotonin Syndrome; Sertraline; Substance-Related Disorders; Thiazoles; Young Adult | 2017 |
Effects of haloperidol, olanzapine, ziprasidone, and PHA-543613 on spatial learning and memory in the Morris water maze test in naïve and MK-801-treated mice.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Bridged Bicyclo Compounds, Heterocyclic; Disease Models, Animal; Haloperidol; Male; Maze Learning; Memory; Mice; Mice, Inbred C57BL; Olanzapine; Piperazines; Quinuclidines; Schizophrenia; Spatial Learning; Thiazoles; Treatment Outcome | 2017 |
Impact of Ketamine Use on Adjunctive Analgesic and Sedative Medications in Critically Ill Trauma Patients.
Topics: Adult; Analgesics; Analgesics, Opioid; Critical Illness; Dexmedetomidine; Drug Utilization; Female; Humans; Hypnotics and Sedatives; Infusions, Intravenous; Ketamine; Male; Middle Aged; Piperazines; Respiration, Artificial; Retrospective Studies; Thiazoles; Time Factors; Wounds and Injuries | 2017 |
Ziprasidone, a second-generation antipsychotic drug, triggers a macrophage inflammatory response in vitro.
Topics: Animals; Antipsychotic Agents; Biomarkers; Cell Cycle; Cytokines; Inflammation; Macrophages; Mice; Oxidation-Reduction; Piperazines; RAW 264.7 Cells; Thiazoles | 2018 |
Comparative effects of aripiprazole and selected antipsychotic drugs on lipid peroxidation in plasma.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Blood; Clozapine; Female; Humans; Lipid Peroxidation; Male; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Thiazoles; Thiobarbituric Acid Reactive Substances; Young Adult | 2018 |
Computationally Assessing the Bioactivation of Drugs by N-Dealkylation.
Topics: Aldehydes; Amines; Dealkylation; Humans; Indinavir; Liver; Microsomes, Liver; Models, Molecular; Molecular Structure; Piperacillin; Piperazines; Thiazoles; Verapamil | 2018 |
Psychotropic Pharmacotherapy Associated With QT Prolongation Among Veterans With Posttraumatic Stress Disorder.
Topics: Adult; Aged; Aged, 80 and over; Amitriptyline; Arrhythmias, Cardiac; Buspirone; Female; Humans; Male; Methadone; Middle Aged; Piperazines; Psychotropic Drugs; Quetiapine Fumarate; Sotalol; Stress Disorders, Post-Traumatic; Thiazoles; Veterans; Young Adult | 2018 |
Continuation of Atypical Antipsychotic Medication During Early Pregnancy and the Risk of Gestational Diabetes.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Diabetes, Gestational; Female; Humans; Olanzapine; Piperazines; Pregnancy; Pregnancy Complications; Psychotic Disorders; Quetiapine Fumarate; Risk Factors; Risperidone; Thiazoles; Young Adult | 2018 |
Nanocrystal-silica-lipid hybrid particles for the improved oral delivery of ziprasidone in vitro.
Topics: Administration, Oral; Biological Availability; Chemistry, Pharmaceutical; Drug Carriers; Drug Liberation; Freeze Drying; Lipid Droplets; Lipids; Microscopy, Electron, Scanning; Nanoparticles; Piperazines; Silicon Dioxide; Solubility; Thiazoles; Water | 2018 |
Intramuscular Midazolam, Olanzapine, Ziprasidone, or Haloperidol for Treating Acute Agitation in the Emergency Department.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Cohort Studies; Emergency Medical Services; Female; Haloperidol; Humans; Injections, Intramuscular; Male; Mental Status and Dementia Tests; Midazolam; Middle Aged; Olanzapine; Piperazines; Prospective Studies; Psychomotor Agitation; Thiazoles; Treatment Outcome; Young Adult | 2018 |
Ziprasidone for the Treatment of Stuttering.
Topics: Adult; Antipsychotic Agents; Humans; Male; Piperazines; Stuttering; Thiazoles | 2018 |
Ethics and Regulatory Barriers to Research in Emergency Settings.
Topics: Emergency Service, Hospital; Haloperidol; Midazolam; Olanzapine; Piperazines; Thiazoles | 2018 |
Clozapine, ziprasidone, and sertindole-induced morphological changes in the rat heart and their relationship to antioxidant enzymes function.
Topics: Animals; Antioxidants; Antipsychotic Agents; Clozapine; Heart; Imidazoles; Indoles; Male; Myocardium; Oxidation-Reduction; Piperazines; Rats; Rats, Wistar; Thiazoles | 2018 |
In Vitro Drug-Drug Interaction Potential of Sulfoxide and/or Sulfone Metabolites of Albendazole, Triclabendazole , Aldicarb, Methiocarb, Montelukast and Ziprasidone.
Topics: Acetates; Albendazole; Aldicarb; Biotransformation; Cyclopropanes; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Interactions; Humans; Isoenzymes; Methiocarb; Microsomes, Liver; Piperazines; Quinolines; Risk Assessment; Sulfides; Sulfones; Sulfoxides; Thiazoles; Triclabendazole | 2018 |
Ultra-performance liquid chromatography tandem mass spectrometry for the rapid, simultaneous analysis of ziprasidone and its impurities.
Topics: Chromatography, High Pressure Liquid; Drug Contamination; Least-Squares Analysis; Limit of Detection; Piperazines; Reproducibility of Results; Tandem Mass Spectrometry; Thiazoles | 2019 |
Dopamine Antagonists in ICU Delirium.
Topics: Critical Illness; Delirium; Dopamine Antagonists; Haloperidol; Humans; Intensive Care Units; Piperazines; Thiazoles | 2018 |
Toxic Myopathy due to Antidopaminergic Medication Without Neuroleptic Malignant Syndrome.
Topics: Adult; Creatine Kinase; Dopamine Antagonists; Humans; Male; Muscle, Skeletal; Muscular Diseases; Obsessive-Compulsive Disorder; Piperazines; Thiazoles; Tourette Syndrome | 2018 |
The Influence of a Xanthine-Catechin Chemical Matrix on in vitro Macrophage-Activation Triggered by Antipsychotic Ziprasidone.
Topics: Animals; Antipsychotic Agents; Caffeine; Catechin; Cell Proliferation; Complex Mixtures; Inflammation; Macrophage Activation; Macrophages; Mice; Oxidative Stress; Paullinia; Piperazines; RAW 264.7 Cells; Theobromine; Thiazoles; Xanthine | 2019 |
A Combined Utilization of Plasdone-S630 and HPMCAS-HF in Ziprasidone Hydrochloride Solid Dispersion by Hot-Melt Extrusion to Enhance the Oral Bioavailability and No Food Effect.
Topics: Administration, Oral; Animals; Biological Availability; Dogs; Drug Combinations; Fasting; Methylcellulose; Pharmaceutic Aids; Piperazines; Povidone; Solubility; Spectroscopy, Fourier Transform Infrared; Thiazoles; X-Ray Diffraction | 2019 |
Physiologically-based pharmacokinetics of ziprasidone in pregnant women.
Topics: Adult; Age Factors; Aged; Antipsychotic Agents; Area Under Curve; Caco-2 Cells; Child; Computer Simulation; Dose-Response Relationship, Drug; Drug Dosage Calculations; Female; Healthy Volunteers; Humans; Mental Disorders; Models, Biological; Piperazines; Pregnancy; Pregnancy Complications; Thiazoles | 2019 |
Ziprasidone-loaded arabic gum modified montmorillonite-tailor-made pectin based gastroretentive composites.
Topics: Adhesiveness; Adsorption; Bentonite; Drug Carriers; Drug Liberation; Gastric Mucosa; Gum Arabic; Pectins; Piperazines; Surface Properties; Thiazoles | 2019 |
Intramuscular Midazolam, Olanzapine, Ziprasidone, or Haloperidol for Treating Acute Agitation.
Topics: Emergency Service, Hospital; Haloperidol; Midazolam; Olanzapine; Piperazines; Thiazoles | 2019 |
In reply.
Topics: Emergency Service, Hospital; Haloperidol; Midazolam; Olanzapine; Piperazines; Thiazoles | 2019 |
Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness.
Topics: Critical Illness; Delirium; Haloperidol; Humans; Piperazines; Thiazoles | 2019 |
Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness.
Topics: Critical Illness; Delirium; Haloperidol; Humans; Piperazines; Thiazoles | 2019 |
Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness.
Topics: Critical Illness; Delirium; Haloperidol; Humans; Piperazines; Thiazoles | 2019 |
Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness. Reply.
Topics: Critical Illness; Delirium; Haloperidol; Humans; Piperazines; Thiazoles | 2019 |
Acute Agitation and the Exception From Informed Consent Requirements.
Topics: Emergency Service, Hospital; Haloperidol; Informed Consent; Midazolam; Olanzapine; Piperazines; Thiazoles | 2019 |
In reply.
Topics: Emergency Service, Hospital; Haloperidol; Midazolam; Olanzapine; Piperazines; Thiazoles | 2019 |
In reply.
Topics: Emergency Service, Hospital; Haloperidol; Midazolam; Olanzapine; Piperazines; Thiazoles | 2019 |
Opposite clozapine and ziprasidone effects on the reactivity of plasma albumin SH-group are the consequence of their different binding properties dependent on protein fatty acids content.
Topics: Animals; Clozapine; Fatty Acids; Humans; Male; Piperazines; Protein Binding; Rats; Rats, Wistar; Serum Albumin; Spectrometry, Fluorescence; Spectrophotometry; Sulfhydryl Compounds; Thiazoles | 2019 |
[Additive therapies : Intensive care studies from 2018-2019].
Topics: Critical Care; Critical Illness; Delirium; Haloperidol; Humans; Piperazines; Thiazoles | 2020 |
Sustained Release Ziprasidone Microparticles Prepared by Spray Drying with Soluplus® and Ethyl Cellulose to Eliminate Food Effect and Enhance Bioavailability.
Topics: Animals; Antipsychotic Agents; Biological Availability; Cellulose; Delayed-Action Preparations; Dogs; Food-Drug Interactions; Piperazines; Polyethylene Glycols; Polyvinyls; Solubility; Thiazoles | 2019 |
Royal Eschizophilia. Genealogical delusion or Mignon delusion as a pathoplastic realization.
Topics: Age Factors; Antipsychotic Agents; Carbamazepine; Delusions; Disease Progression; Fellowships and Scholarships; Female; Genealogy and Heraldry; Hallucinations; Humans; Middle Aged; Paliperidone Palmitate; Piperazines; Risperidone; Thiazoles; Time Factors | 2019 |
Health Care Cost in Patients With Schizophrenia Treated With Brexpiprazole Versus Other Oral Atypical Antipsychotic Therapy.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Aripiprazole; Female; Health Care Costs; Hospitalization; Humans; Lurasidone Hydrochloride; Male; Medicaid; Medicare; Middle Aged; Olanzapine; Paliperidone Palmitate; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Thiazoles; Thiophenes; United States | 2020 |
When Green Becomes Mean: Green Tea Extract Reduces Ziprasidone's Effect and Causes Psychosis.
Topics: Antipsychotic Agents; Food-Drug Interactions; Humans; Male; Piperazines; Psychoses, Substance-Induced; Schizophrenia; Tea; Thiazoles; Young Adult | 2020 |
New onset metabolic derangement in a pediatric patient receiving therapeutic plasma exchange for anti-NMDA receptor encephalitis.
Topics: Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Antipsychotic Agents; Child; Dyslipidemias; Female; Humans; Piperazines; Plasma Exchange; Plasmapheresis; Receptors, N-Methyl-D-Aspartate; Thiazoles | 2020 |
Development of Nanocrystal Ziprasidone Orally Disintegrating Tablets: Optimization by Using Design of Experiment and In Vitro Evaluation.
Topics: Administration, Oral; Caco-2 Cells; Humans; Hydrogen-Ion Concentration; Nanoparticles; Permeability; Piperazines; Solubility; Tablets; Thiazoles | 2020 |
[Electroconvulsive Therapy - A beneficial and well tolerated therapy in children and adolescents with schizophrenia].
Topics: Adolescent; Catatonia; Child; Clozapine; Combined Modality Therapy; Electroconvulsive Therapy; Humans; Piperazines; Schizophrenia; Thiazoles; Treatment Outcome | 2020 |
Parenteral Sustained Release Lipid Phase-Transition System of Ziprasidone: Fabrication and Evaluation for Schizophrenia Therapy.
Topics: Animals; Antipsychotic Agents; Delayed-Action Preparations; Lipids; Male; Piperazines; Rats; Rats, Sprague-Dawley; Schizophrenia; Thiazoles | 2020 |
Ziprasidone, a second-generation antipsychotic, affects core clock gene mRNA expression in mice.
Topics: Amygdala; Animals; Antipsychotic Agents; ARNTL Transcription Factors; Biological Clocks; Gene Expression; Gene Expression Regulation; Hippocampus; Light; Male; Mice, Inbred C57BL; Period Circadian Proteins; Piperazines; RNA, Messenger; Thiazoles | 2020 |
The inhibitory effect of ziprasidone on voltage-dependent K
Topics: Animals; Antipsychotic Agents; Cells, Cultured; Coronary Vessels; Myocytes, Smooth Muscle; Patch-Clamp Techniques; Piperazines; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Rabbits; Thiazoles | 2020 |
Identification and Quantification of Antipsychotics in Blood Samples by LC-MS-MS: Case Reports and Data from Three Years of Routine Analysis.
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chromatography, Liquid; Clozapine; Dibenzothiazepines; Female; Forensic Toxicology; Humans; Male; Olanzapine; Paliperidone Palmitate; Piperazines; Quetiapine Fumarate; Retrospective Studies; Risperidone; Schizophrenia; Substance Abuse Detection; Suicide; Sulpiride; Tandem Mass Spectrometry; Thiazoles | 2020 |
Atypical Antipsychotic Drug Ziprasidone Protects against Rotenone-Induced Neurotoxicity: An In Vitro Study.
Topics: Animals; Antioxidants; Antipsychotic Agents; Apoptosis; Cell Death; Cell Nucleus; Cell Survival; Cytoplasm; Mice; Mitochondrial Diseases; Nerve Growth Factor; Neuroprotective Agents; NF-E2-Related Factor 2; Oxidative Stress; PC12 Cells; Piperazines; Rats; Reactive Oxygen Species; Receptor, Serotonin, 5-HT1A; Rotenone; Thiazoles | 2020 |
Neuroleptic Malignant Syndrome: A Potential Etiology of Multisystem Organ Failure in a Burn Patient.
Topics: Accidents, Occupational; Acute Coronary Syndrome; Adult; Antipsychotic Agents; Bipolar Disorder; Body Surface Area; Burns, Chemical; Calcium; Creatine Kinase; Humans; Hypocalcemia; Male; Multiple Organ Failure; Neuroleptic Malignant Syndrome; Piperazines; Tachycardia, Ventricular; Thiazoles; Troponin | 2022 |
Effects of several atypical antipsychotics closapine, sertindole or ziprasidone on hepatic antioxidant enzymes: Possible role in drug-induced liver dysfunction.
Topics: Animals; Antioxidants; Antipsychotic Agents; Clozapine; Imidazoles; Indoles; Liver; Liver Diseases; Male; Piperazines; Rats; Rats, Wistar; Thiazoles | 2021 |
Case Report: Ziprasidone induced neuroleptic malignant syndrome.
Topics: Antipsychotic Agents; Humans; Neuroleptic Malignant Syndrome; Piperazines; Thiazoles | 2021 |
Successful Ziprasidone Treatment for Resistant Attention-Deficit/Hyperactivity Disorder and Provisional Motor Tic Disorder.
Topics: Attention Deficit Disorder with Hyperactivity; Comorbidity; Humans; Methylphenidate; Piperazines; Thiazoles; Tic Disorders | 2022 |
Use of Physiologically Based Pharmacokinetic Modeling for Predicting Drug-Food Interactions: Recommendations for Improving Predictive Performance of Low Confidence Food Effect Models.
Topics: Administration, Oral; Area Under Curve; Benzilates; Biological Availability; Computer Simulation; Food-Drug Interactions; Gastric Emptying; Healthy Volunteers; Humans; Indazoles; Intestinal Absorption; Models, Biological; Nortropanes; Piperazines; Pyrimidines; Solubility; Sulfonamides; Thiazoles | 2021 |
The Influence of Substance Use on Side Effects of Olanzapine, Quetiapine, Risperidone, and Ziprasidone in Psychosis.
Topics: Adult; Benzodiazepines; Female; Humans; Male; Olanzapine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Substance-Related Disorders; Thiazoles | 2021 |
Identification of Novel Impurity of Ziprasidone.
Topics: Chromatography, High Pressure Liquid; Drug Contamination; Piperazines; Thiazoles | 2022 |
Ziprasidone suppresses pancreatic adenocarcinoma cell proliferation by targeting GOT1 to trigger glutamine metabolism reprogramming.
Topics: Adenocarcinoma; Aspartate Aminotransferase, Cytoplasmic; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Glutamine; Humans; Pancreatic Neoplasms; Piperazines; Thiazoles | 2022 |
Can pediatric bipolar disorder be successfully treated when comorbid with conduct disorder? A secondary analysis of clinical trials of risperidone, olanzapine, quetiapine, ziprasidone, and aripiprazole.
Topics: Adolescent; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Child; Clinical Trials as Topic; Conduct Disorder; Humans; Mania; Olanzapine; Piperazines; Prospective Studies; Quetiapine Fumarate; Risperidone; Thiazoles | 2022 |
The safety and efficacy of sequential intramuscular/oral ziprasidone treatment of acute episode in patients with schizophrenia: a multicenter, open-labeled study.
Topics: Antipsychotic Agents; Humans; Injections, Intramuscular; Piperazines; Psychiatric Status Rating Scales; Schizophrenia; Thiazoles; Treatment Outcome | 2023 |